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Cindy  M.  Barbosa  Nuñez  
  
Resurgent  sodium  current  modulation  by  auxiliary  subunits  in  dorsal  root  ganglia  
neurons  and  potential  implications  in  pain  pathologies.  
  
Increased  electrical  activity  in  peripheral  sensory  neurons  contributes  to  
pain.  A  unique  type  of  sodium  current,  fast  resurgent  current,  is  proposed  to  
increase  nerve  activity  and  has  been  associated  with  pain  pathologies.  While  
sodium  channel  isoform  Nav1.6  has  been  identified  as  the  main  carrier  of  fast  
resurgent  currents,  our  understanding  of  how  resurgent  currents  are  modulated  
in  sensory  neurons  is  fairly  limited.  Thus  the  goal  of  this  dissertation  was  to  
identify  resurgent  current  modulators.  In  particular,  we  focused  on  sodium  
channel  beta  subunits  (Navβs)  and  fibroblast  growth  factor  homologous  factors  
(FHFs)  in  dorsal  root  ganglion  (DRG)  neurons.  We  hypothesized  that  Navβ4  and  
FHF2B  act  as  positive  regulators  by  mediating  resurgent  currents  and  modulating  
Nav1.6  inactivation,  respectively.  In  contrast,  we  hypothesized  FHF2A  negatively  
regulates  resurgent  current  by  increasing  the  probability  of  channels  in  
inactivated  states.  Thus,  the  aims  of  this  dissertation  were  to  1)  determine  if  
Navβ4  regulates  fast  resurgent  currents  in  DRG  neurons,  2)  examine  the  effects  
of  Navβ4  knockdown  on  resurgent  currents,  firing  frequency  and  pain  associated  
behavior  in  an  inflammatory  pain  model  and  3)  determine  if  FHF2A  and  FHF2B  
functionally  regulate  Nav1.6  currents,  including  resurgent  currents  in  DRG  
neurons.  To  examine  the  aims,  we  used  biochemical,  electrophysiological  and  
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behavioral  assays.  Our  results  suggest  that  Navβ4  is  a  positive  regulator  of  
resurgent  currents:  in  particular,  the  C-­terminus  likely  mediates  these  currents.  
Localized  knockdown  of  Navβ4  decreased  inflammation-­induced  enhancement  of  
resurgent  currents  and  neuronal  excitability,  and  prevented  the  development  of  
persistent  pain  associated  behavior  in  an  inflammatory  pain  model.  FHF2B  
increased  resurgent  currents  and  delayed  inactivation.  In  contrast,  FHF2A  limited  
resurgent  currents;;  an  effect  that  is  mainly  contributed  by  FHF2A’s  N-­terminus  
activity  that  increased  accumulation  of  channels  in  inactivated  states.  
Interestingly,  in  an  inflammatory  pain  model  FHF2B  was  upregulated  and  FHFA  
isoforms  were  downregulated.  Together  these  results  suggest  that  FHF2A/B  
modulation  might  contribute  to  enhanced  resurgent  currents  and  increased  
neuronal  excitability  observed  in  the  inflammatory  pain  model.  Overall,  our  work  
has  identified  three  resurgent  current  modulators  FHF2A,  FHF2B  and  Navβ4.  
Manipulation  of  these  proteins  or  their  activity  might  result  in  novel  strategies  for  
the  study  and  treatment  of  pain.    
  
Theodore  R.  Cummins,  Ph.D.,  Chair  
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Pain  is  one  of  the  prevalent  reasons  why  people  in  the  United  States  seek  
medical  care.  According  to  the  National  Center  for  Health  Statistics,  around  76.2  
million  people  experience  persistent  pain  (1).  A  third  of  these  people  who  
experience  pain  find  that  it  is  so  significant  that  it  impacts  their  daily  routine  (2).  
One  of  the  main  problems  faced  in  pain  management,  especially  management  of  
persistent  pain,  is  that  the  available  therapeutics  either  are  ineffective  or  have  
unwanted  side  effects  (1).  Such  a  high  incidence  of  pain  and  inadequate  relief  
creates  a  need  for  the  development  of  new  therapeutics.  
  
Peripheral  sensory  neurons  are  an  important  component  of  the  neuronal  
network  that  processes  pain  sensations.  In  mammals,  these  neurons  are  
pseudounipolar  neurons,  possessing  one  axon  that  sends  branches  into  two  
areas:  one  to  the  periphery  (e.g.,  skin,  muscle,  internal  organs)  and  the  other  to  
the  spinal  cord  &  brainstem  of  the  central  nervous  system  (CNS).  The  peripheral  
branch  can  detect  changes  in  mechanical,  thermal  or  chemical  input  and  relay  
the  information  through  the  branch  that  projects  to  the  CNS.  Typically,  when  a  
noxious  stimulus  is  encountered,  “pain-­sensing”  peripheral  sensory  neurons  or  
nociceptors  are  activated  (3).  Alterations  in  the  signaling  process  that  relays  
painful  stimuli  to  the  CNS  (i.e.  nociception)  are  a  common  mechanism  in  pain  
   2  
pathologies.  In  particular,  increased  firing  of  nociceptors  in  dorsal  root  ganglia  
(DRG)  and  trigeminal  ganglia  (TG)  often  results  in  increased  pain  (4-­7).    
  
Voltage-­gated  ion  channels  contribute  to  the  excitability  of  sensory  
neurons.  In  particular,  voltage-­gated  sodium  channels  (VGSCs  or  Nav)  are  
classically  viewed  to  generate  the  rising  phase  of  the  action  potential  (AP).  There  
is  strong  evidence  from  genetic  and  pain  model  studies  that  support  the  
functional  relevance  of  VGSCs  in  pain  sensations  (8-­12).  For  example,  in  
humans  and  mice  loss-­of-­function  of  the  VGSC  isoform,  Nav1.7,  is  associated  
with  congenital  indifference  to  pain.  Furthermore,  alterations  to  the  activity  of  
other  VGSC  isoforms  such  as  Nav1.3,  Nav1.6,  Nav1.8  and  Nav1.9  have  also  
been  associated  with  pain  pathologies  (13-­16).  This  evidence  suggests  that  
inhibition  of  specific  VGSC  isoforms  or  selective  blockade  of  altered  activity  may  
provide  new  therapeutic  strategies  for  pain.  In  particular,  specific  patterns  or  
modes  of  sodium  current  activity  are  likely  to  be  important  in  the  perception  of  
noxious  stimulus  (i.e.,  nociception)  and  the  transmission  of  pain  sensations.  A  
novel  target  for  altered  activity  in  VGSC  that  has  emerged  is  resurgent  sodium  
current.    
  
Resurgent  currents,  an  atypical  VGSC  current,  are  thought  to  increase  the  
firing  frequency  of  neurons  by  providing  a  depolarizing  drive  at  repolarizing  
voltages  (17-­19).  Increased  resurgent  currents  in  sensory  neurons  have  been  
implicated  in  paroxysmal  extreme  pain  disorder  (PEPD),  sea  anemone  toxin  
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ATX-­II  induced  pain,  and  oxaliplatin  acute  cooling-­aggravated  painful  neuropathy  
(19-­26).  Under  baseline  physiological  conditions,  resurgent  currents  are  
observed  in  a  subpopulation  of  DRG  neurons  where  the  major  contributing  
isoform  is  Nav1.6  (27).  Nav1.6  has  been  implicated  in  inflammatory  and  
neuropathic  pain  models  since  knockdown  of  Nav1.6  blocks  the  development  of  
persistent  pain  associated  behaviors  and  increased  activity  of  sensory  neurons  
(14,  15).  Together  these  findings  suggest  that  targeting  resurgent  currents  may  
provide  novel  strategies  for  pain  therapeutics.  However,  our  understanding  of  
how  resurgent  currents  are  modulated  in  peripheral  sensory  neurons  is  limited.  
Thus,  the  main  goal  of  this  dissertation  was  to  identify  potential  modulators  of  
resurgent  currents.    In  particular,  we  focused  on  the  modulation  of  Nav1.6-­
mediated  currents  by  auxiliary  subunits  such  as  beta  subunits  and  fibroblast  
growth  factor  homologous  factors  (FHF).    
  
Brief  history  of  voltage-­gated  sodium  channels  
  
   Our  current  knowledge  of  VGSC  was  spearheaded  by  the  work  of  Hodgkin  
and  Huxley  in  the  1950s  (28-­31).  Hodgkin  and  Huxley  conducted  a  series  of  
experiments  using  the  voltage  clamp  technique  (32,  33),  which  enabled  them  to  
“clamp”  the  membrane  of  the  squid  giant  axon  at  a  specific  voltage  and  examine  
the  ionic  currents  that  contributed  to  the  generation  of  the  action  potential.  They  
identified  three  main  ionic  currents:  sodium,  potassium  and  a  small  leak  current  
(which  included  Cl-­).  Upon  depolarization  the  sodium  conductance  was  
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transiently  activated,  whereas,  the  potassium  conductance  slowly  activated.  
Returning  to  the  initial  resting  membrane  potential  terminated  both  sodium  and  
potassium  conductances.  Based  on  their  findings,  they  proposed  a  mathematical  
model  in  which  the  ionic  conductance  was  dependent  on  the  ion’s  permeability  
and  electrochemical  gradient  (34).  Additionally,  they  introduced  a  novel  concept  
of  regulation  for  the  sodium  and  potassium  conductances  by  charged  particles  
that  acted  as  gates.  Movement  of  these  gates  was  dependent  on  the  membrane  
potential  (i.e.,  voltage-­gated)  and  time.  Therefore,  based  on  their  model,  sodium  
currents  contributed  to  the  rising  phase  of  the  action  potential,  whereas  sodium  
current  inactivation  coupled  with  potassium  current  activation  contributed  to  the  
downward  phase  of  the  action  potential.  
  
Years  later,  it  was  discovered  that  toxins  derived  from  pufferfish  and  
shellfish  selectively  inhibited  sodium  currents  (35-­39).  In  contrast,  the  quaternary  
ammonium  cation,  tetraethylammonium  ion  (TEA),  selectively  inhibited  
potassium  currents  (37,  38,  40,  41).  These  experiments  confirmed  that  sodium  
and  potassium  currents  were  generated  by  specific  channels  or  receptors  which  
Hogdkin  and  Huxley  eluded  to  as  “particles  occupying  the  membrane”  (34).  
During  the  1960-­70s,  several  functional  properties  of  “sodium  receptors”  were  
elucidated  giving  birth  to  new  conceptual  models  for  an  ion  selectivity  filter,  pore  
structure  of  the  channel,  and  activation  and  inactivation  gates  (42-­48).  However,  
the  actual  VGSC  protein  was  not  identified  until  the  1980s,  when  the  subunits  of  
VGSC  were  purified  from  brain  tissue.  These  studies  revealed  a  multimeric  
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complex  composed  of  large  alpha  (α)-­subunits  associated  with  smaller  beta  (β)-­
subunits  (49-­51).  It  was  during  this  time  that  a  major  breakthrough  was  achieved,  
the  first  sodium  channel  α  subunit  was  cloned  (52,  53).  Expression  of  the  α  
subunit  was  sufficient  to  produce  a  functional  channel.  Together,  cloning  of  
VGSC  subunits  and  the  advancement  of  high  resolution  patch  clamp  techniques,  
propelled  the  study  of  VGSCs  (54,  55).  
  
Voltage-­gated  sodium  channel  
  
   VGSCs  are  transmembrane  proteins  that  selectively  mediate  the  inward  
flow  of  sodium  ions  generating  the  rapid  upstroke  of  the  AP  (56).  Nine  α  subunit  
genes  that  encode  VGSC  isoforms  (Nav1.1  -­  Nav1.9)  have  been  identified  in  
mammals.  The  overall  structure  of  the  nine  α  subunit  isoforms  is  highly  
conserved  as  a  single  polypeptide  sequence  (~2,000  amino  acids)  organized  into  
four  homologous  domains  (DI-­DIV)  each  with  six  transmembrane  segments  (S1  -­
S6;;  Figure  1A).  The  α  subunit  folds  into  a  pseudotetrameric  tridimensional  
structure  in  which  S5/6  segments  within  each  domain  form  an  aqueous  pore  
module  selectively  permeable  to  sodium  ions.  The  S1-­4  segments  form  the  
voltage  sensor  domain  arranged  around  the  pore  module.  In  particular,  S4  within  
each  domain  contains  positive  residues  sensitive  to  changes  in  membrane  
potential  and  movement  of  the  voltage  sensors  produces  conformational  
changes  in  the  protein  structure  (53,  57,  58).  In  this  manner,  VGSCs  change  
between  conformations  that  either  conduct  sodium  ions  (open  state)  or  are  
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nonconducting  (inactive  states  and  closed  states).  Classically,  sodium  currents  
are  generated  when  the  membrane  is  depolarized  and  channels  become  
activated  or  open.  Sodium  currents  are  then  terminated  by  channel  inactivation  
(Figure  1B-­C).  There  are  different  modes  of  inactivation  and  these  are  discussed  
below.  The  most  common  mode  of  inactivation  is  fast  inactivation  which  is  
mediated  by  the  cytoplasmic  linker  between  DIII-­DIV.  In  particular,  the  IFM  
(Isoleucine-­Phenylalanine-­Methionine  represented  as  the  inactivation  particle  in  
Figure  1)  motif  within  this  linker  is  essential  (59).    Movement  of  the  inactivation  
particle  occludes  the  pore  as  a  hinged  lid  by  interacting  with  a  putative  receptor  
in  the  VGSC  structure  (60).  Once  inactivated,  VGSCs  become  refractory  and  
require  repolarization  of  the  membrane  to  recover  before  they  are  available  again  
(61).    
  
Many  of  the  α  subunits  have  developmental  and  tissue  specific  
distributions  (62).  For  example,  Nav1.4  is  predominantly  expressed  in  skeletal  
muscle  (63).  In  contrast,  Nav1.5  is  predominantly  in  cardiac  tissue  (64).  Nav1.3  is  
predominantly  expressed  immature  neurons  and  downregulated  in  mature  
neurons  (65).  Nav1.7,  Nav1.8  and  Nav1.9  are  predominantly  expressed  in  the  
peripheral  nervous  system  (PNS).  In  contrast,  in  mature  CNS  neurons  the  
predominant  isoforms  are  Nav1.1,  Nav1.2  and  Nav1.6,  however  Nav1.1  and  
Nav1.6  are  also  expressed  in  PNS  (66,  67).  
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Figure  1:  Structure  and  function  of  VGSC.  A,  Linear  Representation  of  VGSC  α  subunit.  
Regions  highlighted  in  blue  represent  the  regions  between  S5  and  S6  that  yield  the  aqueous  pore  
module  selectively  permeable  to  sodium.  B,  Cross-­sectional  representation  of  VGSC  
conformational  changes  in  response  to  changes  in  membrane  potential.  C,  Representative  trace  
of  whole  cell  patch  clamp  recording  of  sodium  current  upon  a  depolarizing  voltage  step  stimulus  
and  corresponding  state  transitions  from  closed–open-­inactive  states.    
  
  
Sodium  channels  in  DRG  neurons  
  
Peripheral  sensory  neurons,  at  least  in  mammals,  differ  from  neurons  in  
the  CNS  neurons  in  a  number  of  ways,  including  morphology  and  physiology  
(68).  Although  it  has  been  written  that  with  VGSCs  “one  is  impressed  more  with  
the  similarity  of  function  than  with  the  differences”(56)  ,  this  is  clearly  not  the  case  
with  sodium  currents  in  peripheral  sensory  neurons  where  sodium  currents  
exhibit  broad  diversity.  While  sodium  currents  in  the  CNS  are,  for  the  most  part,  
highly  sensitive  to  pufferfish’s  tetrodotoxin  (TTX;;  IC50s  near  10nM),  distinct  
   8  
components  of  the  complex  currents  that  can  be  elicited  in  peripheral  DRG  and  
TG  neurons  are  roughly  1,000  to  50,000  fold  less  sensitive.  As  such,  VGSC  
currents  in  DRG  neurons  can  be  classified  as  TTX-­sensitive  (TTXS)  and  TTX-­
resistant  (TTXR).  
  
The  kinetic  diversity  of  sodium  currents  in  peripheral  sensory  neurons  is  
also  greater  than  that  in  the  CNS.  Peripheral  neurons  may  express  fast,  slow  and  
persistent  sodium  currents  (see  Figure  2)  (69,  70).  The  fast  gating  current  can  be  
generated  by  multiple  TTXS  isoforms  including  Nav1.1,  Nav1.3,  Nav1.6  and  
Nav1.7.  In  adult  DRG  neurons,  Nav1.3  is  not  expressed  but  expression  can  be  
triggered  following  nerve  injury  (71).  The  kinetics  and  voltage-­dependence  of  
TTXS  currents  contribute  to  the  initiation  of  the  AP.  Some  isoforms  may  also  
generate  small  persistent  currents  that  can  influence  the  threshold  for  AP  
generation  (72,  73).  In  contrast,  the  large  slowly  inactivating  and  persistent  
currents  observed  in  peripheral  sensory  neurons  (74-­76)  are  TTXR.  In  adult  DRG  
neurons,  the  slow  component  is  mainly  generated  by  Nav1.8.  This  isoform  
exhibits  a  more  depolarized  voltage-­dependence  of  activation  and  inactivation  
relative  to  TTXS  channels  and  contributes  in  a  major  fashion  to  the  upstroke  of  
AP  in  neurons  where  it  is  expressed  (77,  78).  In  contrast,  Nav1.9  channels  can  
activate  at  more  hyperpolarized  membrane  potentials  where  other  VGSCs  are  
quiescent  generating  the  large  persistent  component  observed  in  DRG  neurons  
(Figure  2D).  Expression  of  Nav1.5,  a  TTXR  channel,  is  detected  in  embryonic  
DRG  neurons  but  is  downregulated  to  negligible  levels  in  adult  neurons  (65,  79,  
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80).  As  such,  it  is  not  considered  to  be  a  major  VGSC  contributor  of  TTXR  




Figure  2:  Examples  of  the  sodium  current  diversity  in  DRG  neurons.  Endogenous  sodium  
current  recordings  were  obtained  from  dissociated  DRG  neurons  grown  in  culture.  A  single  pulse  
of  50ms  from  -­80  to  40  mV  was  used  to  examine  the  current  voltage  relationship  of  the  sodium  
currents..  A,  Representative  traces  of  a  DRG  neuron  with  fast  TTXS  sodium  currents.  B,  
Representative  traces  of  a  DRG  neuron  with  TTXR-­slow  sodium  currents.  C,  Representative  
traces  of  a  DRG  neuron  with  TTXR-­slow  sodium  currents.  For  panel  B  and  C  recordings  were  
obtained  in  the  presence  of  500  nM  TTX.  Sodium  currents  were  normalized  to  the  peak  sodium  
current  of  the  DRG  neurons.  D,  Normalized  current  as  function  of  voltage  shows  that  slow  sodium  
currents  (green  circles)  exhibit  a  more  depolarized  voltage-­dependence  relative  to  fast  (blue  
squares)  and  persistent  currents  (red  triangles).  In  contrast,  persistent  currents  exhibit  a  more  
hyperpolarized  voltage  correlation  relative  to  fast  and  slow  currents.  
  
The  expression  of  VGSC  α  subunits  varies  between  the  different  classes  
of  peripheral  sensory  neurons.  Three  main  classes  of  sensory  fibers  (C,  Aδ  and  
Aα/β)  can  be  differentiated  based  on  conduction  velocity,  soma  diameter,  and  
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activation  threshold  (Table  1).  These  different  types  of  sensory  fibers  are  
activated  selectively  by  the  mode  and  intensity  of  the  peripheral  stimulus.  Fibers,  
that  are  activated  by  a  noxious  stimulus,  are  termed  nociceptors.  Nociceptors  are  
generally  classified  as  high  threshold  neurons  (81).  While  nociceptors  are  
classically  identified  as  fibers  in  the  C-­Aδ  class,  there  is  substantial  evidence  that  
supports  that  a  subset  of  Aβ  fibers  also  likely  function  as  nociceptors  (82).  In  C-­
fiber  neurons,  the  predominant  VGSCs  expressed  are  Nav1.7,  Nav1.8  and  
Nav1.9  (74,  75,  83,  84).  In  contrast,  A-­fiber  neurons  predominantly  express  
Nav1.1,  Nav1.6  and,  (to  a  lesser  extent)  Nav1.7  with  the  exception  of  a  discrete  
subpopulation  that  also  expresses  Nav1.8  at  high  levels  (83,  85,  86).    
     
Fiber  class   Aα/β   Aδ   C  






Myelination   Thick   Thin   None  
Conduction   35-­75m/s   5-­30m/s   0.5-­2m/s  
Threshold   Low  -­  high   Low  -­  high   Low  -­  high  
VGSC  
(predominant  α  subunits)  
Nav1.1,  Nav1.6,  Nav1.7  




Table  1.  Classification  of  peripheral  sensory  neurons  
  
The  focus  of  this  dissertation  is  TTXS  currents,  in  particular  Nav1.6-­
mediated  currents.  Therefore,  we  used  the  differences  of  VGSCs  sensitivity  to  
TTX  inhibition  to  isolate  currents  from  a  specific  isoform  in  transfected  DRG  
neurons.  When  examining  endogenous  sodium  currents  in  DRG  neurons,  we  use  
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the  voltage-­dependence  and  kinetic  differences  between  TTXS/TTXR  channels  
to  digitally  subtract  the  TTXR  component.  
  
VGSCs  and  pain  
  
Because  Nav1.7,  Nav1.8  and  Nav1.9  are  preferentially  expressed  in  
peripheral  neurons  and  highly  expressed  in  typical  nociceptor  neurons,  a  great  
deal  of  attention  has  focused  on  these  three  isoforms.  Studies  of  pain  
mechanisms  in  animal  models,  transgenic  mice,  and  mutations  identified  in  
humans  have  confirmed  that  these  three  isoforms  play  important  roles  in  
nociception.  For  example,  multiple  studies  indicated  that  Nav1.8  currents  are  
substantially  altered  in  animal  models  of  nerve  injury  and  inflammation  (13,  87-­
91).  A  number  of  mutations  in  SCN10A  (the  gene  that  encodes  Nav1.8)  have  
been  identified  in  humans  with  painful  neuropathies  (92,  93).Several  of  these  
mutations  have  been  shown  to  increase  sensory  neuron  excitability  when  
expressed  in  preclinical  models  ,  helping  to  validate  the  importance  of  Nav1.8  in  
pain.  In  contrast,  mutations  in  SCN11  (Nav1.9  gene)  have  been  identified  in  
humans  with  abnormal  pain  sensations.  Interestingly,  putative  gain-­of-­function  
mutations  have  been  identified  in  patients  with  enhanced  sensitivity  to  pain  (94,  
95)  and  patients  with  loss-­of-­pain  sensations  (96).  Gain-­of-­function  mutations  in  
Nav1.7  have  been  identified  in  patients  with  severe  neuropathic  pain  sensations  
such  as  PEPD  and  erythromelalgia  (22,  97,  98).  Conversely,  loss-­of-­function  
mutations  in  Nav1.7  are  associated  with  complete  insensitivity  to  pain  (99,  100).  
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However,  it  is  unclear  if  Nav1.7  is  crucial  to  all  pain  sensations,  especially  in  
adults.  Loss  of  Nav1.7  from  birth  could  predispose  individuals  to  a  complete  
inability  to  sense  pain  throughout  life.  Interestingly,  animals  with  loss  of  Nav1.7  in  
sensory  neurons  do  not  exhibit  a  complete  insensitivity  to  all  pain  conditions  
(101).  This  raises  the  possibility  that  specific  pain  conditions  are  independent  of  
Nav1.7.  For  example,  chemotherapeutic-­induced  pain  does  not  appear  to  
depend  on  classic  nociceptors  and  the  sensory  selective  isoforms  Nav1.7,  





Nav1.6  is  an  isoform  that  is  not  classically  associated  with  sensitivity  to  
pain,  in  part  because  its  expression  is  restricted  to  peripheral  sensory  neurons  
(102-­104).  In  addition  to  peripheral  sensory  neurons,  Nav1.6  is  also  abundantly  
expressed  in  the  adult  mammalian  brain  and  spinal  cord  (105).  Expression  has  
also  been  described  in  cardiomyocytes  and  non-­excitable  cells  such  as  
macrophages,  microglia  and  Schwann  cells  (106-­109),  albeit  at  lower  levels.  
Studies  with  Nav1.6  null  mice  suggest  that  it  is  important  for  proper  neurological  
function  and  development.  In  particular,  Nav1.6  null  animals  suffer  from  motor  
disorders  and  do  not  survive  past  three  weeks  (102).  Mutations  identified  in  
Nav1.6  are  associated  with  pathologies  in  which  brain,  heart  and  motor  functions  
are  altered  (102,  107,  110-­114).  As  such,  until  recently  it  has  not  been  studied  in  
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as  much  detail  in  the  context  of  pain  as  other  isoforms.  For  example,  Nav1.6  is  
important  for  the  development  of  persistent  mechanical  hypersensitivity  mediated  
by  localized  chemogenic  inflammation  of  the  DRG,  a  proposed  radicular  pain  
model  (115,  116).  In  the  early  stages  of  inflammation,  increased  Nav1.6  
expression  was  positively  correlated  with  increased  spontaneous  activity  (14).  
Localized  injection  (near  the  DRG)  of  small  interfering  RNAs  (siRNA)  targeted  to  
Nav1.6  in  parallel  with  the  induction  of  inflammation  prevented  the  development  
of  persistent  mechanical  hypersensitivity(14).  Furthermore,  knockdown  of  
Nav1.6,  but  not  Nav1.7,  abolished  early  stage  inflammation  mediated  increases  
in  electrical  activity(14).  While  resurgent  and  persistent  currents  where  not  
examined  in  this  study,  the  increased  propensity  of  Nav1.6  to  generate  these  
currents  potentially  contributes  to  the  increase  electrical  activity.    
  
The  role  of  Nav1.6  in  nociception  was  also  investigated  in  two  rat  models  
of  neuropathic  pain  (spinal  nerve  ligation  and  chronic  constriction  injury).  
Localized  knockdown  (as  previously  described)  of  Nav1.6  prior  and  at  the  time  of  
nerve  ligation  or  injury  greatly  reduced  mechanical,  but  not  cold-­dependent  pain  
associated  behaviors  (15).  Nav1.6  knockdown  reduced  the  spontaneous  firing  
and  reduced  the  increased  firing  frequency  in  DRG  neurons  that  is  commonly  
observed  in  these  models  (117,  118).  Interestingly,  Nav1.6  knockdown  also  
decreased  abnormal  neuronal  outgrowth  from  sympathetic  neurons  into  DRG  
neurons  (15).  It  is  not  clear  how  these  new  sympathetic  innervation  in  DRG  
neurons  alter  nociception.  Studies  suggest  that  sympathetic  sprouting  is  
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stimulated  by  ectopic  activity  in  DRGs  (119).  Abnormal  sympathetic  contacts  may  
in  turn  stimulate  DRG  neurons,  forming  a  cycle  that  maintains  chronic  pain  
sensations  (120-­122).  This  hypothesis  is  supported  by  the  fact  that  in  these  
models  sympathetic  sprouting  was  highly  co-­localized  to  DRG  neurons  that  
expressed  Nav1.6  (15).  One  possibility  is  that  Nav1.6  mediates  initial  changes  
that  may  later  contribute  to  the  maintenance  of  chronic  pain  sensation  and  thus  
targeting  Nav1.6  activity  (such  as  resurgent  currents)  in  early  stages  may  be  a  
viable  strategy  to  prevent  the  development  of  neuropathic  pain.  
  
Pharmacological  and  genetic  manipulation  of  Nav1.6  in  a  preclinical  model  
of  oxaliplatin  suggest  that  it  is  a  key  factor  in  mediating  oxaliplatin-­induced  
increases  in  electrical  activity  (16,  26).  Oxaliplatin  is  an  anticancer  drug  used  
mainly  to  treat  colorectal  cancer.  The  acute  stage  of  the  neuropathy  arises  
shortly  after  infusion  and  is  observed  with  high  incidence  (123).  Sensory,  and  in  
some  cases  motor  symptoms,  are  aggravated  or  triggered  by  cold  temperatures  
((124)).  One  study  showed  that  DRG  nerve  fibers  from  heterozygous  knockout  
Nav1.6  mice  exhibited  a  dampened  cold  dependent  increase  in  activity  to  
oxaliplatin  exposure.  DRG  fibers  from  homozygous  knockout  Nav1.6  mice  
exhibited  no  increase  in  electrical  activity  to  oxaliplatin  exposure  (26).  At  a  
behavioral  level,  Deuis  et  al,  showed  reversal  of  cold-­triggered  pain  associated  
behaviors  in  an  oxaliplatin  mouse  model  by  selectively  inhibiting  Nav1.6  and  
Nav1.1  with  a  high  concentration  GIIIA  toxin(16).  Consistent  with  these  findings,  
Nav1.6  activity  is  altered  in  a  cold  dependent  manner  upon  exposure  to  
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oxaliplatin.  While  other  mechanisms  may  also  contribute  to  the  acute  painful  
neuropathy,  Nav1.6  may  prove  to  be  a  key  target  that  would  enable  the  patient  to  
withstand  higher  doses  or  more  frequent  treatments  of  oxaliplatin  (16,  26,  125-­
127).    
  
The  role  of  Nav1.6  is  not  clear  in  other  pain  pathologies.  For  example,  in  a  
histological  study  of  a  trigeminal  nerve  injury,  Nav1.6  accumulates  at  the  
proximal  site  of  the  nerve  injury  particularly  at  remodeled  nodes  of  Ranvier  (128).  
The  remodeled  nodes  exhibited  demyelination  resulting  in  widened  gaps  in  the  
myelin  sheath.  The  nodes  of  Ranvier  are  important  for  saltatory  transmission  of  
AP  along  the  axon  (129).  If  the  nodal  structure  is  disrupted  this  may  result  in  
slower  nerve  conduction.  On  the  other  hand,  it  is  possible  that  increased  
expression  of  Nav1.6  promotes  the  generation  of  spontaneous  action  potentials  
and  thus  activation  of  nociceptive  pathways.  The  contribution  of  these  changes  to  
trigeminal  pain  require  further  study.  
  
Another  pain  pathology  in  which  the  role  of  Nav1.6  has  been  controversial  
is  painful  diabetic  neuropathy.  In  animal  model  studies  of  type  1  diabetic  
neuropathy  (early  stage)  where  increased  pain  associated  behavior  was  
confirmed,  Nav1.6  levels  in  DRG  neurons  have  been  reported  to  be  both  
upregulated  (130)  and  downregulated  (131).  In  a  Type  2  diabetes  animal  model,  
Nav1.6  is  upregulated  in  early  stages  of  diabetic  neuropathy,  which  persisted,  in  
the  later  stages  of  the  disease.  In  the  type  2  diabetes  model,  changes  in  pain-­
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associated  behavior  were  positively  correlated  with  increased  Nav1.6  mRNA  
levels  in  DRG  neurons  (132).  Further  studies  may  provide  a  better  understanding  
of  the  role  of  Nav1.6  in  painful  diabetic  neuropathy  (Type  1  or  Type  2).    
  
While  there  is  compelling  evidence  for  Nav1.6’s  role  in  some  pain  
pathologies,  broadly  targeting  Nav1.6  might  result  in  many  unwanted  side  
effects.  Therefore,  targeting  specific  patterns  of  activity  such  as  resurgent  current  
and  persistent  currents  might  provide  a  more  viable  strategy.  Auxiliary  proteins  
that  interact  with  Nav1.6  are  potential  modulators  of  channel  activity  and  may  






Auxiliary  subunits  can  associate  in  multiple  ways  with  VGSCs  resulting  in  
a  variety  of  heteromultimers  that  can  impact  VGSC  properties.  Beta  (β)-­subunits  
are  the  most  commonly  known  auxiliary  subunit  (135,  136).  To  date  four  β-­
subunits  (Navβ1–β4)  have  been  identified.  These  subunits  share  some  common  
features  which  include  a  single  transmembrane  domain,  an  intracellular  C-­
terminal  domain,  and  an  extracellular  N-­terminal  domain  (135).  β-­subunits  can  
associate  with  α  subunits  non-­covalently  (Navβ1,  β3)  or  covalently  (Navβ2,  β4)  
(137).  All  β-­subunits  are  expressed  in  DRG  neurons  although  distribution  can  
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vary  between  specific  DRG  sub-­classes  (133,  138).  For  example,  Navβ4  (a  
subunit  that  has  been  associated  with  the  generation  of  resurgent  currents)  is  
expressed  at  higher  levels  in  the  medium  to  large  compared  to  the  population  of  
small  diameter  neurons  (23,  138).  In  a  similar  manner  Navβ1  is  more  abundant  in  
medium  to  large  population  than  in  small  diameter  neurons  and  Navβ3  is  more  
abundant  in  small  diameter  neurons  than  in  the  medium  to  large  population  of  
DRG  neurons.  Navβ2  is  ubiquitously  expressed  throughout  the  different  size  
classes  (139).    
  
β-­subunits  can  alter  the  expression  and  biophysical  properties  of  the  
channel  such  as  gating,  current  density,  persistent  current  and  resurgent  current  
(140).  These  effects  can  vary  depending  on  the  α-­subunit  expression,  and  cell  
background.  For  example,  in  small  diameter  neurons,  deletion  of  Navβ2  
decreased  the  expression  of  TTXS  channels  and  increased  the  rate  of  activation  
and  inactivation.  However,  TTXR  channels  were  not  significantly  modulated  
(141).  In  contrast,  Navβ1  deletion  decreased  the  expression  of  Nav1.9  and  
shifted  the  voltage-­dependence  of  inactivation  for  TTXS  channels  to  positive  
potentials,  which  resulted  in  hyperexcitability  of  small  diameter  neurons  (142).  
There  is  good  evidence  to  support  the  potential  role  of  β-­subunits  in  pain  
sensations.  For  example,  Navβ2  null  mice  exhibit  reduced  pain  behavior  
responses  after  nerve  injury  (141).  In  contrast,  upregulation  of  Navβ3  in  sensory  
neurons  has  been  associated  with  increased  pain  responses  in  different  animal  
models  (139,  143,  144).  The  role  of  Navβ4  in  pain  sensations  has  not  been  fully  
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explored  and  is  one  of  the  aims  of  this  dissertation.  Additionally,  β-­subunits  can  
act  as  cell  adhesion  molecules  (CAM)  (145).  As  such,  β-­subunits  may  also  be  
important  for  neuronal  outgrowth(136,  146,  147).  However,  this  potential  role  and  
implication  to  pain  sensations  has  not  been  extensively  studied  in  sensory  
neurons  and  will  not  be  explored  in  this  dissertation.  
  
Fibroblast  growth  factor  homologous  factors  
     
FHFs  are  intracellular  signaling  proteins  expressed  mainly  in  excitable  
cells.  Contrary  to  their  homologue  counterparts  (i.e.  fibroblast  growth  factors),  
FHFs  are  neither  secreted  nor  activate  FGF-­Receptors  (148).  While  FHFs  can  
interact  with  multiple  partners  including  microtubules  (149),  kinases  (150),  
scaffolding  proteins  (151,  152),  nuclear  factors  (153)  and  calcium  channels  (154);;  
their  interaction  with  VGSCs  (134,  148)  qualifies  them  to  be  considered  as  VGSC  
auxiliary  proteins.  To  date  four  FHF  genes  have  been  identified  in  vertebrate  
species  (FHF1-­4).  Each  FHF  gene  can  result  in  multiple  isoforms  through  
alternative  splicing  and  promoter  usage  resulting  in  distinct  N-­terminal  sequences  
(155).  Two  commonly  identified  isoforms  are  FHF  Type  A  (FHFA)  and  FHF  Type  
B  (FHFB).  FHFBs  are  cytosolic.  In  contrast,  FHFAs  contain  a  bipartite  nuclear  
localization  signal  that  depending  on  the  properties  of  the  cell  background  may  
be  active  or  silent  (156).  Both  “A”  and  “B”  isoforms  of  FHF  have  conserved  core  
domains  that  enable  them  to  bind  to  the  C-­terminus  of  sodium  channels  (157-­
160).  FHF  interaction  with  VGSC  can  alter  the  biophysical  properties  of  
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activation,  inactivation  and  current  density  (148,  161).  In  particular,  FHFs  binding  
to  the  C-­terminus  of  VGSC  shifts  the  voltage-­dependence  of  inactivation.  For  
example,  heterologous  co-­expression  of  FHF2  and  FHF4  isoforms  with  Nav1.6  
consistently  shifted  the  voltage-­dependence  of  inactivation  to  positive  potentials,  
whereas,  differential  effects  were  observed  in  current  density  depending  on  
isoform  and  cell  background.    
  
Adult  DRG  neurons  can  express  a  variety  of  FHF  isoforms  including  
FHF1,  FHF2  and  FHF4  (134,  162-­165).  FHF1  is  present  mainly  as  variant  B  
(FHF1B),  since  FHF1A  is  downregulated  in  adult  animals.  FHF1  expression  is  
found  in  membrane,  cytosol  and  nucleus;;  therefore,  the  FHF1A  nuclear  signal  is  
predicted  to  be  active  in  DRG  neurons.  A  potential  interaction  of  FHF1B  with  
Nav1.9  was  identified.  However,  this  interaction  is  not  predicted  to  occur  in  
sensory  neurons  since  both  proteins  are  not  generally  expressed  together  in  the  
same  population  of  DRG  neurons  (159,  164).  FHF2  variants  colocalize  with  
Nav1.6  in  different  subpopulations  of  DRG  neurons:  FHF2A  colocalizes  with  
Nav1.6  in  C-­fibers,  whereas,  FHF2B  colocalizes  with  Nav1.6  in  A-­fibers  (162,  
163).  The  FHF2A  nuclear  localization  signal  is  predicted  to  be  silent  since  
expression  is  detected  at  the  membrane  and  in  the  cytosol  of  DRG  neurons,  but  
not  the  nucleus.  FHF3  expression  has  not  been  studied  in  sensory  neurons  in  
much  detail  (148).  Overall,  there  has  not  been  extensive  research  of  FHF’s  
contribution  to  pain  pathologies.  Two  studies  using  cDNA  arrays  reported  FHF2  
cDNA  levels  were  downregulated  with  no  change  in  FHF1  and  FHF4  after  
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peripheral  nerve  injury  (165,  166).  Which  of  the  FHF2  isoforms  contribute  to  this  
change  and  how  these  changes  translate  to  changes  in  VGSC  is  not  known.    
One  possibility  is  modulation  of  resurgent  currents  since  FHFs  are  proposed  to  
modulate  resurgent  current  generation  in  CNS  neurons  (167).  Because  of  the  
gap  in  knowledge,  modulation  of  resurgent  current  by  FHF2  isoforms  is  one  of  
the  areas  explored  in  this  dissertation.  
  
Overall,  VGSCs  subunits  can  form  heteromultimeric  complexes  with  a  
diverse  combination  of  α  subunits  and  auxiliary  proteins.  Although  the  focus  of  
this  dissertation  is  modulation  of  Nav1.6  currents  by  β-­subunits  and  FHF  
isoforms,  these  proteins  are  not  the  only  partners  known  to  interact  with  VGSCs.  
Numerous  other  proteins  have  been  identified  that  reportedly  interact  with  α  
subunits  including  calmodulin,  ankyrins,  multiple  protein  kinases,  Nedd4-­2,  
CRMP2,  syntrophin,  contactin,  annexin  II  light  chain  and  KIF5  (to  name  a  few)  
(168).  The  formation  of  the  complexes  depends  on  expression,  colocalization  
and  interaction  between  the  sodium  subunits  and  auxiliary  proteins  in  a  given  cell  
type.  As  VGSC  activity  is  modulated  by  interactions  with  auxiliary  proteins,  these  
interacting  partners  have  the  potential  to  be  molecular  regulators  of  excitability  
and  nociception.  In  particular,  we  focus  on  how  Navβ4  and  FHF2  isoforms  may  
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Intrinsic  mechanisms  of  VGSC  inactivation  and  contributions  to  
nociception  
  
There  are  several  mechanisms  by  which  VGSCs  intrinsically  inactivate,  
and  major  mechanisms  include  fast  inactivation  and  slow  inactivation  (169,  170).  
Fast  inactivation  occurs  within  milliseconds  of  channel  activation,  as  the  
intracellular  loop  between  the  DIII-­DIV  folds  (inactivation  particle)  and  occludes  
the  cytoplasmic  face  of  the  pore  (59).  Recovery  from  fast  inactivation  (i.e.  
channel  repriming)  typically  occurs  within  10ms.  Interestingly,  the  DIII-­DIV  
intracellular  loop  is  highly  conserved  among  the  nine  different  isoforms,  including  
Nav1.9  despite  its  dramatically  slower  inactivation  kinetics(171).  VGSCs  can  
undergo  both  closed-­state  and  open-­state  fast  inactivation,  but  it  is  not  entirely  
clear  if  the  mechanisms  for  these  two  are  identical.  Alterations  in  fast  inactivation  
are  believed  to  be  important  modulators  of  nociceptor  activity  and  pain  
sensations  (7).  For  example,  recovery  from  inactivation  is  a  limiting  factor  for  
sodium  channel  availability  to  respond  to  an  additional  stimulus.  Indeed,  local  
anesthetics  that  target  sodium  channel  activity  in  peripheral  fibers  are  believed  to  
act  largely  by  stabilizing  fast  inactivation  of  VGSCs  in  nociceptors  (172).    
  
In  contrast  to  fast  inactivation,  slow  inactivation  is  a  gradual  process  that  
occurs  on  the  time  scale  of  seconds  to  minutes  through  conformational  changes  
of  the  channel  pore  (169,  170).  It  is  less  clear  to  what  extent  slow  inactivation  
contributes  to  alterations  in  nociception.  Slow  inactivation  of  Nav1.8  seems  to  
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modulate  the  duration  of  the  AP  firing  in  nociceptive  neurons  in  response  to  
sustained  stimulation  (173).  Interestingly,  slow  inactivation  of  TTX-­S  channels  is  
enhanced  by  cold.  Enhancement  of  slow  inactivation  would  result  in  a  reduction  
of  available  TTXS  VGSC  to  respond  to  a  given  stimulus.  Thus,  enhancement  of  
slow  TTXS  could  contribute  to  the  ability  of  tissue  cooling  to  reduce  some  types  
of  pain  sensations.  Conversely,  a  lack  of  cold  sensitivity  for  Nav1.8  slow  
inactivation  is  believed  to  be  crucial  to  cold-­induced  pain  sensations  (174).  Since,  
Nav1.8  slow  inactivation  is  insensitive,  this  isoform  would  remain  available  to  
generate  the  rising  phase  of  the  AP  in  a  nociceptive  neuron  and  conduct  the  
impulse  to  the  CNS.    
  
Extrinsic  mechanisms:  Long-­term  inactivation  and  excitability  
  
   An  alternate  extrinsic  mechanism  of  inactivation  is  long-­term  inactivation,  
which  is  mediated  by  FHFA  variants  through  a  sequence  of  amino  acid  residues  
in  the  N-­terminus  domain.  Long-­term  inactivation  is  a  distinct  and  competing  
mechanism  to  fast  inactivation.  For  FHF2A,  the  long-­term  inactivation  particle  is  
proposed  to  be  the  20  amino  acid  sequence:  AAAIASSLIRQKRQARERE  (175).  
This  sequence  is  highly  conserved  between  all  FHFA  isoforms.  Binding  of  the  
long-­term  inactivation  particle  to  the  α  subunit  pore  prolongs  the  recovery  period  
of  the  VGSC  from  10ms  to  100-­400ms  (175).  For  example  in  a  DRG-­derived  cell  
line  (ND7/23),  FHF2A  expression  causes  accumulation  of  channel  inactivation  
due  to  slowing  of  recovery  from  inactivation  (163).  Current  clamp  simulations  
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incorporating  long-­term  inactivation  parameters  suggest  that  this  mechanism  
decreases  firing  frequency  (175).  Simulation  predictions  were  later  confirmed  
with  hippocampal  neurons,  which  showed  that  FHFAs  elevated  AP  voltage  
threshold  and  slowed  AP  frequency  with  each  consecutive  stimulus  (176).  Long-­
term  inactivation  induced  by  FHFAs  is  a  recent  finding  and  there  are  no  reported  
studies  examining  whether  it  occurs  in  DRG  neurons.  However,  based  on  CNS  
and  heterologous  cell  expression  systems  studies  we  predict  that  increased  long-­
term  inactivation  would  greatly  reduce  neuronal  excitability  and  firing  frequency  
by  favoring  channels  to  remain  inactive  for  longer  periods  of  times.  One  of  the  
aims  of  this  dissertation  is  to  examine  if  long-­term  inactivation  regulates  
resurgent  currents  in  DRG  neurons  and  potentially  modulate  neuronal  
excitability.  
  
Extrinsic  mechanisms:  Open-­channel  block  and  nociception  
  
   In  addition  to  long-­term  inactivation,  open  channel-­block  is  also  an  
extrinsic  competing  mechanism  with  classic  fast  inactivation  (177).  Although  
binding  of  the  open  channel  blocker  initially  terminates  sodium  current,  rapid  
unbinding  of  the  blocker  at  intermediate  voltages  (e.g.,  -­40  mV)  allows  sodium  
current  to  be  uncharacteristically  generated  during  periods  where  the  channel  is  
usually  refractory.  This  mechanism  is  known  to  produce  atypical  currents  referred  
to  as  resurgent  sodium  currents.  The  present  model  for  resurgent  current  
generation  proposes  that  the  open  channel  blocker  binds  at  positive  voltages  and  
unbinds  upon  membrane  repolarization  (Figure  2A-­B)  (178-­180).  Open  channel  
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block  bypasses  fast  inactivation,  enabling  the  channel  to  recover  faster  and  have  
a  shorter  refractory  period  (180).  Therefore,  resurgent  currents  are  predicted  to  
increase  neuronal  firing  frequency  through  a  more  rapid  channel  recovery  in  
conjunction  with  the  depolarizing  contribution  during  the  repolarization  phase  of  
the  action  potential  (17-­19,  181,  182).  The  identity  of  the  open  channel  blocker  in  
sensory  neurons  is  not  completely  clear.  Thus,  one  of  the  aims  of  this  
dissertation  is  to  determine  the  identity  of  the  open  channel  blocker  in  sensory  
neurons.  In  particular,  we  examine  the  potential  role  of  Navβ4.  
     
  
Figure  3:  Resurgent  currents:  A,  Simplified  Model  of  Resurgent  Current  State  Transitions.    
As  VGSC  open  upon  depolarization  (+30mV),  the  open  channel  blocker  (represented  as  red  
sphere)  competes  with  the  intrinsic  mechanism  of  inactivation  (intracellular  linker  between  DIII  
and  DIV,  represented  by  the  yellow  sphere).  Binding  of  the  open  channel  blocker  terminates  
classic  sodium  current  but  prevents  inactivation  particle  interaction;;  forcing  the  channel  to  remain  
in  an  open-­blocked  state.  Membrane  repolarization  (-­40mV)  causes  the  blocker  to  unbind  from  
the  channel  in  the  open-­blocked  state  and  resurgence  of  sodium  conductance  occurs  
(i.e.resurgent  currents).  Unbinding  of  the  blocker  allows  channels  to  return  to  closed  state  directly  
or  as  they  recover  from  classic  inactivation.  B,  Representative  traces  of  a  DRG  neuron  with  
resurgent  sodium  current  (red)  and  no  resurgent  sodium  current  (yellow)  due  to  channel  fast  
inactivation  with  respective  voltage  command  protocol.  
  
  
   Two  types  of  resurgent  currents  have  been  identified  in  DRG  neurons  and  
are  classified  based  on  their  kinetics  (fast  and  slow;;  Figure  4).  Nav1.6  is  the  main  
contributing  isoform  to  fast  resurgent  currents  (27).  Under  normal  conditions  fast  
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resurgent  currents  are  observed  in  a  ~50%  of  medium  to  large  diameter  neurons  
but  not  in  small  diameter  neurons  (19,  27).  In  contrast,  slow  resurgent  currents  
are  mediated  by  Nav1.8  and  are  mainly  observed  in  a  small-­medium  diameter  
neurons  (25).  The  voltage-­dependence  of  resurgent  currents  is  different  between  
these  two  currents;;  fast  resurgent  currents  peak  at  -­45mV,  whereas  slow  
resurgent  currents  peak  at  -­25  mV  (Figure  3B),  likely  reflecting  differences  in  




Figure  4:  Slow  and  fast  resurgent  currents  have  different  kinetic  and  voltage  properties.  A,  
Representative  trace  of  slow  resurgent  current  and  (B)  fast  resurgent  current  obtained  from  DRG  
neurons.  Peak  current  amplitude  for  slow  resurgent  current  is  -­25mV  (red  trace)  and  -­45mV  for  





Studies  of  human  VGSCs  mutations  are  the  first  reported  example  of  the  
potential  contribution  of  resurgent  currents  to  pain  pathologies.  Inherited  and  de-­
novo  Nav1.7  mutations  identified  in  patients  that  suffer  from  PEPD  result  in  
functional  channels  with  altered  inactivation  properties  and  increased  resurgent  
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currents  (19,  21,  183-­185).  Recombinant  expression  of  Nav1.7-­PEPD  mutant  
channels  in  sensory  neurons  results  in  hyperexcitability  (22).  Nav1.7  is  an  
isoform  that  does  not  frequently  generate  robust  resurgent  currents  in  DRG  
neurons.  However,  PEPD  mutations  seem  to  increase  the  probability  of  binding  
of  the  open  channel  blocker  due  to  delayed  fast  inactivation  (i.e.  voltage-­
dependence  of  inactivation  shifted  to  positive  potentials  and  in  some  cases  
accompanied  by  slowed  rate  of  inactivation).  DRG  simulation  studies  of  the  
Nav1.7-­I1462T  PEPD  mutant  showed  that  altered  gating  properties  result  in  a  
decrease  in  the  magnitude  of  the  stimulus  needed  to  elicit  an  action  potential  
(rheobase).  Interestingly,  when  increased  resurgent  currents  were  added  into  the  
model  there  was  a  substantial  increase  in  the  number  of  evoked  action  
potentials.  Therefore,  resurgent  currents  were  identified  as  a  key  factor  that  
contributes  to  the  increased  firing  frequency  (19).  The  combined  changes  in  
rheobase  and  firing  frequency  are  thought  to  contribute  to  painful  sensations  in  
PEPD  patients.    
  
Through  a  similar  mechanism  as  seen  with  PEPD,  increased  resurgent  
currents  may  contribute  to  increased  electrical  activity  of  sensory  neurons  in  non-­
inherited  (acquired)  pain  pathologies.  The  first  example  is  ATX-­II  induced  pain.  
ATX-­II  is  a  VGSC  site-­3  neurotoxin  isolated  from  the  venom  of  sea  anemone  
(Anemonia  sulcata;;  (186)).  Intradermal  injection  of  ATX-­II  toxin  into  humans  
induces  pain  and  itch  that  resembles  those  experienced  by  divers  stung  by  the  
anemone,  suggesting  this  component  of  the  venom  contributes  to  the  pain  
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sensations  perceived  by  the  divers  (23).  Using  the  differential  nerve  block  
approach,  A-­type  sensory  fibers  were  identified  to  mediate  the  pain  and  itch  
sensations.  In  congruence  with  this  observation,  ATX-­II  increased  TTXS  
resurgent  and  persistent  currents  in  medium  to  large  diameter  neurons  
(associated  with  A-­type  fibers;;  see  Table  1)  but  not  small  diameter  neurons  (23).  
Increased  resurgent  and  persistent  currents  potentially  increase  the  electrical  
activity  in  A-­fibers.  ATX-­II’s  mechanism  of  action  is  likely  due  to  direct  interaction  
of  the  toxin  with  VGSCs.  As  a  site-­3  toxin  ATX-­II  binds  to  the  extracellular  face  of  
VGSCs  and  restricts  DIVS4  voltage  sensor  movement  (187).  DIVS4  voltage  
sensor  movement  is  important  for  the  channel  to  change  conformations  that  favor  
binding  of  the  inactivation  particle  (188-­190).  Thus  ATX-­II  indirectly  impairs  the  
fast  inactivation  process  and  potentially  increases  the  binding  probability  of  the  
open  channel  blocker  (177).  Other  site-­3  toxins  from  scorpions,  sea  anemones,  
and  spiders  may  also  induce  painful  sensations  through  a  similar  mechanism  
(191).  
  
The  second  example  is  cooling  aggravated  oxaliplatin-­induced  acute  
painful  neuropathy.  As  previously  discussed,  studies  suggest  Nav1.6  is  a  key  
factor  in  mediating  oxaliplatin  induced  increases  in  electrical  activity  (16,  26).  
Consistent  with  these  findings,  fast  resurgent  currents  and  persistent  currents  
increased  in  neurons  from  oxaliplatin  treated  animals  as  temperature  decreased  
suggesting  that  this  mechanism  contributes  to  the  cold  aggravated  painful  
episodes  experienced  by  the  patients.  The  increase  in  resurgent  current  and  
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persistent  current  is  theoretically  due  to  impaired  fast  inactivation,  as  evidenced  
by  slower  inactivation  kinetics  observed  in  medium  to  large  diameter  neurons  
exposed  to  oxaliplatin  (26).    
  
The  third  example  is  increased  resurgent  currents  under  inflammatory  
conditions.  Several  studies  have  shown  that  inflammatory  mediators  alter  the  
firing  properties  of  sensory  neurons,  which  can  result  in  hyperexcitability  and  
contribute  to  persistent  pain  (192,  193).  Inflammatory  mediators  can  also  
increase  the  amplitude  of  fast  and  slow  resurgent  currents  in  sensory  neurons  
(25).  Both  fast  and  slow  resurgent  currents  likely  contribute  to  hyperexcitability  in  
inflammatory  conditions.  In  particular,  activation  of  Protein  Kinase  C  (PKC)  
pathways  (194,  195)  is  seen  under  inflammatory  conditions  and  enhances  
Nav1.7  mediated  resurgent  currents  in  human  embryonic  kidney  (HEK)  (24).The  
phosphorylation  site  identified  in  this  study  is  near  the  inactivation  particle.  
Interestingly,  this  site  is  conserved  in  other  isoforms  (Nav1.1-­Nav1.9),  which  may  
also  be  modulated  by  PKC.  However,  because  modulation  of  VGSC  activity  can  
be  cell  background  dependent  and  isoform  dependent,  further  studies  should  
explore  if  activation  of  this  pathway  results  in  the  same  effects  as  those  seen  with  
Nav1.7  in  HEK  cells.    
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Hypothesis  and  specific  aims  
  
While  there  is  compelling  evidence  of  the  important  role  fast  resurgent  
currents  may  play  in  nociception,  our  limited  knowledge  of  how  they  are  
modulated  in  peripheral  sensory  neurons  hinders  our  capability  to  target  these  
currents.  The  goal  of  this  dissertation  is  to  address  the  gap  in  our  knowledge  and  
identify  resurgent  current  modulators  that  may  yield  novel  therapeutic  targets.  In  
particular,  we  focus  on  Nav1.6  mediated  currents  because  they  are  the  main  
carrier  of  fast  resurgent  currents.  In  addition,  Nav1.6  activity  is  implicated  in  
several  pain  pathologies,  as  previously  discussed.  
  
The  first  question  we  addressed  was:  what  is  the  identity  of  the  open  
channel  blocker  that  mediates  resurgent  currents?  Evidence  from  CNS  studies  
suggest  that  it  is  part  of  the  Navβ4  subunit  (180,  196,  197).  The  Navβ4  subunit  
was  initially  identified  because  the  cytoplasmic  C-­terminus  contains  positively  
charged  and  hydrophobic  residues  that  have  the  necessary  properties  to  act  as  
the  voltage  dependent  open  channel  blocker  (180,  198).  Based  on  this  
observation,  a  synthetic  β4  peptide  was  designed  from  the  C-­terminus  of  Navβ4  
(β4  peptide:  KKLITFILKKTREKKKECLV;;  (180,  199)).  The  synthetic  β4-­peptide  
can  reconstitute  resurgent  currents  in  cerebellar  granule  neurons  and  other  cell  
lines  that  do  not  exhibit  endogenous  resurgent  current.  However,  the  role  of  
Navβ4  is  not  fully  understood  since  heterologous  expression  of  full  length  Navβ4  
is  not  sufficient  to  recapitulate  resurgent  current  generation  (183,  197,  200-­202).  
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Interestingly,  in  DRG  neurons,  the  incorporation  of  the  β4  peptide  into  the  
intracellular  recording  solution  evokes  resurgent  currents  in  neurons  that  do  not  
endogenously  generate  them  (23).  In  DRG  neurons  that  endogenously  generate  
resurgent  currents,  the  synthetic  peptide  increased  resurgent  current  amplitude  
(25).  Therefore,  we  hypothesized  that  Navβ4  is  likely  the  open  channel  blocker  in  
sensory  neurons.  Thus,  the  first  aim  of  this  dissertation  was  to  determine  if  
Navβ4  regulates  fast  resurgent  currents  in  DRG  neurons.    
  
   The  results  from  the  first  aim  suggested  that  Navβ4  is  a  positive  regulator  
of  Nav1.6  resurgent  currents  and  neuronal  excitability  (203).  Therefore,  we  next  
explored  the  role  of  Navβ4  in  pain  associated  behavior.  In  some  preclinical  pain  
models  including  a  model  of  radicular  pain  produced  by  localized  inflammation  of  
the  DRG  (LID),  abnormal  spontaneous  activity  of  sensory  neurons  is  observed  as  
an  early  event,  and  plays  a  key  role  in  initiation  and  maintenance  of  
hypersensitivity  (119,  121,  204-­209).  In  the  radicular  pain  model  spontaneous  
activity  consists  of  high  frequency  bursting  that  occurs  predominantly  in  
myelinated  neurons.  Interestingly,  in  vivo  knockdown  of  Nav1.6  strongly  reduced  
mechanical  hypersensitivity  as  well  as  spontaneous  activity  and  repetitive  firing  
of  myelinated  neurons  (14).  The  propensity  of  Nav1.6  to  generate  persistent  and  
resurgent  currents  is  likely  key  to  spontaneous  and  repetitive  firing  observed  in  
this  model.  In  particular,  resurgent  currents  generated  are  proposed  to  increase  
the  firing  frequency  of  neurons  (17-­19,  182,  210).  Therefore,  we  hypothesized  
that  Navβ4  would  be  a  key  mediator  for  resurgent  currents,  repetitive  firing  and  
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mechanical  hypersensitivity  induced  by  inflammation  in  sensory  neurons.  As  
such,  the  second  aim  of  this  dissertation  was  to  examine  the  effects  of  Navβ4  
knockdown  on  resurgent  currents,  firing  frequency,  and  pain  associated  behavior  
in  the  LID  radicular  pain  model.  
  
We  next  addressed  the  question:  is  there  a  negative  determinant  that  is  
preventing  resurgent  currents  from  being  generated  in  some  DRG  neurons?  As  
previously  discussed,  resurgent  currents  are  normally  observed  in  a  
subpopulation  of  medium  and  large  diameter  DRG  neurons  that  express  Nav1.6  
(27).  The  factors  that  permit  Nav1.6  to  produce  resurgent  current  in  some  cells,  
but  not  in  others,  have  not  yet  been  identified.  We  hypothesized  a  potential  
mechanism  for  the  regulation  of  fast  resurgent  currents  by  integrating  long-­term  
inactivation  and  the  resurgent  current  model.  FHFA  mediated  long-­term  
inactivation  is  proposed  to  compete  with  VGSC’s  fast  inactivation  and  in  a  similar  
manner,  open  channel  block  also  competes  with  fast  inactivation  (177).  Based  on  
these  observations,  we  propose  long-­term  inactivation  and  open  channel  block  
likely  compete  with  each  other  as  suggested  by  Goldfarb  (Figure  5)  (211).  In  a  
HEK  cell  line  stabling  expressing  Nav1.5,  addition  of  long-­term  inactivation  
peptide  reduced  β4-­peptide  mediated  resurgent  currents  supporting  the  
possibility  that  these  particles  compete  with  each  other  (176).  FHF2A  is  capable  
of  mediating  long-­term  inactivation  and  has  been  shown  to  interact  with  Nav1.6.  
FHF2A  predominantly  co-­localizes  with  Nav1.6  in  small  diameter  neurons,  a  
subpopulation  of  DRG  neurons  that  does  not  usually  generate  resurgent  currents  
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(163).  Therefore,  we  hypothesized  FHF2A  limits  fast  resurgent  current  
generation  in  sensory  neurons.    
  
  
Figure  5:  Schematic  representation  of  fast  Inactivation,  long-­term  inactivation,  and  open  
channel  block  as  competing  mechanisms  for  the  open  channel  state.  Intrinsic  fast  
inactivation  is  represented  by  the  yellow  sphere.  Long-­term  inactivation  particle  is  represented  as  
a  blue  sphere  part  of  the  N-­terminus  of  the  FHFA  protein  represented  as  a  blue  octagon.  Open  




In  contrast,  FHF2B  does  not  mediate  long-­term  inactivation,  but  may  alter  
voltage-­dependence  and  the  kinetics  of  inactivation  that  may  favor  open  channel  
block  (148).  For  example,  FHF4B  in  Purkinje  neurons  increased  resurgent  
currents  by  slowing  the  rate  of  inactivation  and  shifting  the  voltage-­dependence  
of  inactivation  to  positive  potentials.  Thus  increasing  the  probability  of  the  
endogenous  open  channel  blocker  to  bind  (167).  In  a  similar  manner,  co-­
expression  of  FHF2B  in  several  cell  lines  shifted  the  voltage-­dependence  of  
Nav1.6  to  positive  potentials  (160,  162).  Because  FHF2B  lacks  the  ability  to  
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mediate  long-­term  inactivation,  but  may  retain  the  capability  to  “delay”  fast  
inactivation,  we  hypothesized  that  FHF2B  enhances  the  generation  of  resurgent  
currents  in  DRG  neurons.  Therefore,  the  third  aim  of  this  dissertation  was  to  
determine  if  FHF2A  and  FHF2B  functionally  regulate  Nav1.6  currents,  including  
resurgent  currents  in  sensory  neurons.  
  
   Overall,  this  dissertation  focuses  on  Nav1.6  mediated  resurgent  sodium  
currents  and  the  molecular  determinants  that  potentially  regulate  them.  The  
results  of  this  research  suggest  that  Navβ4  and  FHF2B  are  positive  regulators,  
whereas,  FHF2A  is  a  negative  determinant  of  fast  resurgent  currents  generation.  
The  results  of  our  work  could  help  identify  potential  approaches  for  the  study  and  
treatment  of  hyperexcitability  associated  with  increased  resurgent  currents  such  
as  PEPD  and  oxaliplatin  acute-­painful  neuropathy  among  many  others.  
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*Partial  content  of  this  chapter  was  adapted  from  a  book  chapter    
published  in  Elsevier.  *  
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  PART  I:  NaVβ4  REGULATES  FAST  RESURGENT  SODIUM  CURRENTS  AND  




   Resurgent  currents  are  proposed  to  enable  high  frequency  firing  and  
increased  resurgent  currents  in  sensory  neurons  are  associated  with  pain  
pathologies.  While  Nav1.6  has  been  identified  as  the  main  carrier  of  fast  
resurgent  currents,  our  understanding  of  the  mechanisms  that  contribute  to  
resurgent  current  generation  is  limited.  Specifically,  the  open  channel  blocker  in  
sensory  neurons  has  not  been  identified.  Previous  studies  suggest  that  Navβ4  
mediates  resurgent  currents  in  CNS  neurons.  The  goal  of  this  study  was  to  
determine  whether  Navβ4  regulates  resurgent  currents  in  DRG  neurons.  Our  
immunocytochemistry  studies  show  that  Navβ4  expression  is  highly  correlated  
with  Nav1.6  expression  predominantly  in  medium  to  large  diameter  rat  DRG  
neurons.  Navβ4  knockdown  decreased  endogenous  fast  resurgent  currents  in  
medium  to  large  diameter  neurons  as  measured  with  whole  cell  voltage  clamp.  
Using  a  reduced  expression  system  in  DRG  neurons,  we  isolated  recombinant  
human  Nav1.6  sodium  currents  in  rat  DRG  neurons  and  found  that  
overexpression  of  Navβ4  enhanced  Nav1.6  resurgent  currents.  By  contrast  
neither  overexpression  of  Navβ2  nor  overexpression  of  a  Navβ4-­mutant,  
predicted  to  be  an  inactive  form  of  Navβ4,  enhanced  Nav1.6  resurgent  current  
generation.  DRG  neurons  transfected  with  wild-­type  Navβ4  exhibited  increased  
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excitability  with  increases  in  both  spontaneous  activity  and  evoked  activity.  Thus,  
Navβ4  overexpression  enhanced  resurgent  currents  and  excitability,  whereas  
knockdown  or  expression  of  mutant  Navβ4  decreased  resurgent  current  
generation.  This  study  identified  Navβ4  as  an  important  regulator  of  resurgent  
currents  and  excitability  in  sensory  neurons.  As  such,  Navβ4  may  be  a  potential  
target  for  the  manipulation  of  neuronal  excitability  and  pain  sensations.  
  




These  studies  used  cDNA  constructs  of  sodium  channel  β  subunits,  
Navβ2  and  Navβ4,  which  were  tagged  at  the  C-­terminus  to  verify  expression.  To  
generate  the  rat  Navβ4  C-­terminal  tagged  construct,  an  ApaI  restriction  enzyme  
site  was  introduced  into  pCMV6  vector  before  the  stop  codon  (Origene  clone,  
RR210027)  using  Quickchange  XL  II  Site  Directed  Mutagenesis  kit  (Agilent  
Technologies).  The  open  reading  frame  for  Navβ4  protein  (NP_001008880.1)  
between  ApaI  and  EcoRI  was  cut  and  inserted  into  mVenus  N1  or  pmTurquoise2  
N1.  Vectors,  mVenus  N1  and  pmTurquoise2  N1,  were  gifts  from  Dr.  Richard  Day  
at  Indiana  University  School  of  Medicine  (Indianapolis,  IN).  Two  constructs  were  
generated  using  this  approach:  Navβ4-­Turquoise  and  Navβ4-­Venus.  A  predicted  
inactive  form  of  Navβ4-­tagged  (Navβ4-­Mt)  was  generated  by  converting  lysines  
at  position  192-­193  and  197-­199  to  alanine  using  Quickchange  XL  II  Site  
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Directed  Mutagenesis  kit.  To  generate  the  rat  Navβ2-­tagged  construct,  cDNA  
encoding  for  rat  Navβ2  protein  (NP_037009.1)  was  codon-­optimized  and  
synthesized.  The  SCN2B  open  reading  frame  was  cut  with  NheI–AgeI  and  
inserted  into  mVenus  N1  vector.    
  
To  generate  the  Nav1.6r  construct,  SCN8A  gene  encoding  for  human  
Nav1.6  protein  (NP_055006.1)  was  codon-­optimized  and  synthesized.  The  open  
reading  frame  was  cut  with  KpnI-­XbaI  and  inserted  into  pcDNA3.1  vector.  The  
resulting  construct  was  modified  by  converting  tyrosine  371  to  serine  to  confer  
high  resistance  to  TTX  as  previously  described  (212,  213).  To  isolate  Nav1.6r  
currents,  Nav1.8  was  knocked  down  with  a  Nav1.8  shRNA-­IRES-­dsRED  
construct.  The  Nav1.8  shRNA-­IRES-­dsRED  construct  is  a  vector  plasmid  
(pIRES2-­dsRed)  that  encodes  for  the  Nav1.8  shRNA  sequence  (targeting  
sequence,  GATGAGGTCGCTGCTAAGG  (214))  and  an  internal  ribosome  entry  
site  for  the  translation  of  fluorescent  protein  marker  dsRed  (IRES-­dsRED)  as  




Adult  rat  DRG  ganglia  were  harvested,  dissociated  and  cultured  as  
previously  described  in  (19,  70,  212).  Briefly,  adult  male  Sprague  Dawley  rats  
were  rendered  unconscious  by  CO2  exposure  and  decapitated.  The  spinal  
column  was  removed  and  dorsal  root  ganglia  were  harvested  from  the  lumbar  
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region  up  to  the  cervical  region.  Excised  ganglia  were  digested  in  Dulbecco’  
modified  Eagle’s  Medium  (DMEM,  Fisher  Scientific)  containing  collagenase  
(1.25mg/mL)  and  neutral  protease  (0.78mg/mL)  for  45  minutes  at  37°C.  Ganglia  
were  mechanically  dissociated  with  sequentially  smaller  pasteur  pipettes  in  10%  
Fetal  Bovine  Serum  (FBS,  Hyclone)  DMEM  (Invitrogen).  Glass  coverslips  coated  
with  poly-­D-­lysine  and  laminin  were  loaded  with  dissociated  cell  suspension.  
After  10  minutes,  cells  settled  and  10%  FBS  DMEM  was  added.  For  knockdown  
experiments,  L4  and  L5  ipsilateral  dorsal  root  ganglia  were  excised  from  rats  
injected  with  non-­targeting  control  or  β4siRNA  (see  below).  The  above  
dissociation  protocol  and  culture  was  followed  with  the  exception  of  the  digestion  
time,  which  was  decreased,  to  28  minutes.  Cells  were  maintained  at  37°C  in  a  
humidified  95%  air  and  5%  CO2  incubator.  Media  was  changed  every  two  days.  
For  experiments  longer  than  two  days,  such  as  isolated  recordings  of  Nav1.6r  
from  DRG  neurons,  10%  FBS  DMEM  was  supplemented  with  mitotic  inhibitors:  
5-­fluoro-­2-­deoxyuridine  (50µM,  Sigma  Aldrich)  and  uridine  (150µM,  Sigma  
Aldrich).  Indiana  University  School  of  Medicine  Institutional  Animal  Care  and  Use  
Committee  approved  the  animal  protocols  described.    
  
Procedure  for  in  vivo  injection  of  siRNA  near  the  DRG  
  
siRNA  ‘‘smartpool’’  consisting  of  four  different  siRNA  constructs  combined  
into  1  reagent  directed  against  rat  Navβ4  subunit  (Gene  ID:  315611)  and  non-­
targeting  control  siRNA  were  purchased  from  Dharmacon.  Catalog  numbers  
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were  M-­101002-­01  (directed  against  Navβ4)  and  D-­001210-­02  (n.t.  control,  
directed  against  firefly  luciferase).  The  non-­targeting  control  siRNAs  are  reported  
to:  1)  not  target  any  known  rat  genes,  2)  have  a  minimum  of  four  mismatches  to  
all  human,  mouse  and  nontargeted  rat  genes,  and  3)  have  minimal  targeting  
confirmed  by  genome  wide  microarray  analysis  as  stated  by  manufacturer.  The  
four  siRNA  sequences  directed  against  Navβ4  were:  construct  1,  
GGAUCGUGAAGAAUGAUAA;;  construct  2,  UCCAAGUGGUUGAUAAAUU;;  
construct  3,  GCAAUACUCAGGCGAGAUG;;  construct  4,  
AAACAACUCUGCUACGAUC.  siRNAs  were  prepared  for  transfection  using  
cationic  linear  polyethylenimine-­based  reagents  (in  vivo  JetPEI,  Polyplus  
Transfection,  distributed  by  VWR  Scientific).  Aliquots  of  3µL  containing  siRNA/Jet  
Pei  mixture  (80pmol  of  siRNA)  were  injected  into  each  L4  and  L5  DRG  on  one  
side,  through  a  small  glass  needle  inserted  close  to  the  DRG  as  previously  
described  by  (14).  Three  days  post-­injection  L4  and  L5  dorsal  root  ganglia  were  
harvested.  16-­30  hours  after  culture  a  fraction  of  the  DRG  neurons  were  
examined  by  immunocytochemistry  to  verify  knockdown  and  another  fraction  was  
used  for  whole  cell  patch  clamp  (see  next  sections  for  more  details).  Indiana  
University  School  of  Medicine  Institutional  Animal  Care  and  Use  Committee  
approved  the  experimental  procedure  described.  
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Immunocytochemistry  
  
The  expression  patterns  of  Nav1.6  and  Navβ4  were  studied  in  dissociated  
cultures  of  DRG  neurons.  DRG  neurons  were  fixed  after  24  hours  in  culture  with  
4%  paraformaldehyde  (0.1M  phosphate  buffer,  pH  7.4)  for  20  minutes  and  
washed  in  phosphate  buffered  saline  (PBS)  three  times.  Cells  were  
permeabilized  in  1%  Triton  X-­100  in  PBS  for  20  minutes  at  room  temperature  
(~22°C),  washed  in  PBS  three  times,  blocked  for  2  hours  (10%  normal  goat  
serum,  0.1%  Triton  X-­100  in  PBS)  at  room  temperature  and  washed  an  
additional  three  times  in  PBS.  Cells  were  then  incubated  in  primary  antibodies  
diluted  in  blocking  solution  overnight  at  4°C.  Primary  antibodies  used  were  anti-­
Nav1.6  clone  K87A/10  (1:200,  AB_2184197,  UC  Davis/NIH  NeuroMab  Facility)  
and  polyclonal  anti-­Navβ4  antibody  (1:500,  #Ab80539,  Abcam).  After  three  
washes,  cells  were  incubated  with  secondary  antibodies  in  blocking  solution  for  2  
hours  at  room  temperature.  Secondary  antibodies  used  were  Alexa  Fluor®  488  
Goat  Anti-­Rabbit  IgG  and  Alexa  Fluor®  594  Goat  Anti-­Mouse  IgG  (Molecular  
Probes,  Life  Technologies)  at  1:2000  concentration.  Coverslips  were  mounted  in  
Prolong  Gold  Antifade  (Molecular  Probes)  and  DRG  neurons  imaged  using  Axio  
Observer  Z1  Widefield  Microscope  with  a  20X  objective  (ZEISS  Microscopy).  
Images  were  analyzed  using  Axio  Vision  software  (Version  4.8.2,  ZEISS  
Microscopy.  Each  cell  was  delineated  as  a  region  of  interest  and  correlation  was  
determined  using  the  colocalization  module  of  the  software.  The  analysis  yielded  
the  Pearson  correlation  coefficient  between  Nav1.6  and  Navβ4  fluorescence  
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signal  and  area  for  each  cell.  The  data  were  grouped  into  small  diameter  neurons  
(<400μm2)  and  medium  to  large  diameter  neurons  (>400μm2).  The  Pearson  
correlation  coefficient  was  compared  between  small  and  medium  to  large  
neurons  using  Student’s  t-­test.  It  is  important  to  note  that  due  to  the  limitations  of  
this  approach,  the  Pearson  correlation  values  do  not  specifically  represent  
colocalization  of  the  proteins  but  rather  describe  the  population  of  cells  that  co-­
express  Navβ4  and  Nav1.6.  Additionally,  images  were  analyzed  using  NIS  
Elements  Advance  Research  (Nikon®)  software  and  mean  intensity  for  Navβ4  
and  Nav1.6  staining  signal  was  determined  for  each  cell  by  defining  the  region  of  
interest.  The  data  were  grouped  into  small  diameter  neurons  (<400μm2)  and  
medium  to  large  diameter  neurons  (>400μm2).  The  mean  intensity  Navβ4  and  
Nav1.6  staining  signal  was  compared  between  small  and  medium  to  large  
neurons  using  Student’s  t-­test.  
  
To  verify  knockdown  of  Navβ4  protein,  L4  and  L5  ipsilateral  DRG  
harvested  and  cultured  from  rats  injected  with  non-­targeting  control  and  β4-­
siRNA  three  days  after  injection  were  examined.  DRG  neurons  were  fixed,  
permeabilized,  blocked  and  treated  with  primary  anti-­Navβ4  antibody  (1:500  
dilution)  and  secondary  antibody  goat  Alexa  Fluor®  488  Goat  Anti-­Rabbit  IgG  
(1:1000  dilution;;  Molecular  Probe,  Life  Technologies).  Coverslips  were  then  
mounted  and  imaged  with  a  Nikon  Eclipse  TE2000-­E  confocal  microscope  with  a  
20X  objective.  Corrected  Total  Cell  Fluorescence  (CTCF)  was  calculated  in  Excel  
   42  
(Microsoft)  by  applying  measurements  obtained  from  NIS  Elements  Advance  
Research  (Nikon®)  software  using  the  following  equations  adapted  from  (215):      
  
Equation  1  
𝐶𝑇𝐶𝐹 = 	   𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑𝐷𝑒𝑛𝑠𝑖𝑡𝑦 − 𝐴𝑟𝑒𝑎	  𝑜𝑓	  𝑠𝑒𝑙𝑒𝑐𝑡𝑒𝑑	  𝑐𝑒𝑙𝑙	  𝑋	  𝑀𝑒𝑎𝑛	  𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒	  𝑜𝑓	  𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑	  𝑟𝑒𝑎𝑑𝑖𝑛𝑔𝑠   
  
Equation  2   𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑	  𝐷𝑒𝑛𝑠𝑖𝑡𝑦 = 𝑀𝑒𝑎𝑛	  𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦	  𝑉𝑎𝑙𝑢𝑒	  𝑋	  𝐴𝑟𝑒𝑎	  𝑜𝑓	  𝑡ℎ𝑒	  𝑐𝑒𝑙𝑙   
  
Quantification  experiments  were  carried  out  independently  at  least  three  times;;  
more  than  250  cells  were  counted  for  each  condition.    
  
Nav1.6r  currents  in  DRG  neurons  
  
The  goal  of  these  experiments  was  to  study  the  modulation  of  Nav1.6  by  β  
subunits:  Navβ4  and  Navβ2.  DRG  neurons  express  a  variety  of  sodium  
channels,  therefore,  Nav1.6  current  properties  needed  to  be  isolated.    In  order  to  
achieve  this  we  expressed  a  Nav1.6  construct  resistant  to  TTX  (i.e.  Nav1.6r)  as  
described  in  the  cDNA  constructs  section.  Endogenous  TTXS  currents  were  
pharmacologically  inhibited  with  the  addition  of  500nM  TTX  to  the  extracellular  
recording  solution.  DRG  neurons  can  also  endogenously  express  TTXR  sodium  
currents:  Nav1.8  and  Nav1.9  (70,  75,  171).  Nav1.8  currents  are  greatly  
decreased  in  culture  (19,  216);;  additionally  Nav1.8  was  further  decreased  by  co-­
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transfecting  a  Nav1.8  shRNA-­IRES-­dsRED  construct  to  minimize  contamination  
of  Nav1.8  currents  in  the  recordings.  Nav1.9  currents  are  not  observed  under  the  
culture  and  recordings  conditions  used  (217,  218).  β  subunits  studied,  Navβ4-­
WT,  Navβ4-­Mt  and  Navβ2,  were  tagged  at  the  C-­terminus  with  fluorescent  
protein  (mVenus  or  pmTurquoise2)  to  verify  expression  as  described  in  the  cDNA  
constructs  section.  No  difference  was  observed  between  modulation  of  the  
biophysical  properties  of  human  Nav1.6r  by  co-­expression  of  Navβ4-­Turquoise  
compared  to  Navβ4-­Venus,  thus,  these  constructs  were  used  interchangeably  in  
experiments.  As  a  negative  control,  fluorescent  proteins  (mVenus  or  
pmTurquoise  2)  were  co-­transfected  instead  of  the  tagged  beta  subunits.  No  
difference  was  observed  between  modulation  of  the  biophysical  properties  of  
human  Nav1.6r  by  co-­expression  of  pmTurquoise2  compared  to  mVenus,  thus  
these  constructs  were  used  interchangeably  in  experiments.  The  Helios  Gene  
Gun  (Bio-­Rad  Laboratories)  was  used  to  transiently  transfect  DRG  neurons  as  
previously  described  in  (212,  218-­220).  DRG  neurons  were  co-­transfected  36-­48  
hours  after  dissociation  with:  Nav1.6r,  Nav1.8shRNA-­IRES-­dsRED,  and  tagged  β  
subunit  or  control  (tag  only)  DNA  at  a  2:1:1  ratio.  DRG  neurons  that  were  positive  
for  1.8shRNA  (indicated  by  dsRed  fluorescence)  and  β  subunit  expression  
(indicated  by  Turquoise  or  Venus  fluorescence)  were  selected  for  whole  cell  
patch  clamp.  In  the  cells  expressing  Nav1.6r  that  were  used  in  the  final  voltage  
clamp  analysis,  the  peak  recombinant  current  amplitude  averaged  21.2  ±  1.7nA  
(n=94).  Cells  that  expressed  Navβ4  or  Navβ2  localized  only  to  intracellular  
compartments  (based  on  fluorescence  localization)  were  excluded.  Cells  with  
   44  
residual  Nav1.8  current  greater  than  3%  of  the  peak  current  of  Nav1.6r  were  
excluded.  Nav1.8  contamination  can  be  determined  for  each  individual  cell  
expressing  recombinant  current  by  examining  the  voltage-­dependence  of  steady-­
state  fast  inactivation.  The  midpoint  of  inactivation  for  Nav1.8  is  much  more  
depolarized  compared  to  Nav1.6.  The  curve  of  the  voltage-­dependence  of  
inactivation  was  used  to  determine  absolute  and  relative  amplitude  for  Nav1.8  
and  Nav1.6r  (19).  Whole  cell  patch  clamp  recordings  in  voltage  clamp  and  
current  clamp  mode  were  obtained  2-­3.5  days  after  transfection.  As  an  
observational  note,  DRG  neurons  that  were  biolistically  transfected  were  
generally  considered  small  diameter  neurons  based  on  their  membrane  




Whole  cell  patch  clamp  recordings  were  conducted  in  voltage  clamp  or  
current  clamp  mode  at  room  temperature  (~22°C)  using  a  HEKA  EPC-­10USB.  
Data  were  acquired  on  a  Windows-­based  Intel  2  Core  using  Patchmaster  
program  (version  2X65;;  HEKA  Elektronik).  Fire  polished  glass  electrodes  (0.7-­
1.1MΩ)  were  fabricated  using  a  P-­97  puller  (Sutter),  and  tips  were  coated  with  
dental  wax  to  minimize  capacitive  artifacts  and  enhance  series  resistance  
compensation.  The  offset  potential  was  zeroed  prior  to  seal  formation.  Capacitive  
transients  were  canceled  using  computer  controlled  circuitry;;  C-­fast  for  pipette  
capacitance  correction  and  C-­slow  for  cell  capacitance  compensation.  Voltage  
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errors  were  minimized  by  series  resistance  compensation  >75%.  Membrane  
currents  were  sampled  at  20KHz  and  filtered  online  at  10KHz.  Leak  currents  
were  linearly  cancelled  by  P/-­5  subtraction  (pulse/number).  
  
   For  voltage  clamp  recordings,  the  electrode  solution  consisted  of  140mM  
CsF,  10mM  NaCl,  1.1mM  EGTA,  and  10mM  HEPES  (adjusted  to  pH  7.3  with  
CsOH).  The  extracellular  bathing  solution  contained  130mM  NaCl,  30mM  TEA  
chloride,  1mM  MgCl2,  3mM  KCl,  1mM  CaCl2,  0.05mM  CdCl2,  10mM  HEPES  and  
10mM  D-­glucose  (adjusted  pH  7.3  with  NaOH).  Recording  solutions  were  
adjusted  using  D-­glucose  to  maintain  physiological  osmolarity  values  (310  mOsm  
for  internal  solution  and  320  mOsm  for  external  solution).  Whole  cell  currents  in  
voltage  clamp  mode  were  not  recorded  before  4  minutes  after  whole  cell  
configuration  for  Nav1.6r  isolation  and  before  2  minutes  after  whole  cell  
configuration  for  endogenous  sodium  currents.  Cells  were  held  at  a  potential  of  -­
100mV.    
  
Current-­voltage  (I/V)  relationships  were  determined  by  steps  of  50ms,  
from  -­100  to  +  80mV,  in  5mV  increments.  The  voltage-­dependence  of  activation  
(m∞)  was  determined  from  sodium  currents  elicited  with  I/V  protocol  from  
voltages  of  -­100mV  to  0mV.  Conductance  (G)  values  were  calculated  at  each  
test  potential  (Vm)  using  the  following  equation,  𝐺 = @ABCAD .  Vr    is  the  voltage  at  
which  the  direction  sodium  influx  reverses.  The  reversal  potential  was  quantified  
for  each  neuron  Goldman-­Hodgkin-­Katz  equation  (221).  Data  were  then  
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normalized  to  the  peak  conductance,  plotted  as  a  function  of  voltage  and  fitted  
using  single-­phase  Boltzmann  distribution  equation,  
  
EEBFG = HHIJ KBLKM/O P .  The  midpoint  voltage  of  activation  (V1/2)  and  slope  
factor  (k)  were  obtained  for  each  cell.    
  
Steady-­state  fast  inactivation  (h∞)  was  assayed  with  500ms  pre-­pulses  
from  -­130  to  5mV  (in  5mV  increments)  followed  by  a  20ms  test  pulse  to  -­20mV  to  
assess  channel  availability.  Currents  at  each  pre-­pulse  were  normalized  to  the  
peak  current.  Data  of  normalized  currents  as  a  function  of  voltage  was  fitted  with  
the  single  phase  Boltzmann  distribution,   @@BFG = HHIJ KBLKM/O P ,  from  which  the  
midpoint  voltage  of  inactivation  (V1/2)  and  slope  factor  (k)  were  obtained  for  each  
cell.  Vm  corresponded  to  the  prepulse  voltage.  Additionally,  current  densities  
were  estimated  for  each  individual  recording  by  dividing  the  peak  transient  
currents  obtained  from  h∞  by  the  membrane  capacitance.  For  endogenous  
current  recordings,  the  fast  component  of  the  sodium  currents  was  isolated  by  
pre-­pulse  subtraction  of  the  slow  component  as  previously  described  in  (88).  
Current  densities  were  estimated  for  each  individual  recording  by  dividing  the  
peak  transient  currents  obtained  from  h∞  protocol  by  the  membrane  capacitance.  
Comparison  of  values  for  inactivation,  activation  and  current  density  were  done  
using  ANOVA  and  post-­hoc  Bonferroni  test.  
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For  current  clamp  recordings,  the  goal  was  to  study  the  activity  mediated    
by  Nav1.6r  under  control  and  Navβ4  overexpression  conditions.  Thus,    
transfected  Nav1.6r  was  isolated  by  silencing  the  function  of  other  voltage-­gated  
sodium  channels  with  TTX  and  Nav1.8-­shRNA  as  described  above.  The  pipette  
solution  contained  140mM  KCl,  0.5mM  EGTA,  5mM  HEPES  and  3mM  Mg-­ATP  
(adjusted  pH  7.3  with  KOH).  The  extracellular  solution  contained  140mM  NaCl,  
3mM  KCl,  2mM  MgCl2,  2mM  CaCl2,  10mM  HEPES  and  500nM  TTX  (adjusted  pH  
7.3  with  NaOH).  Recording  solutions  were  adjusted  using  D-­glucose  to  maintain  
physiological  osmolarity  values.  Recording  were  obtained  from  the  DRG  neuron  
resting  potential.  No  current  was  injected  to  hold  the  cell  at  a  specific  voltage.  A  
cell  was  classified  as  spontaneously  active  if  spontaneous  firing  was  maintained  
for  3  or  more  minutes.  DRG  neurons  that  were  not  spontaneously  active  were  
examined  for  evoked  activity  with  a  series  of  current  injections  from  -­200pA  to  
1.2nA  in  100pA  increments.  For  evoked  activity,  the  maximum  number  of  action  
potentials  elicited  from  each  cell  was  determined  as  the  maximum  action  
potentials  elicited  from  current  injections  from  0  to  1.2nA.  For  non-­spontaneous  
neurons  rheobase  was  determined  as  the  minimum  current  injection  needed  to  
elicit  an  action  potential  response  and  input  resistance  (R)  was  estimated  from  
the  membrane  potential  (∆𝑉)  change  at  -­200pA  current  injection  (I)  using  the  
equation:  V=IR.    
  
Comparison  of  current  clamp  parameters  examined  was  done  using  
Student  t-­test.  Voltage  and  current  clamp  data  were  analyzed  using  Origin  
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(version  8,  OriginLab),  Fitmaster  (v2X65,  HEKA  Electronik),  Excel  (Microsoft)  
and  Prism  (version  6,  GraphPad)  software  programs.    
  
Resurgent  currents  and  analysis  
  
Cells  were  assayed  with  a  step  protocol  that  initially  depolarized  the  
membrane  to  +30mV  for  20ms  from  the  holding  potential,  followed  by  
repolarizing  voltage  steps  from  +15mV  to  -­85  for  100ms  in  -­5mV  increments  to  
test  for  resurgent  currents;;  cells  were  then  returned  to  their  holding  potential.  
Resurgent  currents  display  unique  characteristics  of  slow  onset  and  slow  decay  
along  with  a  non-­monotonic  I/V  relationship.  Currents  that  did  not  meet  these  
characteristics  were  classified  as  negative  for  resurgent  currents.  Based  on  these  
criteria,  the  percentage  of  DRG  that  were  positive/negative  for  detectable  
resurgent  current  was  quantified  for  each  condition.  The  Chi-­square  test  (X2  test)  
was  then  used  to  compare  distributions  between  conditions.  Resurgent  current  
amplitudes  were  measured  from  the  leak-­subtracted  baseline  to  the  peak  after  
3.0ms  into  the  repolarizing  pulse  to  avoid  contamination  from  tail  currents.  
Relative  resurgent  currents  were  calculated  by  dividing  peak  resurgent  current  by  
the  peak  transient  current  and  expressed  as  a  percentage  of  the  peak  transient  
current.  The  peak  transient  current  was  determined  as  the  peak  from  the  h∞  
protocol.  For  endogenous  resurgent  current  recordings,  the  peak  transient  of  the  
h∞  protocol  was  determined  after  subtraction  of  the  slow  component  using  pre-­
pulse  subtraction  (88).  For  population  data,  relative  resurgent  currents  were  
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plotted  as  a  function  of  voltage.  Student’s  t  test  was  used  to  examine  the  




Navβ4  and  Nav1.6  expression  are  correlated  in  DRG  neurons.  
  
The  goal  of  our  study  was  to  determine  if  Navβ4  regulates  fast  resurgent  
currents  in  DRG  neurons.  Therefore,  we  examined  the  expression  pattern  of  
Navβ4  in  rat  DRG  neurons  and  its  correlation  with  Nav1.6  expression  pattern.  
Immunostaining  of  DRG  neurons  in  dissociated  cultures  shows  that  the  Navβ4  
signal  is  present  in  all  size  classes.  However,  the  mean  intensity  of  staining  was  
three-­fold  higher  in  medium  to  large  diameter  neurons  than  in  small  diameter  
neurons  (mean  intensity  p<0.0001:  medium  to  large  diameter,  49.5  ±  2  Arbitrary  
Units  (AU),  n=260;;  small  diameter  17.4  ±  0.5AU,  n=557).  These  medium  to  large  
diameter  neurons,  with  estimated  cross  sectional  area  >400µm2,  most  likely  give  
rise  to  Aδ  and  Aβ  fibers.  Our  results  are  consistent  with  previous  studies,  which  
found  Navβ4  mRNA  levels  to  be  higher  in  medium  to  large  diameter  neurons  
relative  to  small  diameter  neurons  (23,  138).  Similarly,  the  Nav1.6  signal  is  
observed  in  all  size  classes  but  exhibits  more  pronounced  immunostaining  in  
medium  to  large  diameter  neurons,  consistent  with  previous  observations  (13,  
222).  The  mean  intensity  of  staining  was  more  than  two-­fold  higher  in  medium  to  
large  diameter  neurons  than  in  small  diameter  neurons  (mean  intensity  
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p<0.0001:  medium  to  large  diameter,  62.5  ±  2AU,  n=260;;  small  diameter  26.94  ±  
1AU,  n=557).  Representative  images  are  shown  in  Figure  6A-­C.  Co-­expression  
of  the  two  signals  (Navβ4-­green  and  Nav1.6-­red)  in  neurons  was  quantified  using  
the  Pearson  correlation  coefficient  method.  Using  this  approach,  we  found  that  
medium  to  large  diameter  neurons  have  a  stronger  correlation  between  Nav1.6  
and  Navβ4  expression  than  small  diameter  neurons  (Figure  6D-­E,  Pearson  
correlation  coefficient  p<0.0001:  medium  to  large  diameter,  0.81  ±  0.01,  n=344;;  





Figure  6:  Expression  of  Nav1.6  and  Navβ4  in  DRG  neurons.  Examples  of  
immunocytochemical  staining  of  Navβ4  and  Nav1.6  in  primary  cultured  DRG  neurons  are  shown  
in  A  and  B.  Navβ4  signal  is  shown  in  green  and  Nav1.6  signal  is  shown  in  red  with  corresponding  
brightfield  (DIC)  image  shown  in  C.  Merged  image  (D)  shows  that  some  DRG  neurons  but  not  all  
express  both  Nav1.6  and  Navβ4.  E,  Strong  co-­expression  of  Nav1.6  and  Navβ4  signal  is  mainly  
observed  in  medium  to  large  diameter  neurons  (>400um2,  n=344),  but  not  small  diameter  
neurons  (<400um2,  n=347)  as  indicated  by  the  Pearson  correlation  coefficient.  Asterisks  (****)  
represent  p  <0.0001  obtained  from  Student’s  t-­test.  Scale  bar  50μm.  
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Navβ4  knockdown  reduces  resurgent  current  generation.  
  
We  next  investigated  if  Navβ4  functionally  regulates  endogenous  fast  
resurgent  current  generation  in  DRG  neurons.  In  order  to  address  this  question  
we  used  an  in  vivo  knockdown  approach  (223).  Animals  received  localized  
injections  (near  L4  and  L5  DRG)  of  Navβ4-­siRNAs  (β4-­siRNA)  or  non-­targeting  
control  siRNAs  (n.t.  control)  mixed  with  the  transfection  reagent  JetPEI  (see  
Methods).  Three  days  post  injection,  DRG  neurons  were  grown  in  culture.  After  
16-­36  hours  in  culture,  DRG  neurons  were  examined  by  immunocytochemistry  to  
verify  knockdown  and  subjected  to  whole  cell  patch  clamp  recordings  to  assess  
sodium  current  properties.  Representative  images  of  Navβ4  staining  in  n.t.  
control  and  β4-­siRNA  groups  are  shown  in  Figure  7A-­B.  Navβ4  levels  were  
reduced  in  the  β4-­siRNA  group  by  approximately  50%  compared  to  n.t.  control  
(Figure  7C,  corrected  total  cell  fluorescence  p<0.0001:  β4siRNA,  1.3  ±  




Figure  7:  In  vivo  knockdown  decreases  Navβ4  expression  levels.  Representative  images  of  
immunocytochemical  staining  of  Navβ4  in  primary  cultured  DRG  neurons  from  rats  injected  with  
non-­targeting  siRNA  (n.t.  control,  A)  or  Navβ4-­siRNA  (β4-­siRNA,  B)  72  hours  post  injection.  C,  
Corrected  Total  Cell  Fluorescence  (CTFC)  is  significantly  decreased  in  DRG  neurons  from  rats  
injected  with  β4-­siRNA  (n=352  from  3  rats,  p<0.0001)  compared  with  n.t.  control  (n=264  from  3  
rats).  Scale  bar  50μm.  Asterisks  (****)  represent  p<0.0001  obtained  from  Student’s  t-­test.
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   Endogenous  sodium  currents  were  recorded  from  medium  to  large  
diameter  DRG  neurons  cultured  from  rats  treated  with  β4-­siRNA  or  n.t.  control.  
Small  diameter  neurons  were  excluded  because  these  neurons  do  not  
endogenously  generate  fast  resurgent  current  under  normal  conditions  (23,  27),  
possibly  reflecting  the  weak  correlation  of  Nav1.6  and  Navβ4  expression  (Figure  
5).  Cell  size  was  assessed  by  measurement  of  total  membrane  capacitance.  In  
the  39  cells  examined,  the  average  cell  capacitance  was  60.2  ±  2.9pF  and  cell  
capacitance  was  not  different  between  the  groups.  Capacitance  is  linearly  
correlated  to  the  surface  area  of  cell  (224).  We  estimate  that  the  average  cell  
diameter  was  60.2  µm,  assuming  a  spherical  morphology  (34,  225).  Therefore,  
the  DRG  neurons  examined  were  considered  as  part  of  the  large  diameter  
population  (226).    
  
In  order  to  determine  relative  changes  in  fast  resurgent  currents  (which  
are  TTXS)  and  exclude  potential  effects  due  to  changes  in  TTXS  channel  
density,  resurgent  current  amplitudes  were  normalized  to  the  TTXS  peak  
transient  current  amplitudes.  Resurgent  currents  were  examined  using  a  two-­
step  pulse  protocol  described  in  the  Methods  section.  Figures  8A  and  8B  show  
representative  traces  of  endogenous  fast  resurgent  current  obtained  from  each  
group.  β4-­siRNA  treatment  significantly  reduced  the  fraction  of  neurons  positive  
for  the  fast  resurgent  current  relative  to  n.t.  control  (Figure  8C,  X2  test,  p<0.05).  
In  the  β4-­siRNA  group,  7  out  of  20  neurons  (35%)  generated  fast  resurgent  
current,  whereas  in  the  n.t.  control  group,  15  out  of  19  (79%)  neurons  exhibited  
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fast  resurgent  current.  Moreover,  the  average  amplitude  of  the  fast  resurgent  
current  (expressed  as  a  percentage  of  peak  transient  TTXS  current)  was  
significantly  decreased  in  the  β4-­siRNA  group  compared  to  control  (Figure  8D,  




Figure  8:  Navβ4  knockdown  reduces  endogenous  fast  resurgent  current.  Representative  
traces  of  endogenous  fast  resurgent  currents  obtained  from  medium  to  large  diameter  DRG  
neurons  cultured  from  rats  injected  with  n.t.  control  (A)  or  β4siRNA  (B).  Peak  resurgent  current  
traces  are  highlighted  with  black  (n.t.  control)  and  brown  (β4siRNA).  C,  Compared  with  n.t.  
control,  β4siRNA  significantly  decreased  the  percentage  of  DRG  neurons  that  generated  
resurgent  currents  (p<0.0005,  X2  test).  D,  Compared  to  control  (black  squares,  n=19),  Navβ4  
knockdown  (brown  diamonds,  n=20)  significantly  decreased  resurgent  current  amplitude  in  a  
range  of  voltages.  (*,  p<0.05  obtained  from  Student’s  t-­test).  Summary  data  are  mean  ±  SEM.  
  
  
Navβ4  may  also  alter  the  voltage-­dependence  of  activation  and  
inactivation  of  VGSCs  (135).  For  example,  in  cerebellar  granule  neurons  Navβ4  
knockdown  shifted  the  voltage-­dependence  of  inactivation  to  more  negative  
potentials,  whereas,  activation  was  unchanged  (197).  In  contrast,  in  heterologous  
expression  systems,  Navβ4  co-­expression  shifts  the  voltage-­dependence  of  
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activation  to  negative  potentials  but  no  change  in  inactivation  is  observed  (198,  
200,  227).  Modulation  by  Navβ4  seems  to  be  cell  background  specific.  In  the  
endogenous  sodium  current  recordings  obtained,  activation  was  not  studied  due  
to  contamination  with  TTXR  currents  that  cannot  be  readily  subtracted.  However,  
using  pre-­pulse  subtraction,  we  isolated  the  TTXS  component  of  the  sodium  
currents  recorded  with  the  steady-­state  inactivation  protocol  and  compared  the  
voltage-­dependence  of  inactivation  between  groups.  Navβ4  knockdown  slightly  
shifted  the  voltage-­dependence  of  inactivation  to  more  hyperpolarized  potentials.  
This  apparent  shift  did  not  quite  reach  significance  (Figure  9A.  midpoint  voltage  
of  inactivation,  p=0.052;;  n.t.  control  -­67.7  ±  2.4mV,  n=18;;  β4-­siRNA  -­73.6  ±  
2.6mV,  n=20).  The  peak  current  density  of  transient  currents,  which  can  contain  
both  fast  (TTXS)  and  slow  (TTXR)  sodium  currents,  was  not  significantly  
different.  However,  when  the  TTXS  component  was  isolated  by  prepulse  
subtraction,  there  was  a  32%  reduction  in  the  peak  current  density  with  β4-­siRNA  




Figure  9:  Inactivation  properties  and  peak  current  of  endogenous  sodium  current  in  
control  and  β4-­siRNA  groups.  A,  Voltage-­dependence  of  steady-­state  inactivation  in  β4-­siRNA  
group  (brown  diamonds)  and  n.t.  control  (black  squares).  B,  Total  peak  current  density  is  not  
different  between  non-­targeting  control  (n=19)  and  β4-­siRNA  (n=20).  C,  After  pre-­pulse  
subtraction  the  (TTXS)  fast  component  was  isolated  from  total  peak  current  density.  TTXS  peak  
current  density  was  significantly  decreased  in  β4-­siRNA  relative  to  n.t.  control  (*,  p<0.05  obtained  
from  Student’s  t-­test).  Summary  data  are  mean  ±  SEM.  
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Navβ4  increases  Nav1.6r  resurgent  currents  whereas  Navβ2  does  not.  
  
Using  recombinant  expression  in  DRG  neurons  grown  in  culture,  we  
studied  the  effects  of  overexpression  of  Navβ4  and  Navβ2  on  Nav1.6  mediated  
fast  resurgent  currents.  Navβ4  is  most  homologous  to  Navβ2,  with  35%  identity  
(198).  While  they  are  structurally  similar,  Navβ2  has  been  proposed  to  lack  the  
appropriate  properties  to  enable  open  channel  block  (180,  199).  Therefore,  we  
hypothesized  that  Navβ4  overexpression  would  increase  fast  resurgent  current,  
whereas  Navβ2  would  not.  Interestingly,  both  subunits  contain  a  free  cysteine  
that  is  likely  to  form  a  disulfide  bond  with  the  α  subunit  (228-­230).  While  it  is  not  
known  if  Navβ2  and  Navβ4  compete  for  the  same  cysteine  on  the  α  subunit,  if  
they  do  compete,  then  Navβ2  would  be  predicted  to  decrease  fast  resurgent  
current.    
  
Dissociated  DRG  neuronal  cultures  were  co-­transfected  with  recombinant  
human  Nav1.6  and  either  wild-­type  (WT)  Navβ4  or  Navβ2.  We  used  a  Nav1.6  
construct  (Nav1.6r)  that  has  been  mutated  to  be  resistant  to  TTX  (213).  This  
allows  500nM  TTX  to  be  used  to  block  endogenous  TTXS  currents  without  
blocking  Nav1.6r  currents,  enabling  pharmacological  isolation  of  Nav1.6r  
mediated  fast  resurgent  currents  (19)  (see  Methods  section).  β  subunit  
constructs  were  tagged  with  a  fluorescent  protein  (Venus  or  Turquoise)  at  the  C-­
terminus  to  verify  expression.  As  a  control,  Nav1.6r  was  co-­expressed  with  
fluorescent  protein  (corresponding  to  the  tag).  In  addition,  Nav1.8  was  knocked  
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down  with  co-­transfection  of  a  Nav1.8  shRNA-­IRES-­dsRED  construct  to  minimize  
contamination  by  Nav1.8  currents  (19,  218)  (see  Methods  section).  Whole  cell  
patch  clamp  recordings  were  obtained  2-­3.5  days  post-­transfection.    
  
Representative  traces  of  Nav1.6r  resurgent  currents  recorded  with  co-­
transfection  of  control  (fluorescent  tag),  Navβ4-­WT  and  Navβ2-­WT  are  shown  in  
Figure  10A-­C.  The  percentage  of  transfected  cells  exhibiting  fast  resurgent  
current  increased  significantly  with  Navβ4-­WT  overexpression  (Figure  10D,  X2-­
test,  p<0.0001).  For  the  Navβ4-­WT  group,  24  out  24  cells  (100%)  generated  fast  
resurgent  current,  whereas  in  the  control  group  20  out  of  36  cells  (56%)  exhibited  
identifiable  fast  resurgent  currents.    No  difference  in  resurgent  current  frequency  
was  observed  between  Navβ2  (7  out  of  17  cells,  41%)  and  control.  
Overexpression  of  Navβ4-­WT  also  resulted  in  a  three-­fold  increase  in  fast  
resurgent  current  amplitude  relative  to  control  (Figure  10E,  p<0.0001;;  control  
0.84  ±  0.2%,  n=36;;  Navβ4-­WT  2.94  ±  0.3%,  n=24).  In  contrast,  there  was  no  
difference  in  fast  resurgent  current  amplitude  between  the  Navβ2-­WT  group  and  
control  (0.7  ±  0.2%,  n=17).    
  
   Nav1.6r  transient  current  recordings  were  analyzed  for  potential  
alterations  in  activation,  steady-­state  fast  inactivation  and  current  density.  
Overexpression  of  Navβ4-­WT  caused  a  significant  decrease  in  current  density,  a  
depolarizing  shift  in  inactivation  and  no  change  in  activation  relative  to  control.    T  
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Navβ2-­WT  overexpression  only  altered  the  slope  of  the  voltage-­dependence  of  




Figure  10:  Overexpression  of  Navβ4-­WT  of  DRG  neuron  increases  Nav1.6r  resurgent  
currents  whereas  Navβ2-­WT  does  not.  DRG  neurons  were  transfected  with  Nav1.6r  and  
Navβ4-­WT,  Navβ2-­WT  or  fluorescent  protein  tag  (control).  β  subunits  were  tagged  with  
fluorescent  protein  to  monitor  expression.  Representative  traces  were  obtained  from  transfected  
DRG  neurons  and  peak  resurgent  currents  are  highlighted  for  control  (A,  black),  Navβ4-­WT  (B,  
blue),  and  Navβ2-­WT  (C,  green).  D,  Overexpression  of  Navβ4-­WT  significantly  increased  the  
percentage  of  DRG  neurons  that  generated  resurgent  current  compared  to  control  (p<0.0001,  χ2  
test).  The  percentage  of  DRG  neurons  that  generated  resurgent  currents  was  not  different  
between  Navβ2-­WT  and  control  groups.  E,  Compared  to  control  (black  circles,  n=36),  
overexpression  of  Navβ4-­WT  (blue  squares,  n=24)  increased  resurgent  current  amplitude.  
Navβ2-­WT  (green  triangles,  n=17)  did  not  alter  resurgent  current  amplitude  relative  to  control.  
Note  that  resurgent  currents  were  normalized  to  peak  transient  currents  and  plotted  as  a  function  
















Figure  11:  Biophysical  properties  of  Nav1.6r  transient  current  with  β  subunit  co-­
expression.  Representative  traces  of  Nav1.6r  transient  current  recordings  with  co-­expression  of  
fluorescent  tag  (control,  A,  black  circles),  Navβ4-­WT  (B,  blue  squares),  Navβ2-­WT  (C,  green  
triangles)  and  Navβ4-­Mt  (D,  purple  diamonds).  E,  Navβ4-­WT  and  Navβ4-­Mt  co-­expression  
significantly  shift  the  voltage-­dependence  of  steady-­state  fast  inactivation  to  depolarizing  
potentials  relative  to  control  whereas  Navβ2-­WT  does  not.  Navβ4-­Mt  shifted  significantly  the  
voltage-­dependence  of  inactivation  to  more  depolarized  potentials  relative  to  Navβ4-­WT.  F,  
Navβ4-­Mt  co-­expression  shifts  the  voltage-­dependence  of  activation  of  Nav1.6r  to  depolarized  
potentials  relative  to  control  and  Navβ4-­WT.  Navβ2  and  Navβ4-­WT  do  not  significantly  alter  the  
voltage-­dependence  of  activation  relative  to  control.  Table  1  contains  the  values  for  Boltzmann  fit  
for  steady-­state  fast  inactivation,  activation  and  corresponding  comparisons.    
  
  

















   Activation   Inactivation   Current  
Density  
(nA/pF)  
V1/2  (mV)   k   V1/2  (mV)   k  
Control  
n  
-­41.1  ±  1.7  
34  
5.3  ±  0.3  
34  
-­76.2  ±  1.3  
35  
6.2  ±  0.1  
35  




-­46.0  ±  2.5  
15  
4.2  ±  0.3*  
15  
-­77.1  ±  2.5  
15  
7.2  ±  0.2#  
15  




-­42.4  ±  1.8  
24  
5.9  ±  0.4  
24  
-­72.3  ±  1.8*  
21  
6.0  ±  0.1  
21  




-­30.5  ±  1.9#,†  
16  
5.7  ±  0.3  
16  
-­67.1  ±  1.7#,  †  
16  
8.3  ±  0.5#,  †  
16  




Table  2:  Parameters  of  human  Nav1.6r  transient  currents  with  β  subunit  co-­expression.  
Abbreviations  are;;  k,  slope  factor  and  V1/2,  midpoint  voltage  of  activation  or  inactivation.  Groups  
were  compared  to  control  using  Student  t-­test.  *p<0.05  (vs.  control);;  #p<0.0005  (vs.  control);;  †  
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Navβ4  C-­terminus  is  important  for  the  regulation  of  Nav1.6r  resurgent  currents  
  
We  next  investigated  if  the  C-­terminal  region  proposed  to  act  as  an  open  
channel  blocker  (Amino  Acids:  184-­203;;  β4  peptide)  (180,  183,  197)  was  
important  for  Navβ4-­WT  positive  regulation  of  fast  resurgent  currents  in  DRG  
neurons.  While  the  β4-­peptide  can  recapitulate  resurgent  currents  in  various  cell  
types  (199),  the  role  of  this  region  has  not  been  studied  in  full  length  Navβ4.  
Therefore,  we  generated  a  mutant  Navβ4  (Navβ4-­Mt)  in  which  five  lysine  
residues  at  positions  192-­193  and  197-­199  were  converted  to  alanine  (Figure  
12A).  These  residues  were  chosen  because  the  positive  charges  at  these  
positions  are  highly  conserved  between  Navβ4  of  different  species  and  have  
been  shown  to  be  important  for  β4-­peptide  open  channel  blocker  activity  (180,  
199).  Based  on  peptide  studies,  we  predicted  that  the  C-­terminus  of  Navβ4-­Mt  
would  not  be  able  to  bind  to  the  sodium  channel  pore  and  therefore  would  not  
facilitate  the  generation  of  fast  resurgent  current.    
  
In  contrast  to  Navβ4-­WT,  overexpression  of  Navβ4-­Mt  did  not  enhance  
fast  resurgent  current  generation.  Figure  12B,  shows  a  comparison  of  
representative  traces  of  Nav1.6r  resurgent  currents  recorded  after  co-­transfection  
of  Navβ4-­Mt,  control  (fluorescent  tag)  and  Navβ4-­WT.  Overexpression  of  Navβ4-­
Mt  decreased  the  percentage  of  resurgent  current  positive  neurons  (Figure  12C:  
%  of  fast  resurgent  current  positive  neurons,  Navβ4-­Mt,  31%,  X2-­test,  p<0.0001)  
relative  to  Navβ4-­WT  group  but  was  not  significantly  different  from  control  
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(p=0.053).  Similarly,  fast  resurgent  current  amplitude  was  significantly  decreased  
relative  to  Navβ4-­WT  (Figure  12D,  p<0.0001;;  Navβ4-­Mt  0.61  ±  0.3%,  n=16)  but  
was  not  significantly  different  compared  to  control.  Surprisingly,  analysis  of  
transient  current  recordings  revealed  that  Navβ4-­Mt  overexpression  shifted  the  
voltage-­dependence  of  steady-­state  fast  inactivation  and  activation  to  positive  





Figure  12:  Navβ4  C-­terminus  is  important  for  positive  regulation  of  resurgent  currents.  A,  
Illustration  of  Navβ4  subunit,  which  consists  of  an  extracellular  immunoglobulin-­like  domain,  a  
single  transmembrane  domain,  and  a  cytoplasmic  domain.  The  cytoplasmic  domain  contains  the  
β4  peptide  sequence  (amino  acids  183-­203)  proposed  to  mediate  resurgent  currents.  Inset,  
highlights  the  20  amino  acids  segment  sequence  of  the  cytoplasmic  domainl  of  Navβ4  
corresponding  to  residues  183-­203  of  the  rat  protein.  Red  lettering  indicates  five  lysine  residues  
corresponding  to  Navβ4-­WT  (β4-­WT)  sequence  in  C-­terminal  region  that  were  neutralized  to  
alanine  to  generate  a  predicted  inactive  form  of  Navβ4  (Navβ4-­Mt).  B,  Representative  trace  
obtained  from  transfected  DRG  neurons  with  Nav1.6r  and  Navβ4-­Mt.  Navβ4-­Mt  peak  resurgent  
current  is  highlighted  in  purple.  For  comparison  representative  trace  of  peak  resurgent  current  
obtained  from  Navβ4-­WT  group  is  highlighted  in  blue  and  control  is  highlighted  in  black.  C,  
Overexpression  of  Navβ4-­Mt  significantly  decreased  the  percentage  of  DRG  neurons  that  
generated  resurgent  current  compared  to  Navβ4-­WT  (p<0.0001,  X2  test)  but  not  significantly  
different  to  control.  D,  Resurgent  current  amplitude  in  Navβ4-­Mt  group  (purple  circles,  n=16)  was  
significantly  decreased  compared  to  Navβ4-­WT  (blue  line)  but  not  different  to  control.  Note  that  
resurgent  currents  were  normalized  to  peak  transient  currents  and  plotted  as  a  function  of  
voltage.  Navβ4-­WT  and  control  data  are  plotted  as  a  line  of  the  average  for  reference.  Navβ4-­Mt  
summary  data  are  mean  ±  SEM.  
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Navβ4  expression  increases  excitability  of  DRG  neurons  
  
Our  data  demonstrate  that  Navβ4-­WT  overexpression  increased  Nav1.6r  
resurgent  currents  DRG  neurons.  Therefore,  we  used  this  as  an  opportunity  to  
study  the  impact  of  increased  fast  resurgent  current  on  DRG  neuronal  
excitability.  DRG  neurons  were  co-­transfected  with  Nav1.6r  and  either  the  
fluorescent  tag  (control)  or  Navβ4-­WT.  Current  clamp  experiments  were  
conducted  on  transfected  neurons  using  Nav1.8  shRNA  and  TTX  to  block  
endogenous  sodium  currents.  This  approach  allowed  us  to  examine  Nav1.6r  
dependent  neuronal  excitability.  Spontaneous  activity  was  observed  in  the  
Navβ4-­WT  group  but  not  in  the  control  neurons  (Figure  13A-­B).  Four  out  of  15  
cells  (27%)  transfected  with  Navβ4-­WT  were  spontaneously  active  while  zero  of  
15  control  cells  (0%)  were  spontaneously  active.  Thus,  overexpression  of  Navβ4-­
WT  significantly  increased  spontaneous  activity  (X2  test,  p<0.05).  In  cells  that  did  
not  exhibit  spontaneous  activity,  neuronal  excitability  was  examined  by  a  series  
of  1s  current  injections  (-­200pA  up  to  1.2nA  in  100pA  increments)  from  their  
resting  membrane  potentials.  Representative  membrane  responses  to  current  
injections  (evoked  activity  at  rheobase)  in  control  and  Navβ4-­WT  transfected  
neurons  are  shown  in  Figure  13C.  Navβ4  overexpression  significantly  increased  
the  maximum  number  of  evoked  action  potentials  (Figure  13D:  Navβ4-­WT  4.5  ±  
1.8,  n=11;;  control  1.2  ±  0.1,  n=15,  p<0.05).  The  maximum  number  of  evoked  
action  potentials  was  defined  as  the  maximum  number  of  action  potentials  
elicited  at  a  given  current  injection  from  -­200pA  to  1.2nA  for  each  cell.  The  
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number  of  evoked  action  potentials  was  also  significantly  greater  with  Navβ4  
overexpression  when  measured  specifically  at  rheobase,  and  at  2X  and  3X  
rheobase  compared  to  control  (Figure  14).  In  cells  that  we  examined  for  evoked  
activity  no  significant  change  was  observed  in  resting  membrane  potential,  input  




Figure  13:  Overexpression  of  Navβ4-­WT  increases  excitability  of  DRG  neurons.    DRG  
neurons  co-­transfected  with  Nav1.6r  and  fluorescent  probe  tag  (control)  or  Navβ4-­WT  were  
examined  under  current  clamp  conditions.  500nM  TTX  was  included  in  the  bath  solution  to  block  
endogenous  TTXS  channels  and  Nav1.8  was  knocked-­down  with  shRNA.  A,  Representative  
traces  of  spontaneous  activity  recorded  in  control  (left  panel)  and  Navβ4  (right  panel)  groups.  B,  
Overexpression  of  Navβ4  (n=14)  increased  the  percentage  of  neurons  that  were  spontaneously  
active  (p<0.05,  Fisher’s  exact  test)  compared  to  control  (n=15).  Cells  that  were  not  spontaneously  
active  were  examined  for  evoked  activity.  A  series  of  one  second  depolarizing  current  steps  (0pA  
up  1.2nA  in  100pA  increments)  were  injected  into  transfected  DRG  neurons  from  their  resting  
membrane  potentials.  C,  Representative  membrane  responses  to  current  injections  at  rheobase  
in  control  (left  panel)  and  Navβ4-­WT  (right  panel).  D,  Compared  with  control,  Navβ4-­WT  
overexpression  significantly  increased  the  maximum  number  of  evoked  action  potential.  The  
maximum  number  of  evoked  action  potentials  was  defined  as  the  maximum  number  of  action  
potentials  elicited  at  a  give  current  injection  from  -­200pA  to  1.2nA  for  each  cell.  Data  are  mean  ±  















Figure  14:  Navβ4  increased  evoked  action  potentials  in  response  to  a  range  of  stimuli  
intensities.  Non-­spontaneous  cells  were  stimulated  with  1X,  2X  and  3X  rheobase  current  
injections.  Compared  to  control  (black,  n=15),  Navβ4-­WT  (blue,  n=11)  overexpression  
significantly  increased  the  maximum  number  of  evoked  action  potential  at  1X,  2X  and  3X  
















Table  3:  Measured  excitability  parameters  of  non-­spontaneously  active  cells  in  control    
and  Navβ4-­WT  groups.  No  significant  difference  was  observed  when  groups  were  compared  
using  Student’s  t-­test.  
  
  
Parameters   Control   Navβ4  




-­47.3  ±  1.8  
15  
-­48.8  ±  2.4  
11  




236  ±  40  
15  






287  ±  37  
15  
227  ±  38  
11  
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Discussion  
  
In  this  study  we  tested  the  hypothesis  that  Navβ4  is  key  to  the  generation  
of  fast  resurgent  sodium  currents  in  DRG  sensory  neurons.  Five  principle  
findings  support  the  conclusion  that  Navβ4  is  the  primary  open  channel  blocker  
underlying  sensory  neuron  fast  resurgent  currents.  First,  Navβ4  antibody  staining  
is  highly  correlated  with  Nav1.6  antibody  staining,  and  this  relationship  is  
predominantly  observed  in  medium  to  large  neurons  where  endogenous  fast  
resurgent  currents  are  typically  observed.  Second,  Navβ4  knockdown  
substantially  attenuates  endogenous  fast  resurgent  sodium  currents  in  medium  
to  large  diameter  sensory  neurons.  Third,  co-­expressing  Navβ4  with  recombinant  
Nav1.6r  channels  in  cultured  sensory  neurons  resulted  in  a  3-­fold  increase  in  
Nav1.6r  resurgent  current  amplitude  relative  to  control.  Fourth,  co-­expressing  the  
closely  related  Navβ2  with  recombinant  Nav1.6r  channels  in  cultured  sensory  
neurons  did  not  increase  Nav1.6r  resurgent  current  amplitude  relative  to  control.    
Fifth,  co-­expressing  a  mutant  Navβ4  with  recombinant  Nav1.6r  channels  in    
cultured  sensory  neurons  also  did  not  increase  Nav1.6r  resurgent  current  
amplitude  relative  to  control,  although  other  channel  properties  were  altered.  In  
addition,  co-­expressing  the  wild-­type  Navβ4  with  recombinant  Nav1.6r  channels  
in  cultured  sensory  neurons  substantially  increased  neuronal  excitability,  
indicating  that  resurgent  sodium  currents  are  important  regulators  of  sensory  
neuron  action  potential  activity.  
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Sensory  neurons  express  multiple  isoforms  of  the  voltage-­gated  sodium  
channel,  including  TTXS  and  TTXR  channels.  In  a  previous  study,  fast  resurgent  
sodium  currents  were  observed  in  44%  of  mouse  sensory  neurons  with  larger  
diameter  somas,  but  were  not  observed  in  neurons  from  Nav1.6-­knockout  mice  
(27).  In  the  current  study,  we  observed  a  high  degree  of  association  between  
Nav1.6  and  Navβ4  antibody  staining  in  medium  to  large  diameter  rat  neurons,  
79%  of  which  generated  fast  resurgent  currents.  Although  the  
immunocytochemistry  we  performed  demonstrates  that  expression  of  Nav1.6  and  
Navβ4  is  highly  correlated  in  medium  to  large  diameter  neurons,  it  cannot  
determine  if  these  subunits  interact.  All  of  the  neurons  co-­transfected  with  Navβ4  
and  Nav1.6r  channels  generated  fast  resurgent  sodium  currents,  supporting  the  
hypothesis  that  Nav1.6  and  Navβ4  interact  and  suggesting  that  expression  of  
Navβ4  might  be  sufficient  for  fast  resurgent  sodium  current  generation  in  DRG  
sensory  neurons  expressing  Nav1.6.  However,  it  is  important  to  point  out  that  the  
neurons  typically  transfected  and  recorded  from  in  our  sensory  neuron  
expression  system  experiments  are  almost  always  small  diameter  sensory  
neurons;;  larger  diameter  neurons  do  not  survive  the  culturing  and  transfection  
procedure  very  well.  It  is  possible,  and  even  likely,  that  in  some  neuronal  
populations  there  are  other  factors  that  limit  the  ability  of  Navβ4  to  generate  
resurgent  sodium  currents  (176).  
  
Navβ2  co-­expressed  with  Nav1.6r  did  not  result  in  increased  resurgent  
sodium  currents.  Although  the  percentage  of  transfected  Navβ2  cells  that  
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generated  fast  resurgent  sodium  currents  seemed  slightly  lower  than  that  of  
control  neurons,  this  difference  was  not  significant  (nor  was  the  resurgent  current  
amplitude  significantly  different).  Both  Navβ4  and  Navβ2  are  thought  to  form  a  
disulfide  linkage  with  sodium  channel  α  subunits  and  because  of  this  it  has  been  
proposed  that  a  given  α  subunit  may  associate  with  either  Navβ4  or  Navβ2,  but  
not  both  (231).  Although  Navβ2  overexpression  did  not  significantly  reduce  fast  
resurgent  current  amplitude,  this  does  not  necessarily  indicate  that  Navβ4  and  
Navβ2  can  simultaneously  associate  with  α  subunits.  One  possibility  is  that  
Navβ2  may  poorly  associate  with  Nav1.6r  channels.  Another  possibility  is  that  the  
expression  of  Navβ2  was  not  high  enough  to  compete  with  endogenous  Navβ4  
(although  expression  of  Navβ2  was  visually  confirmed  with  a  fluorescent  tag).  
Interestingly,  expression  of  a  mutant  Navβ4  also  did  not  reduce  the  baseline  
resurgent  current  amplitude  significantly.  However,  this  construct  shifted  the  
voltage-­dependence  of  Nav1.6r  channel  activation  and  inactivation,  indicating  it  
does  associate  with  Nav1.6r  channels.  This  raises  the  possibility  that  there  might  
be  another  open  channel  blocker,  at  least  in  small  diameter  sensory  neurons,  
that  could  contribute  to  fast  resurgent  current  generation  independent  of  Navβ4  
association.  
  
Although  Nav1.6  appears  to  be  the  predominant  generator  of  fast  TTXS  
resurgent  currents  in  sensory  neurons,  it  is  not  the  only  isoform  that  can  generate  
resurgent  sodium  currents  (19,  232,  233).  Nav1.7  is  not  an  efficient  generator  of  
resurgent  sodium  currents  (19)  despite  having  similar  kinetics  of  open-­state  
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inactivation  to  Nav1.6  (212),  but  mutations  identified  in  patients  with  PEPD  can  
substantially  increase  Nav1.7  resurgent  currents  (19,  24,  183).  Nav1.8  channels  
can  also  generate  resurgent  sodium  currents  in  DRG  sensory  neurons  (25).  
Nav1.8  resurgent  currents  are  much  slower  and  are  resistant  to  TTX.  Although  
we  did  not  examine  slow  TTXR  resurgent  currents  in  this  study,  it  is  likely  that  
Navβ4  plays  an  important  role  in  these  currents,  as  inclusion  of  a  14-­mer  peptide  
corresponding  to  the  proximal  portion  of  the  Navβ4  cytoplasmic  C-­terminus  (the  
first  14  amino  acids  highlighted  in  Figure  12A)  significantly  enhanced  slow  TTXR  
resurgent  currents  in  DRG  neurons  (25).  
  
Resurgent  currents  are  likely  to  be  an  important  determinant  of  sensory  
neuron  excitability.  Overexpression  of  Navβ4  with  Nav1.6r  substantially  
enhanced  both  spontaneous  and  evoked  firing  in  sensory  neurons  compared  to  
neurons  transfected  with  Nav1.6r  and  the  fluorescent  tag.  It  is  important  to  note  
that  the  activity  of  endogenous  sodium  channels  was  blocked  in  these  
experiments,  so  the  increased  excitability  most  likely  reflects  enhanced  Nav1.6r  
activity.  Overexpression  of  wild-­type  Navβ4  increased  resurgent  current  
amplitude  by  3-­fold  and  shifted  the  voltage-­dependence  of  inactivation  by  +4  mV.  
Based  on  the  small  magnitude  of  the  shift  in  the  voltage-­dependence  of  
inactivation,  we  predict  that  the  3-­fold  increase  in  resurgent  currents  was  the  
major  factor  in  the  increased  evoked  action  potential  firing  that  we  observed.    
Although  the  mutant  Navβ4  did  not  enhance  resurgent  currents,  it  induced  a  
pronounced  shift  in  activation  that  precluded  its  use  in  the  current  clamp  
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experiments.  The  increased  spontaneous  activity  observed  with  overexpression  
of  wild-­type  Navβ4  is  intriguing,  but  as  resurgent  currents  are  predicted  to  have  
their  pronounced  impact  during  the  repolarization  phase  of  action  potentials,  it  is  
not  entirely  clear  how  the  increased  spontaneous  activity  might  result  from  
enhanced  resurgent  current  activity.  One  possibility  is  that,  in  addition  to  
enhancing  resurgent  currents,  Navβ4  might  also  increase  persistent  sodium  
currents  associated  with  Nav1.6.  Although  we  did  not  examine  persistent  
currents  in  this  set  of  experiments,  our  work  with  Navβ4  knockdown  in  the  
localized  inflammation  of  the  DRG  pain  model  (see  Part  II)  suggests  that  indeed  
Navβ4  plays  a  role  in  modulating  persistent  currents.  Alternatively,  Navβ4  may  
alter  other  targets  that  contribute  to  spontaneous  activity.  For  example,  Navβ1  
has  been  reported  to  modulate  voltage-­gated  potassium  channels  in  CNS  
neurons  (234,  235).  Voltage  gated  potassium  channels  are  major  contributors  to  
the  action  potential  waveform  and  can  thus  substantially  modulate  the  excitability  
of  neurons  (236).  Although  we  did  not  see  a  significant  change  in  resting  
membrane  potential  or  input  resistance  in  non-­spontaneously  active  cells,  it  is  
possible  that  spontaneously  active  neurons  did  exhibit  these  changes.  Further  
studies  would  be  needed  to  elucidate  if  Navβ4  modulates  potassium  channels  in  
DRG  neurons.  
  
Enhanced  Nav1.6  resurgent  currents  have  been  proposed  to  underlie  the  
sensory  neuronal  excitability  associated  with  oxaliplatin  and  sea  anemone  toxin  
ATX-­II  induced  pain  sensations  (23,  26).  Furthermore,  an  inflammatory  mediators  
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applied  to  cultured  DRG  neurons  increased  both  TTXS  and  TTXR  resurgent  
currents,  suggesting  that  resurgent  currents  can  also  play  a  role  in  inflammatory  
pain  (25).  Inflammatory  mediators  can  increase  the  activity  of  multiple  kinases  
and  phosphorylation  is  known  to  enhance  resurgent  current  generation  (24,  237).    
It  will  be  interesting  to  determine  if  chronic  oxaliplatin  treatment  and/or  chronic  
inflammation  can  induce  an  upregulation  of  Navβ4  in  sensory  neurons.  
  
Nav1.6  and  Navβ4  expression  is  highly  correlated  in  medium  to  large  
diameter  neurons.  Navβ4  overexpression  enhanced  resurgent  currents  and  
excitability,  whereas  knockdown  or  expression  of  mutant  Navβ4  decreased  
resurgent  current  generation.    Overall,  our  data  suggest  that  Navβ4  is  a  major  
contributor  to  fast  resurgent  current  generation,  particularly  in  larger  diameter  
neurons.  Although  it  is  not  clear  what  sensory  modalities  are  most  impacted  by  
fast  resurgent  sodium  currents,  Navβ4  is  likely  to  be  an  important  determinant  of  
sensory  neuronal  hyperexcitability  and  thus  could  represent  an  important  target  
for  the  development  of  novel  therapeutics.    
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*The  content  of  this  chapter  was  adapted  from  a  published  manuscript  in  
Molecular  Pain.  *  
  
Barbosa  C,  Tan  ZY,  Wang  R,  Xie  W,  Strong  JA,  Patel  RR,  Vasko  MR,  Zhang  JM,  
Cummins  TR.  Navbeta4  regulates  fast  resurgent  sodium  currents  and  excitability  
in  sensory  neurons.  Mol  Pain.  2015;;11:60.  doi:  10.1186/s12990-­015-­0063-­9.  
PubMed  PMID:  26408173;;  PMCID:  PMC4582632.  
  
  
       
   72  
PART  II:  UPREGULATION  OF  THE  SODIUM  CHANNEL  NaVβ4  SUBUNIT  AND  
ITS  CONTRIBUTIONS  TO  MECHANICAL  HYPERSENSITIVITY  AND  
NEURONAL  HYPEREXCITABILITY  IN  A  RAT  MODEL  OF  RADICULAR  PAIN  
INDUCED  BY  LOCAL  DRG  INFLAMMATION  
  
Special  Acknowledgement:  This  study  was  a  collaboration  between  Dr.  
Jun-­Ming  Zhang’s  laboratory  at  University  of  Cincinnati  and  Dr.  Theodore  
Cummins’  laboratory  at  Indiana  University.  Dr.  Judith  Strong  and  Dr.  Wenrui  Xie  
carried  out  the  surgical  procedures,  behavioral  tests,  immunohistochemical  
assays,  Western  blotting  and  microelectrode  experiments.  C  Barbosa  and  Dr.  
Zhiyong  Tan  carried  out  the  surgical  procedures,  patch  clamp  experiments,  
immunocytochemical  assays  and  corroborated  mechanical  hypersensitivity  
effects  of  LID  and  Navβ4  knockdown.  The  results  were  published  in  PAIN.  Dr.  
Strong  produced  the  initial  draft  of  the  manuscript,  which  was  subsequently  
edited  and  revised  by  all  collaborators.  This  part  of  the  dissertation  is  adapted  




High  frequency  spontaneous  firing  in  myelinated  sensory  neurons  plays  a  
key  role  in  initiating  pain  behaviors  in  several  different  models,  including  a  
radicular  model  in  which  the  rat  lumbar  DRG  are  locally  inflamed.  Sodium  
channel  isoform  Nav1.6,  the  main  carrier  of  fast  resurgent  currents,  contributes  to  
pain  behaviors  and  spontaneous  activity  in  this  radicular  pain  model.  Resurgent  
   73  
currents  are  generated  by  an  alternate  mechanism  of  inactivation  that  blocks  the  
channel  in  the  open  conformation.  As  the  blocking  particle  disengages  during  
membrane  repolarization,  atypical  sodium  influx  is  generated  and  may  promote  
high  frequency  firing.  Our  previous  study  suggests  the  regulatory  Navβ4  subunit  
is  likely  the  endogenous  blocker  in  DRG  neurons.  Therefore,  we  used  in-­vivo  
siRNA  mediated  knockdown  of  Navβ4  to  examine  its  role  in  this  radicular  pain  
model  induced  by  localized  inflammation.  Navβ4  siRNA,  but  not  control  siRNA  
reduced  persistent  mechanical  hypersensitivity  induced  by  inflammation.  
Microelectrode  recordings  in  isolated  whole  DRG  showed  that  Navβ4-­siRNA  
blocked  inflammation  induced  increases  in  spontaneous  activity  of  Aβ  neurons,  
reduced  repetitive  firing  and  attenuated  other  measures  of  excitability.  Navβ4  
was  preferentially  expressed  in  larger  diameter  cells;;  inflammation  of  the  DRG  
increased  Navβ4  expression  and  this  was  reversed  by  Navβ4-­siRNA,  based  on  
immunohistochemistry  and  Western  blotting.  Patch  clamp  recordings  of  TTXS  
currents  in  acutely  cultured  medium  diameter  DRG  neurons  showed  that  DRG  
inflammation  increased  transient  and  fast  resurgent  sodium  currents;;  effects  
reduced  by  Navβ4-­siRNA.  Based  on  our  findings,  Navβ4  may  prove  to  be  a  novel  
target  for  pain  conditions  that  depend  on  hyperexcitability  of  myelinated  neurons  
expressing  Nav1.6.  
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Materials  and  Methods  
  
Procedure  for  in  vivo  injection  of  siRNA  near  the  DRG  
  
The  experimental  protocol  was  approved  by  the  Institutional  Animal  Care  
and  Use  Committees  of  the  University  of  Cincinnati  and  Indiana  University  
School  of  Medicine.  Experiments  were  conducted  in  accordance  with  the  
National  Institutes  of  Health  Guide  for  the  Care  and  Use  of  Laboratory  Animals.  
Adult  Sprague  Dawley  rats  (Harlan,  Indianapolis,  USA)  of  both  sexes  were  used  
as  indicated.    
  
siRNAs  directed  against  rat  Navβ4  subunit  (Scn4b;;  gene  ID  315611)  and  
non-­targeting  control  were  designed  by  and  purchased  from  
Dharmacon/ThermoFisher  (Lafayette,  CO).  The  Navβ4-­siRNA  was  siGENOME™  
siRNA  consisting  of  a  “smartpool”  of  four  different  siRNA  constructs  combined  
into  one  reagent.  Catalog  numbers  were  M-­101002-­01  (directed  against  Navβ4)  
and  D-­001210-­02  (non-­targeting  control  directed  against  firefly  luciferase,  
screened  to  have  minimal  off-­target  effects  and  at  least  4  mismatches  with  all  
known  human,  mouse  and  rat  genes  according  to  the  manufacturer).  The  
sequences  for  the  Navβ4-­siRNA  were:  AAACAACUCUGCUACGAUC,  
GCAAUACUCAGGCGAGAUG,  UCCAAGUGGUUGAUAAAUU  and  
GGAUCGUGAAGAAUGAUAA.  Aliquots  of  3  µL  containing  80pmoles  of  siRNA  
mixed  with  cationic  linear  polyethylenimine  (PEI)  based  transfection  reagent  (“in  
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vivo  JetPEI”,  Polyplus  Transfection,  distributed  by  WVR  Scientific,  USA)  at  a  
nitrogen/phosphorus  ratio  of  8  were  injected  near  each  L4  and  L5  DRG  on  one  
side,  through  a  small  glass  needle  inserted  close  to  the  DRG  through  a  small  
hole  cut  into  the  overlying  membrane,  as  previously  described  (223).  The  siRNA  
was  injected  just  prior  to  DRG  inflammation  in  experiments  using  both  
procedures.    
  
The  surgical  procedures  for  local  inflammation  of  the  DRG  (LID)  were  
performed  as  previously  described  (238).  The  L5  DRG  was  inflamed  by  
depositing  the  immune  activator  zymosan  (2mg/mL,  10μL,  in  incomplete  
Freund’s  adjuvant)  over  the  L5  DRG  via  a  small  needle  inserted  into  the  L5  
intervertebral  foramen.  For  animals  used  for  electrophysiological  and  microscopy  
experiments  the  L4  DRG  was  also  inflamed.  Naive  or  Sham  operated  animals  
were  used  as  a  control.  Sham  operated  animal  underwent  the  above  procedure  




     Mechanical  sensitivity  was  tested  by  applying  a  series  of  von  Frey  
filaments  to  the  heel  region  of  the  paws,  using  the  up-­and-­down  method  (239).  A  
cutoff  value  of  15  grams  was  assigned  to  animals  that  did  not  respond  to  the  
highest  filament  strength.  A  wisp  of  cotton  pulled  up  from,  but  still  attached  to  a  
cotton  swab  was  stroked  mediolaterally  across  the  plantar  surface  of  the  
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hindpaws  to  score  the  presence  or  absence  of  a  brisk  withdrawal  response  to  a  
normally  innocuous  mechanical  stimulus  (light  touch-­evoked  tactile  allodynia).  
This  stimulus  does  not  evoke  a  response  in  normal  animals.  Cold  sensitivity  was  
scored  as  withdrawal  responses  to  a  drop  of  acetone  applied  to  the  ventral  
surface  of  the  hind  paw.  When  observed,  responses  to  acetone  or  light  brush  
strokes  consisted  of  several  rapid  flicks  of  the  paw  and/or  licking  and  shaking  of  
the  paw;;  walking  movements  were  not  scored  as  positive  responses.  
Hypersensitivity  to  thermal  (heat)  stimuli  was  not  examined  because  we  have  
previously  observed  that  this  behavior  is  minimally  affected  in  this  model  (116).  
True  blinding  of  the  experimenter  to  the  siRNA  type  injected  was  found  to  be  
difficult  due  to  the  large  effect  size;;  however,  a  subset  of  behavioral  experiments  




Microelectrode  current  clamp  recordings  in  whole  DRG:  Intracellular  
recording  in  current  clamp  mode  was  performed  at  36-­37°C  using  
microelectrodes  on  sensory  neurons  near  the  dorsal  surface  of  an  acutely  
isolated  whole  DRG  preparation,  as  previously  described  (238).  This  preparation  
allows  neurons  to  be  recorded  without  enzymatic  dissociation,  with  the  
surrounding  satellite  glia  cells  and  neighboring  neurons  intact  (117,  118)  but  
does  not  allow  voltage  clamp  of  sodium  currents.  DRG  were  continuously  
perfused  with  artificial  cerebrospinal  fluid  (in  mM:  NaCl  130,  KCl  3.5,  NaH2PO4  
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1.25,  NaHCO3  24,  Dextrose  10,  MgCl2  1.2,  CaCl2  1.2,  16  HEPES,  pH=7.3,  
bubbled  with  95%  O2/  5%  CO2).  Cells  were  classified  by  conduction  velocity  
(stimulation  of  attached  dorsal  root)  as  follows:  <1.2  m/s,  C;;  ≥7.5  m/s,  Aβ;;  
between  1.2  and  7.5  m/s,  Aδ  (240).  Excitability  parameters  were  analyzed  as  
described  previously  in  (15).  Briefly,  after  measurement  of  any  stable  
spontaneous  activity,  action  potential  parameters  were  measured  during  the  
smallest  depolarizing  current  that  could  evoke  an  action  potential  (rheobase).  
Longer  suprathreshold  current  steps  were  then  applied  to  determine  the  
maximum  number  of  action  potentials  that  could  be  evoked,  and  whether  
subthreshold  membrane  oscillations  (with  characteristic  frequencies  in  the  range  
of  100–200Hz)  could  be  evoked.  
  
Patch  clamp  recordings  of  sodium  currents:  Adult  rat  DRG  ganglia  were  
dissociated  and  grown  in  culture  as  previously  described  (19,  25).  Transient,  
persistent,  and  resurgent  sodium  currents  were  recorded  from  neurons  after  14–
28  hours  in  primary  culture.  Neurons  were  dissociated  from  sham  or  inflamed  
(after  3  days)  L4  and  L5  DRGs  or  3  days  after  siRNA  injection  and  DRG  
inflammation.  The  extracellular  solution  consisted  of  (in  mM):  130  NaCl,  30  TEA  
chloride,  1  MgCl2,  3  KCl,  1  CaCl2,  0.05  CdCl2,  10  HEPES,  and  10  Dextrose,  pH  
7.3.  The  pipette  solution  contained  (in  mM)  140  CsF,  10  NaCl,  1.1  EGTA,  and  10  
HEPES,  pH  7.3.  Resurgent  currents  were  recorded  using  a  two-­voltage  step  
protocol.  A  20ms,  +30mV  voltage  pulse  was  first  used  to  inactivate  transient  
sodium  currents.  This  was  followed  by  a  series  of  repolarizing  pulses  to  elicit  
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resurgent  currents.  The  repolarizing  pulses  were  450ms  long,  from  +5  to  -­85mV  
in  5mV  steps.  Resurgent  currents  were  measured  as  the  peak  inward  current  
elicited  during  the  repolarizing  step.  Persistent  currents  were  measured  during  
the  last  20ms  of  the  450ms  repolarization  pulses.  Transient  current  amplitudes  
were  measured  using  a  steady-­state  inactivation  protocol  that  depolarized  the  
membrane  to  0mV  from  500ms  pre-­holding  at  voltage  levels  from  -­130  to  -­5mV,  
with  an  increment  of  5mV.  Peak  transient  currents  were  measured  from  the  pre-­
holding  level  of  -­110  mV.  Peak  transient,  resurgent  and  persistent  currents  were  
normalized  to  cell  capacitance  and  expressed  as  current  density.  Voltage-­
dependence  of  inactivation  and  activation  of  the  transient  current  was  determined  
as  in  reference  (19);;  values  of  V1/2  (voltages  at  which  activation  or  inactivation  
was  half  maximal)  are  reported.  Cells  used  for  recording  had  diameters  of  35–
45µm.  The  median  capacitance  was  53.8pF  with  25th–75th  percentile  falling  in  




DRG  sections  were  cut  at  40µm  on  a  cryostat  after  fixation  in  4%  
paraformaldehyde  in  0.1M  Phosphate  Buffer  and  4%  sucrose.  The  primary  
Navβ4  antibody  was  from  Alomone  (Jerusalem,  Israel,  catalog  ASC-­044)  used  at  
a  dilution  of  1:150.  The  secondary  antibody  conjugated  to  Alexa  Fluor  594  
(Invitrogen,  Carlsbad,  CA)  was  used  at  a  dilution  of  1:1000.  Images  from  multiple  
sections  of  each  DRG  were  captured  under  an  Olympus  BX61  fluorescent  
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microscope  using  Slidebook  4.1  imaging  acquisition  software  (Intelligent  Imaging  
Innovation,  Denver,  CO).  To  measure  the  expression  of  Navβ4  in  the  DRG  
neurons,  the  summed  intensities  of  the  Navβ4  signal  were  measured  and  
normalized  by  the  cellular  area  in  each  analyzed  section  to  give  an  intensity  ratio.  
In  all  immunohistochemical  experiments,  data  from  at  least  four  animals  were  
included  to  control  for  interanimal  variability.  For  experiments  examining  the  
effect  of  Navβ4  knockdown  on  Nav1.6  expression,  the  procedure  was  the  same  
as  described  above  except  that  the  polyclonal  antibody  against  Nav1.6  was  used  
(Alomone;;  catalog  ASC-­009,  used  at  1:100  dilution).  For  quantification  of  
immunohistochemical  data,  sections  from  different  experimental  groups  were  




To  verify  knockdown  of  Navβ4  protein  in  dissociated  DRG  cultures  under  
the  conditions  used  for  patch  clamp  measurements  of  sodium  currents,  L4/L5  
ipsilateral  LID  DRG  ganglia  were  harvested  and  cultured  from  rats  injected  with  
non-­targeting  control  or  Navβ4-­siRNA  three  days  after  siRNA  injection  and  DRG  
inflammation.  DRG  neurons  were  fixed  after  24  hours  in  culture  with  4%  
paraformaldehyde  (0.1M  phosphate  buffer,  pH  7.4)  for  20  minutes  and  washed  in  
phosphate  buffered  saline  (PBS)  three  times.  Cells  were  permeabilized  in  1%  
Triton  X-­100  in  PBS  for  20  minutes  at  room  temperature  (~22  °C),  washed  in  
PBS  three  times,  blocked  for  2  hours  (10%  normal  goat  serum,  0.1%  Triton  X-­
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100  in  PBS)  at  room  temperature  and  washed  an  additional  three  times  in  PBS.  
Cells  were  then  incubated  with  primary  antibody  against  Navβ4  (#Ab80539,  
Abcam,  Cambridge,  MA,  USA)  diluted  1:500  in  blocking  solution  at  4°C  
overnight.  After  three  washes,  cells  were  incubated  with  secondary  antibody  
diluted  in  blocking  solution  1:1000  (Alexa  Fluor®  488  Goat  Anti-­Rabbit  IgG,  
Molecular  Probes,  Life  Technologies,  Grand  Island,  NY,  USA)  for  2  hours  at  
room  temperature.  Coverslips  were  mounted  unto  microscope  slides  with  
Prolong  Gold  Antifade  (Molecular  Probes).  Cells  were  imaged  with  Nikon  Eclipse  
TE2000-­E  microscope.  Images  were  analyzed  with  NIS  Elements  Advance  
(Nikon®)  software.  
  
Western  blot  analysis  of  Navβ4  
  
DRGs  were  isolated  and  homogenized  in  ice-­cold  lysis  buffer  (50mM  Tris  
pH  7.4,  5mM  EDTA  pH  8),  1%  Triton  X-­100  and  protease  inhibitor  cocktail  
(Complete,  EDTA-­free,  Roche,  Life  Sciences,  Indianapolis  IN  USA)  followed  by  
centrifugation  at  57,000  x  g  at  4°C  for  60  minutes.  Samples  (20μg  of  total  protein  
per  lane)  were  subjected  to  sodium  dodecyl  sulfate  polyacrylamide  gel  
electrophoresis  (SDS-­PAGE)  running  in  NuPAGE  MES  SDS  running  buffer  
(Invitrogen).  Reducing  conditions  were  used  to  break  covalent  bonds  to  the  α  
subunits  (198,  228).  Electrophoresis  was  followed  by  electrophoretic  transfer  to  
nitrocellulose  membrane  (Bio-­Rad,  Hercules,  CA,  USA)  in  Tris-­glycine-­SDS  
transfer  buffer.  Nonspecific  binding  sites  were  blocked  with  5%  nonfat  dry  milk  in  
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Tween  (Bio-­Rad;;  0.1%)–phosphate-­buffered  saline  at  room  temperature  for  1  
hour.  The  rabbit  antibodies  to  Navβ4  (1:400,  Alomone)  and  to  β-­Actin  (1:2000,  
Abcam)  were  applied  to  the  blot  followed  by  incubation  with  immunopure  
peroxidase  conjugated  goat  anti-­rabbit  IgG  (H+L)  (1:20,000,  Pierce,  Rockford,  
IL).  The  signal  was  detected  using  a  ChemiDoc-­It  system  controlled  by  
VisionWorksLS  software  version  7  (UVP,  Upland,  CA).  After  background  
subtraction,  signals  in  the  Navβ4  band  were  normalized  to  the  intensity  of  the  β  




Behavioral  time  course  data  were  analyzed  using  two-­way  repeated  
measures  ANOVA  with  Bonferroni  post-­hoc  test  to  determine  on  which  days  
experimental  groups  differed.  For  electrophysiological,  Western  blot,  and  
immunohistochemical  data,  comparison  of  values  between  different  experimental  
groups  was  done  using  nonparametric  methods  for  data  that  did  not  show  a  
normal  distribution  based  on  the  D’Agostino  and  Pearson  omnibus  normality  test.  
The  statistical  test  used  in  each  case  is  indicated  in  the  text,  or  figure  legend.  
Significance  was  ascribed  for  p<0.05.  Levels  of  significance  are  indicated  by  the  
number  of  symbols,  e.g.,  *,  p=0.01  to  <0.05;;  **,  p=0.001  to  0.01;;  ***,  p<0.001.  
Data  are  presented  as  the  mean  ±  S.E.M.    
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RESULTS  
  
Navβ4  knockdown  reduces  mechanical  hypersensitivity  in  the    
DRG  inflammation  model  
  
Previous  studies  have  shown  that  local  inflammation  of  the  L5  DRG  (LID)  
causes  pronounced  mechanical  hypersensitivity  in  the  ipsilateral  hindpaw  as  
measured  by  the  von  Frey  test.  LID  also  produces  mechanical  allodynia  as  
measured  by  the  withdrawal  responses  to  stroking  the  paw  with  a  light  cotton  
wisp;;  and  cold  allodynia  as  measured  by  increased  withdrawal  to  acetone  stimuli  
(116,  238,  241).  These  behaviors  are  observed  as  early  as  postoperative  day  
(POD)1.  The  mechanical  hypersensitivity  is  maintained  for  at  least  4  weeks  at  
which  point  the  other  behaviors  are  beginning  to  resolve.  In  the  present  study,  
similar  results  were  obtained  when  non-­targeting  (n.t.)  control  siRNA  was  
injected  into  the  L4  and  L5  DRG  just  prior  to  DRG  inflammation  (Figure  15).  In  
the  control  group,  the  von  Frey  threshold  differed  from  baseline  on  all  tested  
days.  However,  in  animals  injected  with  siRNA  directed  against  Navβ4,  the  
ipsilateral  mechanical  hypersensitivity  (von  Frey  test)  was  significantly  reduced  
compared  to  control  siRNA  on  all  days  tested,  and  differed  from  baseline  only  on  
POD1.  The  ipsilateral  mechanical  allodynia  responses  (cotton  wisp  test)  were  
also  significantly  reduced  from  the  control  siRNA  group  on  most  days  (Figure  
15B),  and  were  significantly  different  from  baseline  only  on  POD1.  In  contrast,  
cold  allodynia  (acetone  test)  induced  by  DRG  inflammation  was  not  significantly  
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reduced  by  Navβ4-­siRNA,  either  ipsilaterally  (Figure  15C)  or  contralaterally.  As  
previously  reported  in  this  model  (14,  238),  contralateral  von  Frey  threshold  
reductions  in  the  control  siRNA  group  were  very  modest,  with  the  lowest  average  
value  observed  on  any  day  being  11  grams.  In  the  Navβ4-­siRNA  group,  
contralateral  thresholds  differed  from  baseline  only  on  POD1.  No  animals  in  
either  group  showed  contralateral  responses  to  the  mechanical  allodynia  test  on  
any  day  (data  not  shown).  As  shown  in  Figure  15,  Navβ4-­siRNA  had  no  effect  on  
baseline  behaviors  prior  to  implementation  of  the  pain  model;;  however,  the  tests  
used  reached  cut-­off  values  and  would  not  have  detected  increased  thresholds.  
     




Figure  15:  Effects  of  Navβ4  knockdown  on  pain  behaviors  elicited  by  local  inflammation  of  
the  L5  DRG.  Baseline  measurements  plotted  on  post  operative  day  (POD)  0  are  the  average  of  2  
measurements  made  3-­5  days  prior  to  inflammation  of  the  L5  DRG  and  injection  of  siRNA  
directed  against  Navβ4  or  non-­targeting  control  siRNA  on  POD0.  The  behavioral  data  was  
obtained  from  the  ipsilateral  paw  of  the  animals.  A,  Mechanical  threshold  measured  by  the  von  
Frey  test  was  significantly  reduced  for  the  duration  of  the  experiment  in  the  n.t.  injected  animals.  
In  Navβ4-­siRNA  injected  animals  the  threshold  differed  from  the  n.t.  animals  on  all  days  except  
baseline.  B,  Mechanical  allodynia,  measured  as  withdrawal  to  stroking  the  paw  with  a  fine  cotton  
wisp,  was  never  observed  prior  to  DRG  inflammation  (average  baseline  plotted  on  POD0),  was  
increased  by  DRG  inflammation  in  n.t.  siRNA  injected  animals,  and  was  significantly  less  on  most  
days  in  Navβ4-­siRNA  injected  animals.  In  Navβ4-­siRNA  injected  animals  the  decreased  threshold  
was  significantly  different  from  baseline  only  on  POD1;;  in  n.t  injected  animals  the  decreased  
threshold  differed  significantly  from  baseline  on  all  POD  except  POD  14  and  22.  C,  Cold  
allodynia,  measured  as  withdrawal  to  a  drop  of  acetone  placed  on  the  paw,  was  increased  by  
DRG  inflammation  but  not  significantly  affected  by  Navβ4-­siRNA.  N=6  n.t.  and  8  Navβ4-­siRNA  
injected  male  rats.  *,  p<0.05;;  **,  p<0.01;;  ***,  p<0.001,  significant  difference  between  the  two  
groups  (two-­way  repeated  measures  ANOVA  with  Bonferroni  posttest).  Differences  from  baseline  
on  later  POD  within  each  group  discussed  above  were  tested  using  one-­way  ANOVA  with  
Dunnett’s  posttest.  The  data  presented  in  the  figure  were  not  obtained  with  blinding  of  the  
experimenter;;  however,  the  findings  about  the  initial  time  course  of  pain  behaviors  were  
confirmed  in  a  separate  experiment  in  which  the  experimenter  was  blinded  to  the  siRNA  status  of  
the  animals,  n=4  per  group,  data  not  shown.     
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Immunohistochemistry  and  Western  blotting  confirm  Navβ4  knockdown  by  siRNA  
and  upregulation  by  DRG  inflammation  
  
Immunohistochemical  staining  for  Navβ4  was  performed  in  DRG  sections  
from  normal  animals,  and  on  POD4  after  DRG  inflammation  and  injection  of  non-­
targeting  or  Navβ4-­siRNA.  The  immunohistochemical  staining  of  Navβ4  showed  
that  DRG  inflammation  upregulated  Navβ4  and  this  upregulation  was  blocked  by  
Navβ4-­siRNA  (Figure  16A-­D)  This  result  was  confirmed  by  Western  blotting  
(Figure  16E).  A  representative  Western  blot  is  shown  in  Figure  16F.  Navβ4  
protein  signal  (24kDa)  was  normalized  to  actin  protein  signal  (42kDa).  In  a  
separate  set  of  immunohistochemical  experiments,  examination  of  sections  from  
both  normal  and  inflamed  DRGs  showed  that  Navβ4  was  not  as  highly  expressed  
in  the  cells  with  the  smallest  cross-­sectional  areas.  The  average  cell  area  of  
Navβ4-­positive  cells  was  larger  than  that  of  Navβ4-­negative  cells  in  both  
conditions,  and  there  were  no  striking  changes  in  the  cell  size  distribution  after  
DRG  inflammation.  The  inflammation-­induced  increase  in  staining  for  Navβ4  
seemed  to  be  primarily  due  to  an  increase  in  the  intensity  per  cell  rather  than  an  
increase  in  the  percentage  of  cells  expressing  Navβ4;;  62%  of  all  cells  scored  in  
normal  DRG  were  Navβ4-­positive  (61.5%  ±  2.2%,  based  on  average  values  from  
4  animals),  while  67%  of  all  cells  scored  in  inflamed  DRG  were  Navβ4-­postive  
(67.7%  ±  3.4%,  based  on  average  values  from  4  animals).  This  apparent  
increase  in  percentage  was  not  significant  when  analyzed  based  on  the  average  
animal  values  (p=0.17,  t-­test)  and  could  not  account  for  the  overall  64%  
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increased  average  intensity  in  inflamed  compared  to  normal  DRG  shown  in  
Figure  16D.  Navβ4  has  also  been  observed  in  peripheral  axons  and  nodes  (228).  
The  data  in  Figure  16A-­D  were  obtained  from  cellular  regions  of  the  DRG  
sections,  however,  Navβ4  was  also  observed  in  axonal  regions,  albeit  at  lower  
intensities.  These  regions  also  showed  increased  staining  after  DRG  
inflammation  and  reduced  staining  after  Navβ4-­siRNA  injection  (data  not  shown).  
     






Figure  16:  Immunohistochemical  and  Western  blot  detection  of  Navβ4.  Sample  sections  
stained  for  Navβ4  are  shown  from  normal  DRG  (A),  and  DRG  4  days  after  DRG  inflammation  
(“LID”)  and  injection  of  either  Navβ4  (β4  siRNA,B)  or  non-­targeting  (n.t.)  siRNA  (C).  Scale  bar,  
50µm.  D,  summary  data  of  Navβ4  intensity  normalized  to  cellular  area  in  DRG  sections.  **,  
p<0.01;;  ***,  p<0.001significant  difference  between  the  indicated  groups  (one-­way  ANOVA  with  
Tukey’s  posttest).  n=4  animals  per  group,  19  to  34  sections  per  animal.  Graph  and  statistical  
analysis  are  based  on  the  animal  averages.  E,  Summary  data  of  the  ratio  of  Navβ4  intensity  to  
actin  intensity  from  Western  blot  analysis  of  the  same  3  experimental  groups.  Actin  always  
appeared  as  a  double  band  and  both  lanes  were  included  in  the  actin  measurement.  *,  p<0.05;;  **,  
p<0.01;;  significant  difference  between  the  indicated  groups,  one-­way  ANOVA  with  Tukey’s  
posttest.  n=6  samples  per  group.  F,  Two  sample  lanes  from  each  experimental  group.  Some  
intervening  lanes  from  a  different  experiment  run  on  the  same  gel  have  been  removed.  Male  and  
female  animals  were  used  for  these  experiments.       
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NaVβ4  knockdown  reduces  NaV1.6  expression  
  
The  Navβ  subunits  can  also  regulate  localization  and  trafficking  of  the  α  
subunits.  We  therefore  examined  the  effect  of  Navβ4-­siRNA  on  expression  of  
Nav1.6  in  DRG  sections.  DRG  were  inflamed  and  injected  with  siRNA  directed  
against  Navβ4  or  the  non-­targeting  (n.t.)  control  construct.  Four  days  later  DRGs  
were  fixed  and  sectioned  and  stained  for  Nav1.6.  As  shown  in  the  examples  in  
Figure  17,  the  expression  of  Nav1.6  was  higher  in  n.t.  siRNA  injected  DRG  
(Figure  17A-­C)  than  in  Navβ4-­siRNA  injected  DRG  (Figure  17D-­F).  Summary  
data  from  4  animals  per  group,  104  sections  per  animal,  showed  that  Nav1.6  was  
1.6  ±  0.18  times  higher  in  n.t.  siRNA  injected  DRG  than  in  Navβ4-­siRNA  injected  
DRG  (ratio  t-­test  based  on  animal  averages,  p=0.002).  
     







Figure  17:  Effect  of  Navβ4-­siRNA  on  immunohistochemical  detection  of  
Nav1.6  in  DRG  sections.  Sample  sections  are  shown  from  DRG  4  days  after  
DRG  inflammation  and  injection  of  either  non-­targeting  siRNA  (A,  B,  C)  or  
Navβ4-­siRNA  (D,  E,  F).  Scale  bar,  100µm.  
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Navβ4  knockdown  reduces  hyperexcitability  induced  by  
DRG  inflammation  in  Aβ  sensory  neurons.  
  
   It  had  been  previously  shown  by  our  colleagues  that  DRG  inflammation  
leads  to  marked  neuronal  hyperexcitability  and  spontaneous  activity  of  
myelinated  Aβ  neurons  in  the  inflamed  DRG,  as  measured  on  POD  3-­4  in  the  
isolated  whole  DRG  preparation  with  sharp  electrode  recording  Methods  (238).  In  
addition,  it  was  also  shown  that  injecting  siRNA  directed  against  Nav1.6  restored  
many  of  these  hyperexcitability  parameters  towards  normal  values(14).  In  our  
collaboration,  we  observed  a  similar  reduction  of  inflammation-­induced  
hyperexcitability  of  Aβ  myelinated  cells  by  injecting  Navβ4-­siRNA  at  the  time  of  
DRG  inflammation  (Figure  18).  Spontaneous  activity  induced  by  DRG  
inflammation  was  restored  to  normal  levels  by  the  Navβ4-­siRNA.  The  LID-­
induced  decrease  in  rheobase  was  partially  normalized  by  the  Navβ4-­siRNA  
(Figure  18B);;  a  similar  result  was  observed  when  spontaneously  active  cells,  with  
rheobase  defined  as  zero,  were  excluded  from  the  calculation  (data  not  shown).  
The  observed  changes  in  rheobase  did  not  reflect  changes  in  input  resistance  
(16.3  ±  0.1  MΩ,  16.0  ±  0.7  MΩ,  and  17.0  ±  0.7MΩ  in  normal  +  n.t.  siRNA,  LID  +  
Navβ4-­siRNA  ,  and  LID  +  n.t.    siRNA,  respectively;;  no  significant  differences  
between  groups  per  Kruskal-­Wallis  test  with  Dunn’s  post-­test).  DRG  inflammation  
caused  a  small  depolarization  of  the  resting  membrane  potential  (from  -­66.2  ±  
0.5  mV  to  -­62.1  ±  0.7mV)  that  was  partially  normalized  by  Navβ4-­siRNA  (to  -­64.1  
±  0.5mV;;  Figure  18D).  Action  potential  duration  was  slightly  increased  by  LID  but  
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not  affected  by  Navβ4-­siRNA  (Figure  18C).  Action  potential  threshold  did  not  
differ  between  the  three  groups.  Parameters  particularly  associated  with  
resurgent  and  persistent  currents,  such  as  the  ability  to  fire  repetitively  or  show  
subthreshold  membrane  oscillations  in  response  to  long  suprathreshold  current  
injections,  were  also  increased  by  DRG  inflammation  and  largely  normalized  by  
Navβ4  knockdown  (Figure  18E-­F).  The  number  of  Aδ  cells  observed  in  these  
experiments  was  relatively  small  (26  in  the  control  group,  only  8  in  the  LID  +  non-­
targeting  siRNA  group,  and  45  in  the  LID  +  Navβ4-­siRNA  group);;  few  significant  
differences  in  the  electrophysiological  parameters  were  observed  and  none  of  
the  Aδ  cells  showed  spontaneous  activity  (data  not  shown).  In  contrast,  
excitability  parameters  of  C  cells  were  much  less  affected  by  DRG  inflammation  
or  Navβ4-­siRNA.  Spontaneous  activity  was  low  or  zero  in  DRG  neurons  treated  
with  Navβ4-­siRNA  or  non-­targeting  siRNA  and  there  were  no  significant  
differences  between  the  groups.  Rheobase,  membrane  potential,  and  the  ability  
to  fire  repetitively  were  not  affected  by  DRG  inflammation  or  by  Navβ4-­siRNA  
(data  shown  in  (242)).    
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Figure  18:  Navβ4  knockdown  reduces  hyperexcitability  of  myelinated  Aβ  cells  induced  by  
DRG  inflammation.  L4/L5  DRGs  were  injected  in  vivo  with  either  Navβ4  or  non-­targeting  siRNA  
and  inflamed  (“LID”).  For  comparison  normal  DRGs  were  injected  with  non-­targeting  siRNA  but  
not  inflamed.  Four  days  later  DRGs  were  isolated  for  in  vitro  whole  DRG  microelectrode  
recording.  Data  are  from  myelinated  Aβ  cells  based  on  dorsal  root  conduction  velocity.  A,  
Incidence  of  spontaneous  activity  was  increased  by  LID  and  normalized  by  Navβ4  knockdown.  B,  
Rheobase  was  reduced  by  LID  and  partially  normalized  by  Navβ4  knockdown.  C,  Action  potential  
duration  was  modestly  increased  by  LID  but  not  affected  by  Navβ4-­siRNA.  D,  Resting  membrane  
potential  was  depolarized  by  LID  and  partially  normalized  by  Navβ4-­siRNA.  Responses  to  longer  
suprathreshold  current  injections  showed  that  the  percentage  of  cells  that  could  be  induced  to  fire  
repetitively  (>  2  action  potentials;;  E)  or  demonstrate  subthreshold  oscillations  (F)  was  significantly  
increased  by  LID  and  partially  normalized  by  Navβ4-­siRNA.  *,  p<0.05;;  **,  p<0.01;;  ***,  p<0.001;;  
significant  difference  between  groups,  X2  test  (A,  E,  F);;  Kruskal-­Wallis  test  with  Dunn’s  multiple  
comparison  posttest  (B,  C);;  ANOVA  with  Bonferroni’s  posttest  (D).  n=123  normal  +  n.t.  siRNA  
cells  from  4  female  rats,  n=74  LID  +  n.t.  siRNA  cells  from  3  female  rats,  and  n=172  LID  +  Navβ4-­
siRNA  cells  from  6  female  rats.    
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DRG  inflammation  increases  transient  and  resurgent  TTXS    
sodium  currents  in  medium  diameter  cells  in  vitro.  
  
We  next  examined  the  effects  of  DRG  inflammation  and  Navβ4  
knockdown  on  resurgent  sodium  currents,  since  these  currents  are  thought  to  
facilitate  high  frequency  repetitive  firing.  Transient,  resurgent,  and  persistent  
sodium  currents  were  recorded  in  acutely  isolated,  medium  to  large  diameter  (35  
to  45µm)  neurons  from  DRGs  from  sham  operated  animals  or  DRGs  isolated  3  
days  after  DRG  inflammation.  Medium  to  large  sized  DRG  neurons  with  35  to  
45µm  diameter  were  chosen  to  ensure  a  better  quality  of  recording  and  better  
voltage  control.  DRG  neurons  with  a  diameter  greater  than  45µm  were  not  
examined.  In  addition,  previous  microelectrode  studies  have  shown  that  
spontaneous  activity  occurs  primarily  in  Aβ  cells  towards  the  smaller  end  of  the  
diameter  distribution  (238).  Previous  patch  clamp  studies  showed  that  medium  to  
large  diameter  neurons  have  a  high  likelihood  of  expressing  Nav1.6,  the  main  
carrier  of  TTXS  resurgent  current  in  DRG  neurons  (27).  Cells  were  classified  as  
having  predominantly  TTXS  current  (based  on  fast  current  kinetics  and  a  single  
component  in  their  steady-­state  inactivation  curves)  or  mixed  TTXS  and  TTXR  
currents,  as  previously  described  (88,  243).  Because  previous  studies  with  this  
model  showed  that  spontaneous  activity  and  hyperexcitability  are  predominantly  
observed  in  Aβ  cells  and  are  TTXS  (238),  we  focused  on  the  subset  of  cells  that  
predominantly  express  TTXS  currents.  In  addition,  cells  with  predominantly  TTXS  
current  have  previously  been  observed  to  be  the  ones  to  express  TTXS  
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resurgent  currents  (25).  Excluding  cells  with  mixed  TTXR  and  TTXS  sodium  
currents  also  most  likely  excluded  most  cells  with  Aδ  conduction  velocities  as  
measured  in  vivo  (84),  even  though  those  would  otherwise  be  expected  to  be  
enriched  in  the  size  range  examined.  In  those  cells  with  predominantly  TTXS  
current,  both  peak  transient  and  peak  resurgent  current  densities  were  increased  
by  DRG  inflammation  (Figure  19).  The  ratio  of  resurgent  to  transient  current  
increased  from  0.034  ±  0.002  in  control  cells  to  0.041  ±  0.002  in  inflamed  cells  
(p=0.02,  Mann-­Whitney  test).  The  persistent  current  density  was  4.0  ±  0.63pA/pF  
in  control  cells  vs.  5.7  ±  0.61pA/pF  in  cells  from  inflamed  DRG  (p=0.055,  Mann-­
Whitney  test).  The  ratio  of  persistent  to  transient  current  was  0.003  ±  0.0005  in  
control  cells  and  0.003  ±  0.0004  in  cells  from  inflamed  DRG  (p=0.46,  t-­  test).    
  
Cells  from  inflamed  DRG  also  had  a  negative  shift  in  the  voltage-­
dependence  of  activation  of  the  transient  current  (V1/2  of  -­46.4  ±  0.9mV  compared  
to  -­41.8  ±  1.6mV  in  control  cells;;  p=0.03,  t-­test).  There  was  also  a  small  shift  in  
steady-­state  inactivation  (~2.5mV)  which  may  not  have  had  a  major  impact  on  
channel  availability  (V1/2=-­57.3  ±  0.8mV  in  LID  cells  vs.  -­59.9  ±  0.8mV  in  control  




















Figure  19:  TTXS  resurgent  and  transient  currents  are  increased  by  DRG  inflammation.  
Sodium  currents  were  recorded  in  acutely  cultured  medium  to  large  diameter  DRG  neurons  from  
sham  operated  animals  (control)  or  animals  with  localized  inflammation  of  the  DRG  (LID)  at  
POD3.  Data  are  from  medium  to  large  diameter  cells  that  expressed  only  TTXS  sodium  current.  
Representative  traces  of  resurgent  current  recordings  are  shown  for  control  (A)  and  LID  (B)  
cultured  DRG  neurons.  The  much  larger  transient  current  during  the  20  mV  pre-­pulse  (inset:  
voltage  protocol)  is  off-­scale.  C-­E,  Summary  data  shows  both  peak  transient  current  (C)  and  
resurgent  current  (E)  densities  were  higher  in  cells  from  inflamed  DRG  (n=15  cells  from  3  male  
rats)  compared  to  sham  control  DRG  (n=20  cells  from  3  male  rats).  Increase  in  persistent  current  
(D)  did  not  reach  significance  (p=0.055,  Mann-­Whitney  test).  **,  p<0.01;;  ***,  p<0.001;;  significantly  
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Navβ4  knockdown  in  vivo  preferentially  reduces  TTXS  persistent  and  resurgent  
currents  in  medium  to  large  diameter  neurons  cultured  from  inflamed  DRG  
  
In  a  separate  set  of  experiments,  transient,  resurgent,  and  persistent  
sodium  currents  were  recorded  in  acutely  isolated,  medium  to  large  (35  to  45µm)  
diameter  neurons  from  cultured  DRGs  isolated  3  days  after  in  vivo  DRG  
inflammation  and  injection  of  either  non-­targeting  control  or  Navβ4-­siRNA.  Cells  
having  only  TTXS  currents  were  chosen  to  study  based  on  the  same  criteria  and  
reasons  described  above.  In  those  cells,  densities  of  both  resurgent  currents  and  
persistent  currents  were  reduced  by  the  Navβ4-­siRNA  (Figure  20).  The  ratio  of  
resurgent  to  transient  current  was  also  significantly  lower  in  Navβ4-­siRNA  treated  
cells  (0.048  ±  0.003  with  n.t.  siRNA  vs.  0.033  ±  0.002  with  Navβ4-­siRNA,  
p=0.0003,  Mann-­Whitney  test).  In  addition,  the  ratio  of  persistent  to  transient  
current  was  lower  (0.0034  ±  0.0003  in  n.t.  siRNA  group  vs.  0.0023  ±  0.0003,  
p=0.0005,  Mann-­Whitney  test).  Navβ4  knockdown  also  resulted  in  a  depolarizing  
shift  in  the  voltage-­dependence  of  activation  of  the  transient  current  (from  V1/2  of  -­
48.2  ±  1.9  to  -­42.4  ±  1.2mV,  p=0.01,  t-­test).  There  was  no  significant  difference  
between  the  2  groups  in  the  voltage-­dependence  of  inactivation.    
  
Knockdown  of  Navβ4  under  the  experimental  conditions  used  for  the  
patch  clamp  recordings  was  confirmed  with  immunostaining  of  cultured  neurons  
(Figure  21).  To  parallel  the  protocol  used  for  the  patch  clamp  experiments,  siRNA  
(non-­targeting  or  Navβ4  directed)  was  injected  in  vivo  at  the  time  of  DRG  
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inflammation;;  DRGs  were  isolated  and  dissociated  3  days  later,  and  cultured  





Figure  20:  Navβ4  knockdown  in  vivo  reduces  TTXS  persistent  and  resurgent  currents  in  
medium  to  large  diameter  neurons  cultured  from  inflamed  DRG.  Sodium  currents  were  
recorded  in  acutely  cultured  medium  to  large  diameter  DRG  neurons  from  LID  animals  injected  
with  non-­targeting  (n.t.)  or  Navβ4-­siRNA.  Data  are  from  neurons  that  expressed  only  TTX-­
sensitive  current.  Representative  traces  of  resurgent  current  recordings  are  shown  for  LID  +n.t.  
siRNA  (A)  and  LID  +  Navβ4-­siRNA  (B)  groups.  The  much  larger  transient  current  during  the  20  
mV  pre-­pulse  (inset:  voltage  protocol)  is  off-­scale.  C-­E:  Summary  data  shows  both  persistent  
current  (D)  and  resurgent  current  (E)  densities  were  reduced  in  LID  +  Navβ4-­siRNA  (n=31  from  5  
males  rats)  group  relative  to  LID  +  n.t.siRNA  (n=25  from  5  males  rats).  No  difference  was  
observed  in  transient  current  density.  **,  p<0.01,  ***,  p<0.001,  significantly  different  from  n.t.  








Figure  21:  Immunocytochemical  detection  of  Navβ4  in  cultured  DRG  cells.  DRG  neurons  
were  obtained  under  the  same  conditions  as  for  the  electrophysiological  experiments  in  Figure  
20.  L4/L5  DRG  were  isolated  at  POD3  and  cultured  for  24  hours  before  fixation  and  staining.  
Representative  images  of  DRG  neurons  cultured  from  LID  animals  injected  with  n.t.  siRNA  (A)  or  
Navβ4-­siRNA  (B).  Scale  bars  are  50µm.  C,  Summary  data  of  intensity  per  cell  area  shows  
decreased  Navβ4  staining  for  LID  +  Navβ4  (n=1164  from  4  male  rats)  cultured  DRG  neurons  
relative  to  LID  +  n.t  siRNA  (n=1132  from  3  male  rats).  ***,  significant  difference  between  the  
groups  (p<0.001),  t  test.  Intensity  units  are  not  comparable  to  Figure  16D  because  different  
microscopes  and  analysis  programs  were  used.       
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Discussion  
  
In  this  collaborative  study  we  investigated  the  effects  of  Navβ4  knockdown  
on  pain  associated  behaviors,  DRG  neuronal  excitability  and  sodium  currents.  
Knockdown  of  Navβ4  via  intraganglionic  siRNA  injection  prevented  the  
development  of  persistent  mechanical  hypersensitivity  after  local  inflammation  of  
the  DRG  and  reduced  inflammation  induced  increases  in  neuronal  excitability  
Navβ4  expression  was  upregulated  on  POD  3-­4  in  DRG  neurons  from  LID  
animals.  At  this  time  point,  POD  3-­4,  DRG  inflammation  increased  TTXS  
resurgent  and  transient  currents  in  medium  to  large  diameter  neurons.  Navβ4  
knockdown  selectively  reduced  the  inflammation  induced  increase  of  resurgent  
currents  and  persistent  currents  but  did  not  alter  transient  current  density.  
  
β-­subunits  can  be  expressed  in  nonneuronal  cells  and  have  effects  
independent  of  the  Navα  subunits  (136,  244).  However,  our  
immunohistochemical  data  in  DRG  sections  and  cultured  neurons  show  that  the  
majority  of  DRG  neurons  express  Navβ4.  The  behavioral  effects  of  Navβ4  
knockdown  in  the  lumbar  DRG  are  also  strikingly  similar  to  those  of  Nav1.6  
knockdown  (14).  The  only  difference  between  Navβ4  and  Nav1.6  knockdown  
was  at  POD1.  At  this  time  point,  Navβ4  knockdown  effect  on  von  Frey  
responding  was  only  partially  reversed  but  the  Nav1.6  knockdown  effect  is  a  
complete  reversal  to  baseline  level.  Both  Navβ4  and  Nav1.6  knockdown  reduce  
mechanical  pain  behaviors  for  the  duration  of  the  experiment  (at  least  4  weeks).  
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As  it  is  unlikely  that  the  single  siRNA  injection  was  effective  for  this  long,  we  
interpret  this  to  mean  that  an  early  period  of  spontaneous  activity  is  required  to  
initiate  long  lasting  pain  behaviors,  consistent  with  other  studies  in  this  and  other  
rat  pain  models  (15,  119,  238).    
  
We  propose  two  mechanisms  that  may  contribute  to  the  observed  
behavioral  and  electrophysiological  effects  of  Navβ4  knockdown  and  reduction  of  
spontaneous  activity  in  myelinated  Aβ  cells:  (1)  reduction  of  Nav1.6  expression;;  
and  (2)  reduction  of  resurgent  and  persistent  current,  mitigating  their  upregulation  
by  DRG  inflammation.  The  first  potential  mechanism  reflects  that,  in  addition  to  
their  roles  regulating  electrophysiological  properties  of  the  pore-­forming  α  
subunits,  Navβ  subunits  have  been  shown  to  regulate  trafficking  to  the  
membrane,  subcellular  localization,  and  even  gene  expression  of  α  subunits  
(136,  228,  244).  In  the  PNS,  Navβ4  is  enriched  at  the  nodes  of  Ranvier,  
particularly  at  nodes  in  large  diameter  axons.  In  the  CNS,  Navβ4  may  be  
localized  at  the  axon  initial  segment,  unmyelinated  axons  or  at  the  nodes  of  
Ranvier  depending  on  the  cell  type  and  region  (228).  Navβ4  co-­expression  did  
not  increase  peak  Nav1.6  current  in  a  heterologous  expression  system  (227)  
though  not  all  aspects  of  sodium  channel  function  are  captured  in  such  systems.  
While  we  did  detect  a  reduction  in  Nav1.6  immunohistochemistry  with  Navβ4  
knockdown  relative  to  control  siRNA,  we  did  not  see  a  reduction  in  TTXS  current  
density  in  corresponding  patch  clamp  experiments,  which  were  conducted  on  a  
defined  subset  of  neurons.  In  our  previous  study  with  large  diameter  neurons  in  
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the  higher  end  of  the  cell  size  spectrum  (~60  µm;;  see  Part  I),  we  did  detect  a  
small  reduction  in  TTXS  current  density  with  Navβ4  knockdown.  The  β  subunit  
background  may  be  different  between  these  two  populations  (35-­45  µm  vs.  60  
µm).  Therefore,  by  knocking  down  Navβ4  other  beta  subunits  may  compensate  
depending  on  the  cell  background.  It  is  also  possible  that  not  all  the  Nav1.6  
protein  visualized  by  immunohistochemistry  was  necessarily  functional  
membrane-­localized  channels;;  conversely  the  patch  clamp  experiments  may  not  
reflect  changes  in  axonal  current  densities.  The  staining  for  Nav1.6  was  diffuse  
and  did  not  appear  restricted  to  the  membrane.  However,  we  did  not  use  thin  
sections  to  specifically  address  this  question  but  other  studies  have  shown  a  
similar  pattern  (13,  222,  245).  Details  of  possible  Navβ4  effects  on  α  subunit  
trafficking  and  expression  require  further  study.  In  particular,  studies  with  other  β  
subunits  suggest  two  potential  pathways  that  may  regulate  trafficking  and  
expression  (244).  Navβs  are  part  of  the  immunoglobulin  CAM  superfamily  and  
the  extracellular  domain  is  essential  for  CAM  activity  (198,  246).  Therefore,  one  
way  Navβs  may  regulate  VGSC  localization  is  through  interactions  with  the  
extracellular  matrix  or  other  CAMs.  On  the  other  hand,  Navβ  subunits  have  been  
reported  to  interact  with  cytoskeletal  proteins  such  as  Ankyrin  which  may  
regulate  expression  and  localization  of  VGSCs  (228,  247,  248).      
  
The  second  proposed  mechanism  to  explain  the  impact  of  Navβ4  
knockdown  focuses  on  alterations  in  sodium  channel  gating  properties.  The  
electrophysiological  parameters  that  seem  to  best  correlate  with  mechanical  
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hypersensitivity  is  the  incidence  of  high-­frequency  spontaneous  activity  in  Aβ  
neurons.  Increased  resurgent  and  persistent  currents  can  facilitate  such  high  
frequency  spontaneous  activity,  and  Navβ4  knockdown  effects  on  these  currents  
may  have  contributed  to  our  electrophysiological  and  behavioral  findings.  The  
decrease  in  resurgent  and  persistent  currents  in  voltage  clamp  experiments  in  
response  to  Navβ4-­siRNA  was  not  due  to  a  decrease  in  total  TTXS  current  
(which  was  unaffected  by  the  siRNA);;  both  the  absolute  values  and  the  ratios  of  
resurgent-­to-­transient  and  persistent-­to-­transient  current  were  significantly  
reduced  by  Navβ4  knockdown.  Navβ4  knockdown  also  decreased  persistent  
sodium  currents  in  cerebellar  granule  neurons  (197).  Consistent  with  known  
properties  of  persistent  currents,  we  observed  that  DRG  inflammation  
depolarized  the  resting  membrane  potential  of  Aβ  neurons,  an  effect  that  was  
partially  reversed  by  Navβ4  knockdown.  Although  other  sodium  channel  α  
subunit  isoforms  can  generate  resurgent  currents  when  the  cytoplasmic  terminal  
peptide  of  Navβ4  is  introduced,  in  vivo,  fast  TTXS  resurgent  currents  in  most  
(though  not  all)  of  the  neurons  studied  to  date  seem  likely  to  be  the  result  of  
Navβ4  in  association  with  Nav1.6,  in  both  central  and  DRG  neurons  (27,  182,  
228,  249).  The  upregulation  of  Navβ4  in  the  DRG  inflammation  model  is  a  
plausible  mechanism  for  facilitating  the  high  frequency  repetitive  firing  seen  in  
spontaneously  active  Aβ  neurons.  In  our  experimental  conditions  knockdown  of  
either  Navβ4  or  Nav1.6  had  relatively  minor  effects  on  evoked  single  action  
potentials,  and  no  effect  on  action  potential  duration,  but  pronounced  effects  on  
spontaneous  activity  or  repetitive  firing  capability.  Our  results  suggest  that  the  
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latter  two  electrophysiological  parameters  best  correlate  with  mechanical  
hypersensitivity.  
  
Changes  in  the  voltage-­dependence  of  sodium  channel  activation  and  
inactivation  can  also  contribute  to  altered  excitability.  Previous  studies  examining  
the  impact  of  Navβ4  on  recombinant  Nav1.6  channels  expressed  in  heterologous  
cells  such  as  HEK293  cells  indicate  that  Navβ4  can  induce  negative  shifts  in  the  
voltage-­dependence  of  activation  (by  almost  -­10  mV)  and,  to  a  lesser  extent,  
steady-­state  inactivation  (227).  We  observed  a  hyperpolarizing  shift  in  activation  
with  inflammation  of  the  DRG;;  this  is  likely  to  enhance  spontaneous  firing  in  
sensory  neurons.  Navβ4  knockdown  also  induced  a  +6  mV  shift  in  the  voltage-­
dependence  of  activation,  supporting  the  notion  that  Navβ4  subunits  modify  
Nav1.6  voltage-­dependence  of  activation.  In  our  previous  study  (see  Part  I),  co-­
expression  of  rat  Navβ4  with  human  Nav1.6  did  not  produce  a  change  in  
activation  in  small  diameter  neurons  (203).  A  possible  explanation  for  this  
discrepancy  is  that  inflammation  may  trigger  additional  mechanisms  (e.g.,  
activating  kinase  pathways)  that  endow  Navβ4  to  mediate  this  enhanced  activity.  
The  effect  may  depend  on  neuronal  background  (e.g.,  small  diameter  vs.  
medium  diameter  neurons).  An  alternative  possibility  is  that  the  small  species  
differences  between  human  Nav1.6  and  rat  Nav1.6  account  for  this  effect.  
Interestingly,  co-­expression  of  Navβ4  with  mouse  Nav1.6  which  is  more  similar  to  
rat  Nav1.6  than  human,  did  produce  a  similar  shift  in  activation  (data  not  shown).  
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Our  results  with  the  LID  model  confirm  work  in  the  previous  section  
showing  that  Navβ4  is  primarily  expressed  in  larger  sensory  neurons  and  extend  
it  by  showing  that  it  plays  a  key  role  in  mediating  resurgent  currents  in  inflamed,  
hypersensitive  sensory  neurons  (23,  198,  203).  In  this  study,  the  patch  clamp  
experiments  on  sodium  currents  were  conducted  on  medium  diameter  neurons  
expressing  only  TTXS  sodium  currents.    This  focus  was  dictated  by  our  
collaborators’  previous  work  showing  that  spontaneous  activity  in  this  model  is  
sensitive  to  TTX  and  largely  observed  in  cells  at  the  smaller  end  of  the  size  range  
for  Aβ  neurons(238).  By  excluding  cells  expressing  both  TTXR  and  TTXS  
currents,  we  most  likely  eliminated  many  Aδ  neurons  (84).  TTXR  resurgent  
sodium  currents  mediated  by  Nav1.8  and  enhanced  by  the  Navβ4  cytoplasmic  
terminus  have  also  been  observed  in  DRG  neurons  (25).  These  resurgent  
currents  activate  over  an  order  of  magnitude  more  slowly  than  those  mediated  by  
Nav1.6;;  e.g.  at  -­20mV  the  times  to  peak  are  130ms  for  TTXR  resurgent  current  
currents  compared  to  3.5ms  for  TTXS  resurgent  currents.  Thus,  it  is  not  clear  if  
these  TTXR  currents  could  facilitate  the  high  frequency  firing  observed  in  the  LID  
model,  in  which  the  interspike  interval  is  commonly  less  than  10ms.  Nav1.8  has  
recently  been  found  to  be  upregulated  in  myelinated  Aβ  neurons  by  peripheral  
inflammation  (CFA  paw  injection)  (250)  and  therefore  a  possible  role  of  Nav1.8  in  
our  model  remains  to  be  investigated.  Arguing  against  Nav1.8  playing  a  
predominant  role  in  our  model  are  the  observations  that  peripheral  inflammation  
with  CFA  and  local  DRG  inflammation  yield  DRG  gene  expression  changes  with  
almost  no  overlap  (251),  and  the  reduction  of  pain  associated  behaviors  and  
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spontaneous  activity  by  Nav1.6  knockdown  in  the  LID  model  (14).  In  addition,  
preliminary  experiments  from  our  collaborators  in  the  Zhang  lab  using  protocols  
similar  to  the  current  study  showed  no  effect  of  Nav1.8  knockdown  on  pain  
associated  behaviors  induced  by  DRG  inflammation  through  POD  4.    
  
In  conclusion,  although  NaV1.6  has  not  generally  been  considered  a  good  
therapeutic  target  for  pain,  due  to  its  widespread  distribution  and  key  role  in  the  
node  of  Ranvier,  our  results  suggest  that  targeting  the  persistent  and  resurgent  
currents  generated  by  this  channel  (which  appear  to  depend  on  Navβ4)  might  be  
a  promising  approach.    
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*The  content  of  this  chapter  was  adapted  from  a  manuscript    
published  in  PAIN.  *  
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PART  III:  FHF2  ISOFORMS  DIFFERENTIALLY  REGULATE  NaV1.6-­





   The  sodium  channel  subtype  Nav1.6  as  well  as  the  Nav1.6-­mediated  
resurgent  currents  have  been  implicated  in  several  pain  pathologies.  However,  
our  knowledge  of  how  fast  resurgent  currents  are  modulated  in  DRG  neurons  is  
limited.  This  study  explored  the  potential  regulation  of  Nav1.6-­mediated  
resurgent  currents  by  isoforms  of  Fibroblast  growth  Factor  Homologous  factor  2  
(FHF2)  in  an  effort  to  address  the  gap  in  our  knowledge  of  resurgent  current  
modulation.  FHF2  isoforms  colocalize  with  Nav1.6  in  peripheral  sensory  neurons.  
Heterologous  expression  of  FHF2  isoforms  suggests  that  these  proteins  
differentially  regulate  inactivation  of  VGSCs.  In  particular,  FHF2A  mediates  long-­
term  inactivation  (175),  a  mechanism  proposed  to  compete  with  the  open  
channel  blocker  mechanism  that  mediates  resurgent  currents.  On  the  other  hand,  
FHF2B  lacks  the  ability  to  mediate  long-­term  inactivation  and  may  delay  
inactivation,  favoring  open  channel  block.  Based  on  these  observations,  we  
hypothesized  that  FHF2A  limits  the  generation  of  resurgent  current,  whereas,  
FHF2B  enhances  resurgent  currents.  Overall,  our  results  suggest  that  FHF2A  
negatively  regulated  fast  resurgent  current  by  enhancing  long-­term  inactivation  
and  delaying  recovery.  In  contrast,  FHF2B  positively  regulated  resurgent  current  
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and  did  not  alter  long-­term  inactivation.  Chimeric  constructs  of  FHF2A  and  Navβ4  
(likely  the  main  open  channel  blocker  in  DRG  neurons;;  see  Part  I)  exhibited  
differential  effects  on  resurgent  currents  suggesting  that  specific  regions  within  
FHF2A  and  Navβ4  have  opposing  regulatory  functions.  Interestingly,  FHFAs  and  
FHF2B  isoforms  were  differentially  regulated  in  a  radicular  pain  model  in  a  
manner  that  likely  contributes  to  enhanced  resurgent  currents.  As  such,  these  
findings  suggest  that  FHF2A  and  FHF2B  regulate  resurgent  current  in  DRG  
neurons  and  may  contribute  to  hyperexcitability  associated  with  some  pain  
pathologies.  
  




   These  studies  used  cDNA  constructs  of  the  sodium  channel  auxiliary  
subunits,  FHF2A,  FHF2B  and  chimeric  constructs  of  FHF2A  and  Navβ4.  All  
constructs  were  tagged  at  the  C-­terminus  with  photostable  monomeric  
Turquoise2  (pmTurquoise2)  to  verify  expression.  To  generate  the  FHF2A  and  
FHF2B  tagged  constructs,  the  coding  sequence  corresponding  to  mouse  FHF2A  
(National  Center  for  Biotechnology  Information  database  (252)  reference  
number:  NP_034330.2)  and  human  FHF2B  (NP_378668.1)  were  synthesized  
and  purchased  from  Genscript  (Piscataway,  NJ).  Mouse  FHF2A  protein  is  
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identical  to  rat  FHF2A  (NC_005120.4).  Human  FHF2B  protein  is  99.48%  identical  
to  mouse  (NP_001277344.1)  and  rat  FHF2B  (NP_445880.1).  The  FHF2A  
sequence  was  cut  from  a  pUC57  vector  and  inserted  into  the  pmTurquoise2-­N1  
vector  with  HindIII/KpnI  restriction  enzymes.  The  FHF2B  sequence  was  cut  from  
pcDNA3.1  (+)  vector  and  inserted  into  pmTurquoise2-­N1  vector  with  
HindIII/BamHI  restriction  enzymes.  The  sequences  were  moved  in-­frame  by  site  
directed  mutagenesis  (Quickchange  XL  II  Site  Directed  Mutagenesis  kit,  Agilent  
Technologies).    
  
The  chimeric  constructs  of  FHF2A  and  Navβ4  were  designed  by  replacing  
the  long-­term  inactivation  particle  sequence  (AAAIASSLIRQKRQAREREK,  20  
amino  acids  (175))  with  the  Navβ4  open  channel  blocker  sequence  
(KKLITFILKKTREKKKECLV,  20  amino  acids  (199))  to  generate  the  F2A(β4)  
construct.  Conversely,  the  open  channel  blocker  sequence  in  rat  Navβ4  
(NP_001008880.1)  was  replaced  with  the  long-­term  inactivation  particle  of  
FHF2A  to  generate  the  (β4)F2A  construct.  The  full  chimeric  sequences  were  
synthesized  and  purchased  from  Genscript  (Piscataway,  NJ).  The  F2A(β4)  and  
(β4)F2A  sequences  were  cut  from  the  pUC57  vector  and  sub-­cloned  into  
pmTurquoise-­N1  with  NheI/XhoI  restriction  enzymes.  To  move  the  sequences  in  
frame  with  the  fluorescent  protein,  the  stop  codon  was  mutated  to  a  glycine  
residue  using  site-­directed  mutagenesis.  
  
To  study  Nav1.6  in  isolation  from  endogenous  TTXS  channels  we  used  a  
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Nav1.6  TTXR  construct  previously  described  in  (181).  Briefly,  the  sequence  
corresponding  to  human  Nav1.6  protein  (NP_055006.1)  was  codon-­optimized  
and  purchased  from  Genscript  (Piscataway,  NJ).  The  sequence  was  then  sub-­
cloned  into  pcDNA3.1  (+)  with  KpnI/XbaI  restriction  enzymes.  The  Nav1.6  
sequence  was  then  modified  with  site  directed  mutagenesis  to  confer  high  
resistance  to  TTX  by  converting  tyrosine  residue  371  to  serine  as  previously  
described  (212,  213).  The  resulting  construct  was  named  Nav1.6r.  Additionally,  
we  knocked  down  endogenous  TTXR  Nav1.8  channels  with  a  small  hairpin  RNA  
(shRNA)  plasmid  to  aid  in  the  isolation  of  Nav1.6r  currents.  The  Nav1.8  shRNA-­
IRES-­dsRED  plasmid  encoded  for  Nav1.8  shRNA  sequence  (targeting  
sequence,  GATGAGGTCGCTGCTAAG,  (214)  and  an  internal  ribosome  entry  
site  for  the  translation  of  fluorescent  protein  marker  dsRed  (IRES-­dsRED)  as  




   DRG  neurons  were  obtained  from  adult  male  Sprague  Dawley  rats.  Rats  
were  euthanized  by  CO2  exposure  and  secondary  decapitation.  The  spinal  
column  was  then  removed  and  DRG  were  harvested  from  the  lumbar  to  cervical  
region.  The  nerve  processes  were  cut  from  the  excised  ganglia.  Ganglia  were  
then  digested  in  Dulbecco’  modified  Eagle’s  Medium  (DMEM,  Fisher  Scientific)  
containing  collagenase  (1.25  mg/mL)  and  neutral  protease  (0.78mg/mL)  for  45  
minutes  at  37°C.  Subsequently,  the  digested  ganglia  were  centrifuged  at  
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1000rpm  for  five  minutes.  Digestion  media  was  aspirated  and  replaced  with  10%  
Fetal  Bovine  Serum  (FBS,  Hyclone)  DMEM  (Invitrogen)  and  ganglia  were  
mechanically  dissociated  with  sequentially  smaller  glass  pipettes.  Dissociated  
ganglia  were  spun  again  at  700  rpm  for  five  minutes.  Media  was  aspirated  and  
replaced  with  fresh  10%  FBS  DMEM  media.  Aliquots  of  cell  suspension  
(~100 µL)  were  loaded  onto  glass  coverslips  coated  with  poly-­D-­lysine  and  
laminin.  After  10  minutes,  cells  settled  and  500uL  of  10%  FBS  DMEM  was  added  
to  each  well.  For  electrophysiological  experiments  with  transfected  neurons,  the  
10%  FBS  DMEM  media  was  supplemented  with  mitotic  inhibitors,  5-­fluoro-­2-­
deoxyuridine  (50uM,  Sigma  Aldrich)  and  uridine  (150µM,  Sigma  Aldrich),  to  
prevent  overgrowth  of  the  supporting  cells.  Cells  obtained  from  dissociated  DRG  
(neurons  and  supporting  cells)  grown  in  culture  were  maintained  at  37°C  in  a  
humidified  95%  air  and  5%  CO2  incubator.  Media  was  changed  every  two  days.  
  
For  Localized  Inflammation  of  the  DRG  (LID)  experiments,  the  ipsilateral  
L4  and  L5  DRG  were  excised  from  sham  operated  rats  and  inflammation-­induced  
rats  at  post  operative  day  5.  The  above  dissociation  protocol  and  culture  was  
followed  with  the  exception  of  the  digestion  time,  which  was  decreased  to  28  
minutes.  Indiana  University  School  of  Medicine  Institutional  Animal  Care  and  Use  
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Surgical  procedure  for  localized  inflammation  of  the  DRG  
  
   Localized  inflammation  of  the  DRG  was  used  as  a  model  of  radicular  pain  
as  previously  discussed  in  (253)  and  described  in  (238).  Adult  male  Sprague  
Dawley  rats  under  isoflurane  anesthesia  were  used  for  these  procedures.  After  
deep  anesthesia  was  verified,  an  initial  incision  on  the  back  near  the  spinal  
column  was  made  from  L3-­S1  to  expose  and  visualize  the  superficial  area  of  the  
spine.  Then,  a  second  deeper  incision  was  made  on  one  side  of  the  animal  
approximately  1mm  from  the  center  of  the  spine  from  L4  to  S1.  Paraspinal  
muscles  near  L4/L5  were  carefully  teased  apart  until  the  intervertebral  foramen  
could  be  visualized  using  the  transverse  processes,  ilium  and  dorsal/ventral  
ramus  as  guides.  Aliquots  of  10uL  containing  zymosan  diluted  in  incomplete  
Freud’s  Adjuvant  (2mg/mL)  were  injected  near  L4  and  L5  DRG  each,  through  a  
needle  inserted  close  to  the  DRG  through  the  intervertebral  foramen.  The  needle  
was  bent  in  a  90  degree  angle  ~2  mm  from  the  tip  for  easier  access  and  was  left  
for  two  minutes  after  injection  to  prevent  leakage.  Sham  operated  animals  were  
used  as  a  control;;  the  above  procedure  was  followed  with  the  exception  of  
zymosan  injection.  Indiana  University  School  of  Medicine  Institutional  Animal  
Care  and  Use  Committee  approved  the  surgical  procedure  described.  
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Immunocytochemistry  
  
   To  study  the  expression  pattern  of  FHF2A  and  FHF2B  after  inflammation,  
the  L4  and  L5  ipsilateral  DRG  ganglia  were  harvested  and  dissociated  from  sham  
operated  and  inflammation  induced  animals  at  post  operative  day  5.  DRG  
neurons  were  fixed  after  24  hours  in  culture,  permeabilized,  blocked  and  treated  
with  antibodies  in  the  following  manner:  Cells  were  fixed  with  4%  
paraformaldehyde  (0.1M  phosphate  buffer,  pH  7.4)  for  20  minutes  at  room  
temperature,  washed  with  phosphate  buffered  saline  (PBS),  permeabilized  in  1%  
Triton  X-­100  in  PBS  for  20  minutes  at  room  temperature,  washed  with  PBS,  
blocked  for  2  hours  (10%  normal  goat  serum,  0.1%  Triton  X-­100  in  PBS)  at  room  
temperature,  washed  with  PBS,  incubated  in  primary  antibodies  diluted  in  
blocking  solution  overnight  at  4°C,  washed  with  PBS  and  incubated  with  
secondary  antibody  in  blocking  solution  for  2  hours  at  room  temperature.  Primary  
antibodies  used  were  Anti-­Pan-­FHF-­A  (1:200,  Clone  N235/22,  UC  Davis/NIH  
NeuroMab  Facility)  and  monoclonal  Anti-­FGF13/FHF2.B  (1:200,  Clone  
N225A/10,  UC  Davis/NIH  NeuroMab  Facility).  Secondary  antibody  used  was  
Alexa  Fluor®  488  Goat  Anti-­Mouse  IgG  (Molecular  Probes,  Life  Technologies)  at  
1:750  dilution.  Coverslips  were  mounted  on  microscope  slides  with  Prolong  Gold  
Antifade  (Molecular  Probes).  DRG  neurons  were  imaged  using  an  Axio  Observer  
Z1  Widefield  Microscope  with  a  20X  objective  (ZEISS  Microscopy).  Images  were  
analyzed  using  NIS  Elements  Advance  Research  (Nikon®)  software  by  defining  
each  cell  as  a  region  of  interest  and  quantifying  the  mean  intensity  signal  for  
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FHF2A  and  FHF2B.  The  mean  intensity  signal  was  compared  between  sham  and  
LID  groups  using  Student’s  t-­test.  Quantification  experiments  were  carried  out  
independently  at  least  five  times;;  more  than  1000  cells  were  counted  for  each  
condition.    
  
Recombinant  expression  in  DRG  neurons  
  
DRG  neurons  were  transiently  co-­transfected  with  Nav1.6r,  tagged  auxiliary    
subunit  and  Nav1.8  shRNA-­IRES-­dsRED  using  the  Helios  Gene  Gun  (Bio-­Rad  
Laboratories)  36-­48  hours  after  dissociation  in  2:1:1  ratio  respectively.  As  a  
negative  control,  pmTurquoise  2  (tag  only)  was  co-­transfected  instead  of  the  
auxiliary  subunits.  For  peptide  studies,  only  Nav1.6r  and  Nav1.8  shRNA-­IRES-­
dsRED  were  co-­transfected.  Expression  of  the  Nav1.6r  construct  with  Nav1.8  
shRNA  allowed  us  to  study  the  modulation  of  Nav1.6r  by  auxiliary  subunits  in  
isolation  from  endogenous  channels  as  previously  described  (19,  203).  Although  
endogenous  TTXR  Nav1.8  channels  run  down  in  culture  (19,  216),  by  using  the  
Nav1.8  shRNA-­IRES-­dsRED  plasmid  we  further  decreased  Nav1.8  to  minimize  
contamination.  TTXR  Nav1.9  currents  are  not  observed  under  our  recoding  
parameters  as  previously  reported  (217,  218).  Endogenous  TTXS  channels  were  
blocked  with  500nM  TTX.    
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Electrophysiology  and  data  analysis  
  
   General  Setup:  Whole  cell  patch  clamp  recordings  were  obtained  with  a  
HEKA  EPC-­10USB  amplifier.  Data  were  acquired  on  a  Windows-­based  Intel  2  
Core  computer  using  the  Patchmaster  program  (version  2X65;;  HEKA  Elektronik).  
Fire  polished  glass  electrodes  (0.7-­1.1MΩ)  were  fabricated  using  a  P-­97  puller  
(Sutter),  and  tips  were  coated  with  dental  wax  to  minimize  capacitive  artifacts  
and  enhance  series  resistance  compensation.  The  offset  potential  was  zeroed  
prior  to  seal  formation.  Capacitive  transients  were  canceled  using  computer-­
controlled  circuitry;;  C-­fast  for  pipette  capacitance  correction  and  C-­slow  for  cell  
capacitance  compensation.  Voltage  errors  were  minimized  by  series  resistance  
compensation  >75%.  Membrane  currents  were  sampled  at  20KHz  and  filtered  
online  at  10KHz.  Leak  currents  were  linearly  cancelled  by  P/-­5  subtraction  
(pulse/number).  Whole  cell  patch  clamp  recordings  in  voltage  clamp  mode  were  
obtained  2-­3.5  days  after  transfection  at  room  temperature  (~22°C).  Cells  
examined  were  selected  based  on  fluorescence  of  Turquoise  (corresponding  to  
auxiliary  subunit)  and  dsRed  (corresponding  to  Nav1.8  shRNA)  signal.  For  
peptide  studies,  only  the  dsRed  signal  was  used  as  selection  criteria  since  no  
auxiliary  subunits  were  co-­transfected.  Cells  with  residual  Nav1.8  current  greater  
than  3%  of  the  peak  current  of  Nav1.6r  were  excluded.  Nav1.8  contamination  
was  determined  by  examining  the  voltage-­dependence  of  steady-­state  fast  
inactivation  as  described  previously  (203).  Whole  cell  patch  clamp  recordings  
were  started  five  minutes  after  the  whole  cell  configuration  was  obtained.  
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Electrophysiology  data  were  analyzed  using  the  software  programs  Origin  
(version  8,  OriginLab),  Fitmaster  (v2X65,  HEKA  Electronik),  Excel  (Microsoft)  
and  final  graphs  were  made  in  Prism  (version  6,  GraphPad).    
  
Recording  solutions:  The  electrode  solution  consisted  of  140mM  CsF,  
10mM  NaCl,  1.1mM  EGTA,  and  10mM  HEPES  (adjusted  to  pH  7.3  with  CsOH).  
The  extracellular  bathing  solution  contained  130mM  NaCl,  30mM  TEA  chloride,  
1mM  MgCl2,  3mM  KCl,  1mM  CaCl2,  0.05mM  CdCl2,  10mM  HEPES,10mM  D-­
glucose  and  500nM  TTX  (adjusted  pH  7.3  with  NaOH).  Recording  solutions  were  
adjusted  using  D-­glucose  to  maintain  physiological  values  of  osmolarity  (310  
mOsm  for  internal  solution  and  320  mOsm  for  external  solution).    
  
Peptide  Experiments:  To  study  the  effects  of  FHF2A`s  long-­term  
inactivation  particle,  we  used  a  FHF2A  derived  peptide  corresponding  to  amino  
acids  residues  2-­21  as  reported  in  (175).  The  peptide,  FHFA,  was  modified  with  
an  N-­terminal  acetyl  group  and  C-­terminal  hydroxyl  group  yielding  the  following  
sequence:  Ac-­AAAIASSLIRQKRQAREREK-­OH  (purchased  from  Biopeptides  
Co).  The  FHFA  peptide  was  added  to  the  electrode  solution  at  a  1mM  
concentration.  In  the  control  group  no  peptide  was  added  to  the  intracellular  
solution.    
  
Steady-­State  Activation:  Current-­voltage  (I/V)  relationships  were  
determined  by  steps  of  50ms,  from  -­100  to  +  80mV,  in  5mV  increments.  The  
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voltage-­dependence  of  activation  (m∞)  was  determined  from  sodium  currents  
elicited  with  I/V  protocol  from  voltages  of  -­100mV  to  0mV.  Conductance  (G)  
values  were  calculated  at  each  test  potential  (Vm)  using  the  following  equation,  𝐺 = @ABCAD .  Vr    is  the  voltage  at  which  the  direction  sodium  influx  reverses.  The  
reversal  potential  was  quantified  for  each  neuron  Goldman-­Hodgkin-­Katz  
equation  (221).  Data  were  then  normalized  to  the  peak  conductance,  plotted  as  a  
function  of  voltage  and  fitted  using  single-­phase  Boltzmann  distribution  equation,  
  
EEBFG = HHIJ KBLKM/O P .  The  half-­activating  voltage  (V1/2)  and  slope  factor  (k)  
were  obtained  for  each  cell.    
  
Steady-­State  Inactivation:  Steady-­state  fast  inactivation  (h∞)  was  assayed  with  
500ms  pre-­pulses  from  -­130  to  5mV  (in  5mV  increments)  followed  by  a  20ms  test  
pulse  to  -­20mV  to  assess  channel  availability.  Currents  at  each  pre-­pulse  were  
normalized  to  the  peak  current.  Data  of  normalized  currents  as  a  function  of  
voltage  was  fitted  with  the  single  phase  Boltzmann  distribution,   @@BFG =
HHIJ KBLKM/O P ,  from  which  the  half-­point  of  inactivation  (V1/2)  and  slope  factor  (k)  
were  obtained  for  each  cell.  Vm  corresponded  to  the  prepulse  voltage.  
Additionally,  current  densities  were  estimated  for  each  individual  recording  by  
dividing  the  peak  transient  currents  obtained  from  h∞  by  the  membrane  
capacitance.    
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Recovery  from  Inactivation:  Recovery  from  inactivation  was  assayed  with  
a  two-­pulse  protocol  that  depolarized  the  membrane  to  -­20mV  for  20ms  from  the  
holding  potential  (-­100mV).  The  time  between  the  pulses  was  increased  by  an  
additive  2n  factor,  where  n=sweep  number.  At  each  time  point  the  peak  current  
measured  in  the  second  pulse  (I2)  was  normalized  to  the  peak  current  measured  
in  the  first  pulse  (I1),  yielding  the  fraction  of  sodium  channels  available.  The  
fraction  available  (@O@M)	  was  plotted  as  a  function  of  time  (t)  and  fitted  to  a  double  
exponential  equation,  @O@M = 𝐴S + 𝐴UVWX𝑒CX YUVWX + 𝐴WZ[\𝑒CX YWZ[\,  from  which  we  
obtained  the  recovery  time  constants  for  the  fast  (τfast)  and  slow  component  
(τslow)  and  compared  between  groups.    
  
Accumulation  of  long-­term  inactivation:  Cells  were  assayed  with  a  four-­
pulse  protocol,  as  previously  described  (175),  to  measure  long-­term  inactivation.  
Each  pulse  depolarized  the  membrane  to  -­20mV  for  16ms  from  a  holding  
potential  of  -­90mV  with  -­90mV  40ms  interpulse  recovery  phases  between  each  
depolarization  pulse.  Currents  measured  at  each  pulse  were  normalized  to  peak  
current  to  yield  percentage  of  sodium  channels  available.  The  %  of  channels  
available  was  plotted  as  a  function  of  depolarization  cycle  (i.e.,  pulse  number).    
  
Resurgent  Current:  Cells  were  assayed  with  a  two-­pulse  protocol  that  
initially  depolarized  the  membrane  to  +30mV  for  20ms  from  the  holding  potential  
(-­100mV),  followed  by  repolarizing  voltage  steps  from  +15mV  to  -­85mV  for  
100ms  in  -­5mV  increments  to  test  for  resurgent  currents;;  cells  were  then  returned  
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to  their  holding  potential  (-­100mV).  Resurgent  currents  display  unique  
characteristics  of  slow  onset  and  slow  decay  along  with  a  non-­monotonic  I/V  
relationship.  Currents  that  did  not  meet  these  characteristic  were  classified  as  
negative  for  resurgent  currents.  Based  on  these  criteria,  the  percentage  of  DRG  
that  were  positive/negative  for  resurgent  current  was  quantified  for  each  
condition.  Resurgent  current  amplitudes  were  measured  after  3.0ms  into  the  
repolarizing  pulse  to  avoid  contamination  from  tail  currents.  Peak  resurgent  
current  amplitude  at  each  test  potential  was  normalized  to  peak  transient  current  
(obtained  from  the  h∞  protocol)  and  expressed  as  a  percentage  of  the  peak  
transient  current.  Normalized  resurgent  current  amplitude  was  plotted  as  a  
function  of  voltage.    
Statistics  
  
   Data  are  presented  as  mean  ±  standard  error  of  the  mean  (SEM).  The  
data  were  tested  for  a  Gaussian  distribution  fit  with  the  D'Agostino  &  Pearson  
omnibus  normality  test.  Data  that  fit  a  Gaussian  distribution  were  compared  with  
a  parametric  Student’s  t-­test  at  a  95%  level  of  confidence  (α=0.05).  Data  that  did  
not  fit  Gaussian  distribution  were  compared  with  a  non-­parametric  Mann-­Whitney  
Test  with  95%  level  of  confidence  (α=0.05).  The  Chi-­square  test  (X2  test)  was  
used  to  compare  the  frequency  distribution  of  neurons  that  were  positive  or  
negative  for  resurgent  current  at  a  95%  level  of  confidence  (α=0.05).    
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Results  
  
Biophysical  properties  of  Nav1.6r  with  FHF2A  and  FHF2B  
  
We  first  examined  if,  in  DRG  neurons,  FHF2A  could  mediate  the  
characteristic  long-­term  inactivation  that  has  been  reported  in  other  cells  with  
FHFAs  variants  (163,  175).  Primary  cultures  of  DRG  neurons  were  biolistically  
co-­transfected  with  Nav1.6r  and  tagged-­FHF2A  or  tagged-­FHF2B.  As  a  negative  
control,  only  the  tag  (pmTurquoise2;;  fluorescent  protein)  was  transfected.  Whole  
cell  voltage  clamp  recordings  of  isolated  Nav1.6r  currents  were  obtained  by  
pharmacological  (addition  of  500nM  TTX)  and  genetic  (Nav1.8shRNA)  inhibition  
of  endogenous  DRG  sodium  currents.  Long-­term  inactivation  was  measured  
using  a  four-­pulse  step  protocol  (see  Methods).  Representative  traces  obtained  
with  this  long-­term  inactivation  assay  are  shown  in  Figure  22A  for  each  group.  
Overexpression  of  FHF2A  increased  accumulation  of  Nav1.6r  in  long-­term  
inactivated  states,  consistent  with  previous  reports  (163,  175).  FHF2A  
progressively  decreased  Nav1.6r  availability  with  each  depolarization  cycle  
relative  to  control  (Figure  22B,  minimum  sodium  channel  availability  p<0.0001:  
FHF2A  72  ±  3%,  n=18;;  Control  90  ±  2%,  n=28),  whereas,  FHF2B  did  not  (FHF2B  
91  ±  2%,  n=13).    
  
We  also  examined  how  FHF2A  and  FHF2B  alter  other  biophysical  
properties  of  Nav1.6r  in  DRG  neurons  since  in  different  cell  backgrounds  the  
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interaction  of  FHFs  with  VGSCs  have  been  reported  to  alter  current  density,  
inactivation,  activation  and  recovery  (161).  Using  the  current-­voltage  (I/V)  
protocol  for  steady  state  activation  (see  Methods)  we  quantified  the  peak  current  
density  and  the  voltage-­dependence  of  activation.  Overexpression  of  FHF2A  or  
FHF2B  did  not  alter  peak  current  density  of  Nav1.6r  relative  to  control  (current  
density  p=0.10  and  p=0.18  respectively:  FHF2A  2.9  ±  0.2nA/pF,  n=25;;  FHF2B  
1.6  ±  0.3nA/pF,  n=16;;  control  2.0  ±  0.2nA/pF,  n=11).  FHF2A  did  shift  the  voltage-­
dependence  of  activation  to  positive  potentials  by  ~10mV  (Figure  21C),  whereas  
FHF2B  did  not,  relative  to  control  (Table  4).  Consistent  with  previous  reports  
(157,  162,  163,  254),  FHF2A  and  FHF2B  shifted  the  voltage-­dependence  of  
inactivation  to  more  depolarized  potentials  (Figure  22D).  FHF2A  slowed  recovery  
from  inactivation,  whereas,  FHF2B  enhanced  recovery  from  inactivation  relative  
to  control  (Figure  22E).  Table  4  shows  a  summary  of  recovery,  inactivation,  
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Figure  22:  Biophysical  properties  of  Nav1.6r  modulated  by  FHF2A  and  FHF2B.  DRG  
neurons  were  transfected  with  Nav1.6r  and  FHF2A,  FHF2B  or  fluorescent  protein  tag  (control).  A,  
Representative  traces  of  cycle-­dependent  reduction  as  a  measure  of  accumulation  of  long-­term  
inactivation  (LTI)  for  control  (black),  FHF2A  (blue)  and  FHF2B  (purple)  groups.  B,  The  
percentage  of  channels  available  as  a  function  of  depolarization  cycle  shows  overexpression  of  
FHF2A  (n=19)  increased  accumulation  of  long-­term  relative  to  control  (n=28),  whereas,  FHF2B  
(n=13)  did  not.  C,  Normalized  conductance  (G/Gmax)  as  a  function  of  voltage  shows  that  FHF2A  
(blue  squares,  n=16)  overexpression  shifted  the  voltage-­dependence  of  activation  relative  to  
control  (black  circles,  n=25).  No  change  is  observed  for  FHF2B  overexpression  (purple  
diamonds,  n=11)  relative  to  control.  D,  Normalized  current  (I/Imax)  as  a  function  of  voltage  shows  
that  voltage-­dependence  of  inactivation  was  shifted  to  positive  potentials  in  FHF2A  (n=19)  and  
FHF2B  (n=13)  groups  relative  to  control  (n=27).  E,  Fraction  of  channels  available  as  a  function  of  
time  shows  FHF2A  (n=19)  overexpression  greatly  slowed  recovery  from  inactivation  relative  to  
control  (n=15),  whereas,  FHF2B  (Inset,  n=12)  enhanced  channel  recovery.  Asterisks  (*)  represent  
p  <0.0001  obtained  from  Student’s  t-­test.  Data  are  mean  ±  SEM



















   Activation   Inactivation   Recovery  
V1/2  (mV)   k   V1/2  (mV)   k   τfast  (ms)   τslow  (ms)  
Control  
n  
-­41.0  ±  1.9  
25  
4.4  ±  0.4  
25  
-­73.5  ±  1.4  
27  
6.7  ±  0.2  
27  
5.1  ±  0.5  
15  




-­32.5  ±  2.7*  
16  
5.2  ±  0.5  
16  
-­65.6  ±  2.0*  
19  
8.0  ±  0.5  
19  
4.9  ±  0.8  
19  




-­41.0  ±  3.4  
11  
4.9  ±  0.5  
11  
-­64.8  ±  2.5*  
13  
8.1  ±  0.6  
13  
3.2  ±  0.6  *  
12  
17.7  ±  4.4  
12  
  
Table  4:  Biophysical  properties  of  Nav1.6r  in  control,  FHF2A  and  FHF2B  groups.  
Abbreviations  are:  τ,  time  constant;;  k,  slope  factor  of  activation  or  inactivation  curve;;  V1/2,  
midpoint  voltage  of  activation  or  inactivation  curve.  Groups  were  compared  to  control  using  
Student’s  t-­test  (parametric)  or  Mann-­Whitney  U  Test  (non-­parametric).  *p<0.05  (vs.  control);;  
#p<0.005  (vs.  control);;  †  p<0.0001  (vs.  control).  Data  are  mean  ±  SEM  and  n  is  the  number  of  
cells  from  which  recordings  were  obtained.  
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Differential  modulation  of  fast  resurgent  currents  by  FHF2A  and  FHF2B  
  
We  next  investigated  the  modulation  of  resurgent  current  by  these  FHF2  
isoforms.  To  do  so,  we  used  a  two-­pulse  protocol  described  in  the  Methods  
section.  Resurgent  current  amplitudes  were  normalized  to  peak  transient  current  
(obtained  from  the  steady-­state  inactivation  protocol)  and  expressed  as  the  
percentage  of  the  peak  current.  Representative  traces  of  resurgent  currents  are  
shown  in  Figure  23A  for  each  group.  Overall  FHF2A  reduced  the  fraction  of  
neurons  positive  for  resurgent  current  (X2  test  p<0.05)  whereas  FHF2B  did  not,  
relative  to  control  (Figure  23B).  FHF2A  also  reduced  resurgent  current  amplitude  
relative  to  control  (Figure  23C  Peak  Resurgent  Current  Amplitude  p<0.005:  
FHF2A  0.371  ±  0.21%,  n=18;;  Control  1.14  ±  0.27%,  n=29).  FHF2B  exhibited  the  
opposite  effect,  doubling  peak  resurgent  current  amplitude  relative  to  control  
(p<0.05:  FHF2B  2.41  ±  0.22%,  n=13).  
     






Figure  23:  FHF2A  and  FHF2B  differentially  regulate  fast  resurgent  currents.  A,  
Representative  traces  of  Nav1.6r  mediated  resurgent  currents  obtained  from  cultured  DRG  
neurons  with  corresponding  peak  resurgent  currents  highlighted  for  control  (black),  FHF2A  
overexpression  (blue)  and  FHF2B  overexpression  (purple)  conditions.  B,  The  distribution  of  
resurgent  current  positive  (+INaR)/resurgent  current  negative  (-­INaR)  DRG  neurons  was  not  
different  with  FHF2B  (n=13)  overexpression  relative  to  control  (n=29).  FHF2A  (n=18)  
overexpression  significantly  decreased  the  percentage  of  DRG  neurons  that  generated  resurgent  
currents  relative  to  control  (p<0.0005,  X2  test).  C,  Normalized  resurgent  current  amplitude  as  a  
function  of  voltage  shows  FHF2A  overexpression  (blue  squares)  decreased  resurgent  current  
amplitude  in  a  range  of  voltages  relative  to  control  (black  circles).  In  contrast,  FHF2B  
overexpression  (purple  triangles)  increased  resurgent  current  amplitude  in  a  range  a  voltages.  
Asterisks  (*)  represent  p<0.05  (vs  control)  obtained  from  Student’s  t-­test.  Data  are  mean  ±  SEM.  
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FHFA  peptide  replicates  long-­term  inactivation  effects  and  reduces  Nav1.6r  
resurgent  currents  
  
FHF2A  has  two  known  potential  interactions  that  might  contribute  to  
Nav1.6r  modulation:  1)  binding  to  the  C-­terminus  of  sodium  channels  and  2)  
long-­term  inactivation  particle  binding  (presumably  to  the  inner  pore  region).  We  
hypothesized  that  FHF2A’s  long-­term  inactivation  particle  is  the  main  contributor  
for  the  observed  negative  regulation  of  fast  resurgent  currents.  To  explore  this  
possibility,  we  used  a  peptide  (FHFA)  corresponding  to  amino  acid  residues  2-­21  
in  the  FHF2A  protein,  which  was  previously  identified  as  the  long-­term  
inactivation  particle  (175).  FHFA  peptide  (1mM)  was  added  to  the  internal  
recording  solution  as  described  by  Dover  et  al,  2010.  DRG  neurons  were  
transfected  with  Nav1.6r  and  currents  were  isolated  by  pharmacological  (500nM  
TTX)  and  genetic  (Nav1.8shRNA)  inhibition  of  endogenous  sodium  currents  as  
described  in  the  Methods.  Voltage  clamp  recordings  were  obtained  five  minutes  
after  dialysis  of  the  internal  solution  in  the  presence  or  absence  of  the  peptide.  
Using  the  protocols  previously  described  we  examined  current  density,  
activation,  inactivation,  recovery,  long-­term  inactivation  and  resurgent  currents.  
Representative  traces  of  accumulation  of  long-­term  inactivation  are  shown  in  
Figure  24A-­B.  Dialysis  of  the  FHFA  peptide  greatly  increased  the  accumulation  of  
Nav1.6r  in  long-­term  inactivated  state  (Figure  24C,  minimum  sodium  channel  
availability  p<0.0001:  +FHFA  29  ±  3%,  n=15;;  -­FHFA  84  ±  2%,  n=16).  Recovery  
from  inactivation  was  significantly  slowed  in  the  +FHFA  peptide  group  relative  to  
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the  -­FHFA  peptide  group  (Figure  24D  and  Table  5).  Addition  of  the  FHFA  peptide  
did  not  alter  Nav1.6r  current  density  relative  to  control  (current  density  p=0.08:  
+FHFA  Peptide  1.7  ±  0.4nA/pF,  n=16;;  -­FHFA  Peptide  0.9  ±  0.1nA/pF,  n=14).  The  
voltage-­dependence  of  activation  or  voltage-­dependence  of  inactivation,  was  not  
different  between  +FHFA  peptide  group  and  -­FHFA  peptide  control  (Table  5).    
  
Representative  traces  of  peak  Nav1.6r  resurgent  currents  are  shown  in  
Figure  24E.  The  amplitudes  of  the  resurgent  currents  were  normalized  to  peak  
sodium  current  and  are  expressed  as  the  percentage  of  peak  current.  The  
+FHFA  peptide  group  exhibited  reduced  resurgent  current  amplitudes  relative  to  
the  -­FHFA  peptide  group  (Figure  24F,  peak  resurgent  current  p<0.05:  +FHFA  
Peptide  0.88  ±  0.3,  n=16;;  -­FHFA  Peptide  1.9  ±  0.6%,  n=15).  The  fraction  of  
resurgent  current  positive  neurons  was  also  greatly  reduced  in  the  +FHFA  
peptide  group  (X2  test  p<0.005:  20%,  n=15)  relative  to  control  -­FHFA  peptide  
(69%,  n=  16).    
     






Figure  24:  FHFA  peptide  exhibits  long-­term  inactivation  activity  and  recapitulates  
resurgent  current  reduction  effects.  Nav1.6r  currents  were  isolated  in  DRG  neurons  and  
recordings  were  obtained  in  the  presence  (+)  or  absence  (-­)  of  FHFA  peptide  in  the  recording  
pipette.  Representative  traces  of  cycle-­dependent  reduction  as  a  measure  of  accumulation  of  
long-­term  inactivation  (LTI)  are  shown  for  –FHFA  peptide  group  (A,  black)  and  +FHFA  peptide  
group  (B,  pink).  C,  The  percentage  of  channels  available  as  a  function  of  depolarization  cycles  
shows  that  addition  of  the  FHFA  peptide  (black  circles,  n=15)  significantly  increased  
accumulation  of  channels  in  long-­term  inactivated  states  relative  to  –FHFA  peptide  group  (pink  
squares,  n=14).  D,  Recovery  from  inactivation  was  greatly  slowed  in  +FHFA  peptide  group  (n=15)  
relative  to  –FHFA  peptide  group  (n=14).  E,  Representative  traces  of  Nav1.6r  mediated  resurgent  
currents  with  peak  currents  highlighted  for  -­FHFA  peptide  (black)  and  +FHFA  peptide  (pink)  
groups.  F,  Compared  to  –FHFA  peptide  (black  circles,  n=15),  addition  of  the  FHFA  peptide  (pink  
squares,  n=16)  reduced  resurgent  current  amplitude.  Note  resurgent  currents  were  normalized  to  
peak  transient  currents  and  plotted  as  a  function  of  voltage.  Asterisks  (*)  represent  p  <0.05  
obtained  from  Student’s  t-­test.  Data  are  mean  ±  SEM.  
  
  











   Activation   Inactivation   Recovery  
V1/2  (mV)   k   V1/2  (mV)   k   τfast  (ms)   τslow  (ms)  
-­FHFA  
n  
-­39.0  ±  2.6  
16  
5.8  ±  0.6  
16  
-­  71.2  ±  1.4  
16  
  
6.3  ±  0.3  
16  
5.1  ±  0.6  
16  




-­38.5  ±  2.6  
14  
6.5  ±  0.3  
14  
-­75.1  ±  2.2  
15  
5.7  ±  0.3  
15  
7.0  ±  0.8*  
15  
  
139.5  ±  11†  
15  
  
Table  5:  Biophysical  properties  of  Nav1.6r  with  or  without  FHFA  peptide.  Abbreviations  are:  
τ,  time  constant;;  k,  slope  factor  of  inactivation  or  activation  curve;;  V1/2,  midpoint  of  activation  or  
inactivation  curve.  Groups  were  compared  using  Mann-­Whitney  T-­test  or  Student’s  T-­test.    
*p<0.05;;†  p<0.0001.  Data  are  mean  ±  SEM  and  n  is  the  number  of  cells  from  which  recordings  
were  obtained.  
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Modulation  of  Nav1.6r  by  chimeric  constructs  of  Navβ4  and  FHF2A  
  
The  FHF2A  long-­term  inactivation  particle  is  potentially  inhibiting  fast  
resurgent  currents  by  competing  with  the  open  channel  blocker  for  the  open  
channel  state.  Our  previous  reports  suggest  that  Navβ4  is  likely  the  main  open  
channel  blocker  in  DRG  neurons  (203).  Therefore,  we  investigated  if  replacing  
the  proposed  open  channel  blocker  sequence  in  Navβ4  with  FHF2A’s  long-­term  
inactivation  sequence  would  transfer  the  long-­term  inactivation  activity  and  
reduce  resurgent  currents  in  DRG  neurons.  Conversely,  we  replaced  the  long-­
term  inactivation  sequence  in  FHF2A  with  the  open  channel  blocker  in  the  Navβ4  
protein  and  hypothesized  that  this  construct  would  increase  resurgent  current.  
The  sequences  were  codon  optimized  and  synthetically  made  (see  Methods).  
The  resulting  chimeric  constructs  were  named  F2A(β4)  for  the  FHF2A  protein  
containing  the  Navβ4  open  channel  blocker  sequence  and  β4(F2A)  for  the  Navβ4  
protein  containing  the  FHF2A  long-­term  inactivation  sequence  (Figure  25).  Both  
constructs  were  tagged  at  the  C-­terminus  with  a  fluorescent  protein,  
pmTurquoise2,  to  verify  expression.  DRG  neurons  were  biolistically  transfected  
with  Nav1.6r  and  one  of  the  chimeric  constructs.  As  a  control,  tag  only  was  
expressed  instead  of  a  chimeric  subunit.  Nav1.6r  currents  were  isolated  by  
pharmacological  (500nM  TTXR)  and  genetic  (Nav1.8shRNA)  inhibition  of  
endogenous  sodium  currents  as  previously  described.  Using  the  recording  
protocols  previously  described  we  examined  the  biophysical  properties  of  
Nav1.6r  with  co-­expression  of  β4(F2A)  or  F2A(β4)  and  investigated  if  the  
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chimeric  constructs  modulated  resurgent  currents.  Representative  traces  of  
accumulation  of  long-­term  inactivation  for  each  group  are  shown  in  Figure  26A.  
β4(F2A)  slightly  increased  the  accumulation  of  long-­term  inactivation  relative  to  
control  (Figure  26B:  minimum  sodium  channel  availability  p<0.05:  β4(F2A)  84  ±  
2%,  n=12;;  Control  89  ±  2%,  n=14),  whereas,  F2A(β4)  did  not  alter  accumulation  
of  long-­term  inactivation  (88  ±  2%,  n=9).  Expression  of  either  chimera,  β4(F2A)  
or  F2A(β4)  did  not  alter  the  current  density  relative  to  control  (current  density  
p=0.8  and  p=0.4  respectively:  β4(F2A)  1.6  ±  0.3nA/pF,  n=12;;  F2A(β4)  1.1  ±  
0.3nA/pF,  n=9;;  control  4.2  ±  2.6nA/pF,  n=14).  In  a  similar  pattern  as  seen  with  
FHF2A,  F2A(β4)  expression  shifted  the  voltage-­dependence  of  activation  (Figure  
26C)  and  inactivation  (Figure  26D)  of  Nav1.6r  to  positive  potentials  by  5mV  
relative  to  control,  whereas  β4(F2A)  did  not  alter  either  (Table  6).  Expression  of  
F2A(β4)  enhanced  Nav1.6r  recovery  from  steady-­state  inactivation  relative  to  
control  (Figure  26E  Inset).  β4(F2A)  did  not  slow  or  enhance  Nav1.6r  recovery  














Figure  25:  Chimeric  constructs  of  FHF2A  and  Navβ4.  A,  Illustration  of  FHF2A  and  Navβ4  
subunits.  The  Navβ4  subunit  consists  of  an  extracellular  N-­terminal  domain,  single  
transmembrane  and  a  cytosolic  domain  C-­terminal  domain.  The  cytosolic  domain  contains  a  
sequence  of  amino  acids  proposed  to  mediate  open  channel  block  that  generate  resurgent  
currents  (red  sphere  represents  β4  peptide  sequence,  amino  acids  183-­203(197,  199)).  The  
FHF2A  subunit  is  a  cytosolic  protein,  which  contains  a  core  region  homologous  to  all  FHF  with  a  
C-­terminal  epitope  that  enables  interaction  with  the  cytoplasmic  C-­terminal  region  of  sodium  
channels  (160).  Distinct  from  its  FHF2B  counterpart,  the  FHF2A  N-­terminus  sequence  is  much  
longer  and  contains  a  sequence  identified  as  the  long-­term  inactivation  particle  (yellow  sphere,  
amino  acids  1-­20  (175).  Arrow  between  the  subunits  highlights  the  region  that  was  exchanged  
between  these  subunits  to  generate  the  chimeric  constructs.  B,  Illustration  of  the  resulting  
chimeric  constructs.  The  β4(F2A)  contains  all  components  of  the  Navβ4  subunit  with  the  
exception  of  β4-­peptide  sequence,  which  was  replaced  with  long-­term  inactivation  particle  
sequence.  The  F2A(β4)  contains  all  domains  of  the  FHF2A  protein  except  the  long-­term  
inactivation  particle,  which  was  replaced  with  the  β4  peptide  sequence.  Inset,  depicts  the  figure  
legend  for  the  β4-­peptide  and  long-­term  inactivation  particle  with  the  corresponding  amino  acid  
sequence.  
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Figure  26:  Biophysical  properties  of  Nav1.6r  modulated  by  β4(F2A)  and  F2A(β4)  chimeras.  
A,  Representative  traces  of  cycle-­dependent  reduction  as  a  measure  of  long-­term  inactivation  
(LTI)  for  Nav1.6r  isolated  currents  in  DRG  neurons  with  co-­expression  of  fluorescent  tag  (control,  
black),  F2A(β4)  (green)  and  β4(F2A)  (orange).  B,  The  percentage  of  channels  available  as  a  
function  of  depolarization  cycle  shows  increased  accumulation  of  long-­term  inactivation  for  
β4(F2A)  group  (orange  squares,  n=12)  relative  to  control  (black  circles,  n=16),  whereas  no  
difference  is  observed  for  F2A(β4)  group  (green  triangles,  n=8)  relative  to  control.  C,  Normalized  
conductance  as  a  function  of  voltage  shows  that  co-­expression  of  F2A(β4)  (n=8)  shifted  the  
voltage-­dependence  of  activation  to  positive  potentials  relative  to  control  (n=14),  whereas,  no  
change  is  observed  for  the  β4(F2A)  group  (n=12).  D,  Normalized  current  as  a  function  of  voltage  
shows  that  co-­expression  of  F2A(β4)  (n=9)  shifted  the  voltage-­dependence  of  steady-­state  
inactivation  to  positive  potentials  relative  to  control  (n=14),  whereas,  no  change  is  observed  for  
the  β4(F2A)  group  (n=12).  E,  Fraction  of  current  available  as  a  function  of  time  shows  that  
recovery  is  not  significantly  altered  with  co-­expression  of  either  chimera  β4(F2A)  (n=12)  or  
F2A(β4)  (n=9)  relative  to  control  (n=14).  Asterisks  (*)  represent  p<0.05  obtained  from  Student’s  t-­
test.  Data  are  mean  ±  SEM.     








   Activation   Inactivation   Recovery  
V1/2  (mV)   k   V1/2  (mV)   k   τfast  (ms)   τslow  (ms)  
Control  
n  
-­40.3  ±  1.7  
14  
6.1  ±  0.8  
14  
-­  73.8  ±  1.6  
14  
  
7.3  ±  0.3  
14  
4.8  ±  0.5  
14  




-­40.5  ±  3.2  
12  
5.2  ±  0.5  
12  
-­75.17  ±  1.8  
12  
7.2  ±  0.4  
12  
4.8  ±  0.7  
12  
  




-­35.2  ±  2.5*  
8  
6.0  ±  0.5  
8  
-­65.3  ±  3.3*  
9  
7.4  ±  0.4  
9  
  
2.7  ±  0.3*  
9  
43.0  ±  11  
9  
  
Table  6:  Biophysical  properties  of  Nav1.6r  in  control,  F2A(β4)  and  β4(F2A)  groups.  
Abbreviations  are:  τ,  time  constant;;  k,  slope  factor  of  activation  or  inactivation  curve;;  V1/2,  
midpoint  of  activation  or  inactivation  curve.  Groups  were  compared  to  control  using  Student’s  t-­
test  (parametric)  or  Mann-­Whitney  U  Test  (non-­parametric).  *p<0.05  (vs.  control).  Data  are  mean  
±  SEM  and  n  is  the  number  of  cells  from  which  recordings  were  obtained.  
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Differential  modulation  of  fast  resurgent  currents  by  F2A(β4)    
and  β4(F2A)  chimeras  
  
We  next  examined  Nav1.6r-­mediated  resurgent  currents.  Resurgent  
current  amplitude  was  normalized  to  the  peak  sodium  current  obtained  from  the  
steady-­state  inactivation  protocol  and  expressed  as  the  percentage  of  peak  
current.  Representative  traces  of  resurgent  currents  for  each  condition  are  shown  
in  Figure  27A.  Figure  27B  shows  the  distribution  of  resurgent  current  positive  and  
resurgent  current  negative  neurons  for  each  condition.  Overall  the  percentage  of  
resurgent  current  positive  neurons  was  not  significantly  different  with  expression  
of  β4(F2A)  or  F2A(β4)  relative  to  control  (p=0.30  and  p=0.52,  respectively).  The  
percentage  of  resurgent  current  positive  neurons  was  33%  for  β4(F2A),  67%for  
F2A(β4)  and  53%  for  control.  However,  F2A(β4)  expression  increased  the  
resurgent  current  amplitude  by  three-­fold  relative  to  control  (Figure  27C  peak  
resurgent  current  p<0.05:  F2A(β4)  3.1  ±  0.8%,  n=9;;  Control  1.2  ±  0.4%,  n=15).  In  
contrast,  β4(F2A)  reduced  the  amplitude  of  the  resurgent  current  by  two-­fold  













Figure  27:  β4(F2A)  and  F2A(β4)  differentially  modulate  fast  resurgent  currents.  A,  
Representative  traces  of  Nav1.6r  resurgent  currents  obtained  from  cultured  DRG  neurons  with  
corresponding  peak  resurgent  currents  highlighted  for  control  (black),  β4(F2A)  (orange)  and  
F2A(β4)  (green)  groups.  B,  Neither  co-­expression  of  β4(F2A)  (n=12)  nor  co-­expression  of  
F2A(β4)  (n=9)  altered  the  distribution  of  resurgent  current  positive  (+INaR)/resurgent  current  
negative  (-­INaR)  DRG  neurons  relative  to  control  (n=16).  C,  Resurgent  current  amplitude  was  
decreased  with  co-­expression  of  β4(F2A)  (orange  squares,  n=12)  in  a  range  of  voltages  relative  
to  control  (black  circles,  n=15).  In  contrast,  co-­expression  of  F2A(β4)  (green  triangles,  n=9)  
chimera  increased  resurgent  current  amplitude  in  a  range  of  voltages  relative  to  control.  Note  that  
resurgent  currents  were  normalized  to  peak  transient  currents  and  plotted  as  a  function  of  
voltage.  Asterisks  (*)  represent  p  <0.05  obtained  from  Student’s  t-­test.  Summary  data  are  mean  ±  
SEM.  
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Inflammation  causes  differential  effects  on  FHFAs  and  FHF2B  isoforms  
  
The  results  of  overexpression  of  FHF2A  and  FHF2B,  FHFA  peptide  and  
chimeric  constructs  suggest  that  the  FHF2A  and  FHF2B  isoforms  regulate  
resurgent  currents  and  may  contribute  to  pain  pathologies.  Therefore,  we  chose  
to  examine  FHF2A  and  FHF2B  expression  in  a  radicular  pain  model  in  which  we  
previously  reported  increased  resurgent  currents  in  a  collaboration  study  with  Dr.  
J-­M.  Zhang  (242).  In  this  model,  localized  inflammation  of  the  DRG  (LID)  causes  
persistent  mechanical  hypersensitivity  that  starts  as  soon  as  post  operative  day  1  
(14,  120,  121,  242).  To  examine  FHF2A  and  FHF2B  expression,  Sprague  
Dawley  Rats  were  injected  with  zymosan  at  a  2mg/mL  concentration  near  L4  and  
L5  DRG  in  one  side  of  the  spine  (see  Methods).  Sham  operated  rats  that  
underwent  the  same  procedure  with  the  exception  of  the  injections  were  used  as  
a  control.  At  post  operative  day  5,  L4/L5  ipsilateral  DRG  were  harvested  from  LID  
and  Sham  operated  animals.  FHFA  and  FHF2B  levels  were  examined  in  primary  
DRG  cultures  with  immunocytochemistry.  One  caveat  with  the  FHFA  antibody  
used  is  that  it  is  not  selective  to  the  FHF2A  isoform,  because  it  targets  the  long-­
term  inactivation  particle  which  is  highly  conserved  between  all  FHFAs.  However,  
in  adult  DRG  neurons,  FHF4A  is  not  expressed  and  FHF1A  is  downregulated  in  
adulthood  (164).  FHF1A  contains  a  nuclear  localization  signal  that  is  functional  in  
DRG  neurons  and  targets  the  protein  to  the  nucleus  (164).  In  contrast,  the  
nuclear  localization  signal  for  FHF2A  is  predicted  to  be  inactive  since  staining  is  
limited  to  the  cell  periphery  and  not  detected  in  the  nucleus  in  adult  DRG  neurons  
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(163).  Therefore,  given  that  our  model  uses  adult  DRG  neurons  we  expect  that  
cross-­reaction  is  minimal  and  likely  most  of  the  antibody  signal  is  reflecting  
FHF2A  expression.  Representative  images  of  FHFA  staining  are  shown  in  Figure  
28A-­B.  Inflammation  of  the  DRG  reduced  FHFAs  levels  relative  to  Sham  control  
(Figure  28C,  FHF2A  Mean  Intensity  p<0.0001;;  LID  13.0  ±  0.3AU.,  n=1989,  Sham  
24.8  ±  0.8AU,  n=1116).  In  contrast,  FHF2B  expression  was  modulated  in  the  
opposite  direction  as  FHFAs.  Representative  images  of  FHF2B  staining  are  
shown  in  Figure  28D-­E.  FHF2B  was  upregulated  in  the  LID  group  relative  to  
Sham  control  (Figure  28F,  FHF2B  Mean  Intensity  p<0.0001;;  LID  29.5  ±  1.6AU,  
n=1121,  Sham  21.04  ±  0.4AU,  n=1164).  
     







Figure  28:  FHFA  and  FHF2B  levels  are  differentially  altered  after  local  inflammation  of  the  
DRG.  Examples  of  immunocytochemical  staining  against  FHFAs  in  primary  cultured  DRG  
neurons  from  control  (sham  operated,  A)  and  induced  local  inflammation  of  the  DRGs  (LID,  B)  
animals  at  post  operative  day  5.  C,  DRG  neurons  from  LID  animals  (n=1989)  exhibited  an  
increase  in  FHFA  signal  relative  to  sham  control  (n=1116).  Examples  of  immunocytochemical  
staining  against  FHF2B  in  primary  cultured  DRG  neurons  from  sham  (D)  and  LID  (E)  animals  at  
post  operative  day  5.  F,  DRG  neurons  from  LID  animals  (n=1164)  exhibited  a  decrease  in  FHF2B  
signal  relative  to  sham  control  (n=1121).  Five  animals  per  group  were  examined.  Asterisks  (*)  
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Discussion  
  
In  this  study  we  show  that  FHF2A  and  FHF2B  differentially  regulate  
resurgent  sodium  currents  in  DRG  sensory  neurons.  The  first  component  of  the  
third  aim  hypothesis  was  that  FHF2A  limits  the  capacity  of  sensory  neurons  to  
generate  fast  resurgent  currents  by  mediating  long-­term  inactivation.  Three  main  
findings  support  this  hypothesis.  First,  overexpression  of  FHF2A  reduced  the  
resurgent  current  and  increased  the  accumulation  of  channels  in  inactivated  
states  resulting  in  delayed  channel  recovery.  Secondly,  a  peptide  derived  from  
FHF2A`s  long-­term  inactivation  particle  recapitulated  the  reduction  in  resurgent  
current  generation  and  the  enhancement  of  long-­term  inactivation.  The  peptide  
did  not  modulate  the  voltage-­dependence  of  inactivation  and  activation  as  seen  
with  full  length  FHF2A  suggesting  these  changes  do  not  account  for  negative  
regulation  of  resurgent  current.  Thirdly,  the  F2A(β4)  chimera  (in  which  the  long-­
term  inactivation  particle  was  replaced  with  Navβ4’s  open  channel  blocker  
sequence)  did  not  negatively  regulate  resurgent  currents  nor  did  it  induce  long-­
term  inactivation.  The  chimera  produced  the  opposite  effect,  an  enhancement  in  
resurgent  current  modulation  suggesting  this  region  is  key  for  FHF2A`s  resurgent  
current  modulation.    
  
The  second  component  of  our  hypothesis  was  FHF2B  increases  resurgent  
currents  by  delaying  inactivation.  Our  results  support  this  hypothesis.  FHF2B  
increased  resurgent  currents,  shifted  the  voltage-­dependence  of  inactivation  to  
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positive  potentials  and  enhanced  recovery  from  inactivation.  FHF2B’s  inability  to  
mediate  long-­term  inactivation  while  still  shifting  inactivation  to  positive  potentials  
likely  increased  the  accessibility  of  the  putative  open  channel  blocker.  The  faster  
recovery  observed  with  overexpression  of  FHF2B  supports  this  possibility,  since  
recovery  when  the  channel  undergoes  open  channel  block  is  reported  to  occur  in  
a  shorter  time  scale  than  channel  recovery  from  fast  inactivation  (178).  An  
alternative  explanation  is  that  FHF2B  displaces  the  endogenous  negative  
regulation  exerted  by  FHF2A  because  all  FHFs  are  predicted  to  bind  to  a  
conserved  region  within  the  C-­terminus  of  VGSCs  (160).  FHF2A  is  expressed  in  
neurons  of  all  size  classes  and  is  particularly  predominant  in  small  diameter  
neurons  (163).  The  transfected  neurons  examined  in  these  studies  were  mostly  
in  the  small  diameter  range.  Therefore,  it  is  plausible  that  displacement  of  
endogenous  FHF2A  by  exogenous  FHF2B  contributes  to  some  extent  to  
FHF2B’s  positive  regulation  of  fast  resurgent  currents.  
  
Based  on  previous  reports,  the  potential  mechanism  for  FHF2A  negative  
regulation  is  competition  of  the  long-­term  inactivation  particle  with  the  Navβ4  
open  channel  blocker  activity  (176,  203).  The  results  from  FHF2A  and  Navβ4  
chimeras  partially  support  this  hypothesis,  however  the  implications  of  results  
obtained  with  these  chimeric  proteins  is  limited  by  a  few  caveats.  Our  assumption  
was  that  by  replacing  the  peptide  sequence  of  long-­term  inactivation  with  the  
open  channel  blocker  and  vice-­versa  the  activity  of  these  peptide  sequences  
would  be  retained  in  the  resulting  chimera.  However,  the  β4(F2A)  chimera  failed  
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to  delay  channel  recovery  and  produced  only  a  very  mild  enhancement  in  
accumulation  of  inactivated  states;;  suggesting  that  the  long-­term  inactivation  
particle  is  not  fully  functional  in  the  chimeric  construct.  Therefore,  the  reduction  in  
resurgent  current  observed  with  the  expression  of  the  β4(F2A)  chimera  is  likely  
due  to  a  dominant  negative  effect  of  an  inactive  Navβ4,  likely  competing  with  
wildtype  Navβ4  for  α  subunits.  In  a  similar  manner,  there  are  two  possible  
contributions  underlying  F2A(β4)’s  resurgent  current  enhancement:  1)  the  Navβ4  
open  channel  blocker  sequence  is  active  in  the  chimera  and/or  2)  loss  of  the  
long-­term  inactivation  particle  allowed  other  changes  in  the  voltage-­dependence  
to  favor  the  endogenous  open  channel  blocker  interaction  as  seen  with  FHF2B.  
To  further  explore  the  first  possibility,  we  tested  the  F2A(β4)  chimera  in  a  Nav1.5  
HEK  cell  line  that  does  not  generate  resurgent  current  unless  the  β4-­peptide  is  
introduced.  We  found  that  indeed  the  F2A(β4)  chimera  mediated  resurgent  
currents  (Figure  29)  in  a  Nav1.5  cell-­line.  This  result  favors  the  possibility  that  the  
F2A(β4)  chimera  retains  open  channel  blocker  activity.  However,  it  would  be  
simplistic  to  assume  that  the  resurgent  current  enhancement  is  only  due  to  this  
activity.  It  is  likely  a  combined  effect  of  removing  a  limiting  determinant  (i.e.  long-­
term  inactivation  particle),  adding  an  active  open  channel  blocker  sequence  and  
the  shift  in  voltage-­dependence  of  inactivation  contributing  to  the  overall  
enhancement  of  resurgent  current.  Overall,  results  from  β4(F2A)  and  F2A(β4)  
chimeras  confirmed  that  the  N-­terminus  of  FHF2A  and  the  C-­terminus  of  Navβ4  
are  important  modulators  of  fast  resurgent  currents.  
  











Figure  29:  F2A(β4)  but  not  FHF2B  induced  fast  resurgent  currents  mediated  by  Nav1.5  in  
HEK  cells.  HEK293  cells  stably  expressing  Nav1.5  were  transfected  with  tagged-­F2A(β4)  or  
tagged-­FHF2B.  Non-­transfected  cells  were  used  as  a  control.  Resurgent  currents  were  elicited  
with  a  standard  resurgent  current  voltage  protocol,  in  which  cell  membrane  was  initially  
depolarized  to  +30mV  for  20ms,  and  then  repolarized  to  voltages  ranging  from  +15mV  to  -­85  for  
100ms  in  5mV  increments.  A,  Representative  traces  of  Nav1.5  resurgent  currents  are  shown  for  
control  (black),  FHF2B  (purple)  and  F2A(β4)  (green).  Trace  obtained  at  -­40  mv  is  highlighted  for  
each  group.  B,  Resurgent  current  amplitude  was  normalized  to  peak  transient  current.  F2A(β4)  
(green  triangles)  generated  a  biphasic  current  voltage  curve  typically  observed  for  resurgent  
currents,  whereas,  control  (blue  circles)  or  FHF2B  (purple  diamonds)  did  not.  C,  Effects  of  FHF2B  
and  F2A(β4)  on  Nav1.5’s  voltage-­dependence  of  activation.  The  V1/2  values  are  -­47.5  ±  0.9mV  
(control),  -­47.6  ±  0.3mV  (FHF2B)  and  -­45.5  ±  0.4mV  (F2A(β4)),  respectively.  D,  Effects  of  FHF2B  
and  F2A(β4)  on  voltage-­dependence  of  inactivation.  The  V1/2  values  are  -­92.4  ±  1.2mV  (control),  -­
87.5  ±  0.5  mV  (FHF2B)  and  -­85.3  ±  1.0mV  (F2A(β4)),  respectively.  The  holding  potential  was  -­
120  mV.  Data  are  mean  ±  SEM  and  n=5  for  each  group.
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   FHFs  binding  to  the  C-­terminus  of  VGSC  can  cause  changes  in  the  
biophysical  properties  of  the  VGSC  (134).  Expression  of  FHF2A,  FHF2B  or  
F2A(β4)  shifted  the  voltage-­dependence  of  inactivation  to  positive  potentials.  
Since  the  F2A(β4)  chimera  lacks  the  long-­term  inactivation  particle  sequence  yet  
retained  the  ability  to  cause  shifts  in  voltage-­dependence  of  activation  and  
inactivation,  the  results  suggest  that  these  modulations  are  mainly  an  effect  of  
the  FHF2  core  region  binding  to  the  C-­terminus  of  Nav1.6.  The  shift  of  
inactivation  to  positive  potentials  is  consistent  with  previous  reports  of  FHF2  
binding  to  the  C-­terminus  of  different  sodium  channels  including  Nav1.6  (157,  
160,  162,  163).  FHF2A  and  F2A(β4)  also  shifted  activation  to  positive  potentials.  
Since  both  F2A(β4)  and  FHF2A  but  not  FHF2B  exerted  this  effect,  it  is  most  likely  
that  the  N-­terminus  region  that  is  conserved  between  F2A(β4)  and  FHF2A  is  
responsible  for  this  effect.    
  
Interestingly,  the  chimeras  generated  for  this  study  might  serve  as  
valuable  tools  for  the  study  of  resurgent  currents  in  the  future.  The  (β4)F2A  
chimera  did  not  significantly  alter  the  voltage-­dependence  of  activation  or  
inactivation,  recovery  from  inactivation,  or  current  density.  The  main  effect  we  
detected  was  a  significant  reduction  in  resurgent  current.  As  such,  
overexpression  of  this  protein  in  animal  models  or  in  vitro  studies  might  serve  as  
a  tool  to  selectively  target  resurgent  currents.  On  the  other  hand,  the  F2A(β4)  
chimera  might  serve  as  a  tool  to  artificially  induce  fast  resurgent  currents.  The  
applications  for  the  F2A(β4)  might  be  limited  since  it  alters  other  channel  
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properties.  However,  we  envision  that  the  F2A(β4)  chimera  might  be  useful  in  
high-­throughput  assays  to  identify  compounds  that  might  inhibit  resurgent  
currents.  
  
Overall  our  data  suggest  that  FHF2A  and  FHF2B  modulate  resurgent  
currents  in  DRG  neurons.  The  importance  of  this  finding  is  more  evident  when  
we  examine  how  these  proteins  are  regulated  in  a  radicular  pain  model  induced  
by  localized  inflammation  of  the  DRG.  Our  results  show  that  after  inflammation  
FHFA  isoforms  are  downregulated,  whereas  FHF2B  was  upregulated.  The  
change  in  expression  of  these  isoforms  likely  contributes  to  the  increased  
resurgent  current  generation  and  hyperexcitability  reported  in  this  model  (116,  
120,  242).  The  limitation  of  the  antibody  specificity  precludes  us  from  definitively  
attributing  the  effect  solely  to  changes  in  the  FHF2A  isoform.  However,  the  high  
conservation  of  the  long-­term  inactivation  particle  between  all  FHFAs  suggests  
that  if  other  FHFAs  were  to  interact  with  Nav1.6  they  will  likely  have  a  similar  
negative  regulation  on  resurgent  currents.  FHFs  modulation  might  also  contribute  
to  other  pain  pathologies.  For  example,  two  studies  using  cDNA  arrays  reported  
FHF2  cDNA  levels  downregulated  with  no  change  in  FHF1  and  FHF4  after  
peripheral  nerve  injury  (165,  166).  Using  the  Expression  Atlas  (255)  from  
European  Bioinformatics  Institute  and  European  Molecular  Biology  Laboratory  
we  found  that  FHF1  and  FHF2  levels  are  downregulated  in  DRG  neurons  after  
spinal  nerve  ligation,  a  chronic  pain  model  (256).  Which  of  the  FHF1  and  FHF2  
isoforms  contribute  most  to  these  changes  is  unknown.  Our  study  suggests  that  
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FHFs  might  prove  to  be  novel  targets  for  regulating  fast  resurgent  current  in  DRG  
neurons  and  further  studies  might  provide  new  insight  into  possible  therapeutic  




     
   147  
SUMMATION  AND  FUTURE  DIRECTIONS  
  
Increased  fast  resurgent  currents  in  peripheral  sensory  neurons  have  
been  implicated  in  several  pain  pathologies.  However,  our  knowledge  of  how  
these  currents  are  modulated  in  sensory  neurons  is  limited.  The  main  goal  of  this  
dissertation  was  to  identify  fast  resurgent  current  modulators  in  order  to  address  
the  gap  in  our  knowledge  and  potentially  devise  new  therapeutic  or  experimental  
strategies.  We  focused  on  Nav1.6  mediated  currents  because  this  isoform  is  the  
main  carrier  of  fast  resurgent  currents  (27).  Thus,  our  findings  may  be  particularly  
relevant  to  pain  pathologies  associated  with  Nav1.6  channel  activity  that  
contributes  to  DRG’s  hyperexcitability.    
  
Navβ4  and  resurgent  currents  
  
The  identity  of  the  open  channel  blocker  that  mediates  resurgent  currents  
in  DRG  neurons  was  unclear.  Results  from  the  first  aim  of  this  dissertation  
suggest  that  Navβ4  is  the  major  open  channel  blocker  in  DRG  neurons.  
Overexpression  of  Navβ4  greatly  increased  resurgent  currents,  whereas,  
knockdown  or  overexpression  of  a  mutant  form  of  Navβ4  decreased  resurgent  
current  generation.  The  Navβ4  C-­terminal  mutant  data  suggests  that  in  
congruence  with  CNS  studies,  the  C-­terminal  region  of  Navβ4  is  important  for  
resurgent  current  generation  (180,  197,  199).  In  contrast,  our  results  suggest  that  
Navβ2  does  not  modulate  fast  resurgent  currents.    
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Our  interpretation  of  the  results  is  limited  because  we  did  not  directly  
examine  if  Navβ2  or  Navβ4  associates  with  Nav1.6  in  the  DRG  neuronal  
background.  Future  studies  are  needed  to  determine  if  Navβ4  resurgent  current  
modulation  is  due  to  association  with  Nav1.6.  One  potential  approach  to  
determine  whether  there  is  an  association  between  these  subunits,  would  be  to  
use  identified  mutations  at  the  N-­terminus  of  Navβ4  that  disrupt  association  with  
α  subunits  (228,  230).  If  overexpression  of  an  N-­terminal  Navβ4  mutant  that  does  
not  associate  with  Nav1.6  modulates  resurgent  currents  this  might  suggest  that  
Navβ4’s  resurgent  current  modulation  is  independent  of  Nav1.6  association.  An  
alternative  approach  would  be  to  use  pharmacological  tools  to  determine  the  
potential  association  of  Navβ2  or  Navβ4  with  Nav1.6.  For  example,  recent  
studies  have  found  that  Nav1.2  inhibition  by  ProTxII  (a  toxin  isolated  from  the  
tarantula  (257))  is  disrupted  by  association  of  Navβ2  or  Navβ4  (230,  231).  It  is  
unknown  if  the  same  effects  are  observed  for  Nav1.6  but  would  be  an  important  
avenue  to  explore.  However,  these  studies  might  require  a  cell  background  that  
lacks  robust  expression  of  β-­subunits.  Biochemical  assays  such  as  co-­
immunoprecipitation  of  the  β-­subunit:α  subunit  complex  in  DRG  tissue  might  be  
necessary  to  strengthen  any  findings.    
  
Modulation  of  Nav1.6  by  Navβ4  may  also  be  due  to  direct  or  indirect  
interaction  of  Navβ4  protein  fragments.  β  subunits  are  known  substrates  of  
proteases  from  the  secretase  family  (Figure  30)  (244).  Sequential  proteolysis  can  
produce  a  variety  of  fragments.  N-­terminal  cleavage  generates  a  soluble  IgG  
   149  
extracellular  fragment  and  a  transmembrane  C-­terminal  fragment  (258).  The  C-­
terminal  transmembrane  fragment  is  further  processed  to  yield  a  transmembrane  
fragment  and  a  soluble  C-­terminal  fragment  (258,  259).    
  
  
Figure  30:  Schematic  representation  of  secretase  cleavage  sites  in  β-­subunits.  The  
extracellular  N-­terminus  region  close  to  the  transmembrane  domain  contains  a  cleavage  site  for  
β-­site  amyloid  precursor  protein-­cleaving  enzyme  1  (BACE1)(258,  260).  Navβ2  contains  an  
additional  α-­secretase  cleavage  site  at  the  N-­terminus  (259).  The  C-­terminus  juxtamembrane  
region  contains  a   γ-­secretase  cleaveage  site(259).    
  
A  study  by  Huth  el  al,  suggests  that  cleavage  of  Navβ4  by  β-­site  amyloid  
precursor  protein-­cleaving  enzyme  1  (BACE1)  modulates  the  decay  of  resurgent  
sodium  current  in  cerebellar  neurons(261).  Several  studies  concur  that  Navβ4  
association  with  alpha  subunits  is  dependent  on  the  N-­terminal  domain  of  the  
beta  subunit  (198,  228,  230,  262).  Thus,  shedding  of  Navβ4’s  extracellular  
domain  by  BACE1  cleavage  would  potentially  destabilize  the  association  with  an  
alpha  subunit  (261).  It  is  unclear  if  the  resulting  C-­terminal  transmembrane  
domain  can  interact  with  Nav1.6  or  if  further  processing  of  the  C-­terminal  
fragment  yields  a  soluble  peptide  with  open-­channel  blocker  activity.    
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Proteolytic  fragments  may  also  indirectly  modulate  sodium  channels  (244,  
263).  For  example,  the  soluble  C-­terminal  fragment  of  Navβ2  translocates  to  the  
nucleus  (263).  It  has  been  proposed  that  the  nuclear  fragment  exerts  
transcriptional  regulation  of  sodium  channels  by  functioning  as  transcription  
factors  (263).  It  is  possible  that  Navβ4  regulates  Nav1.6  expression  in  this  
manner  or  may  modulate  transcription  of  factors  that  modulate  channel  activity.  
Further  studies  are  needed  to  examine  the  potential  modulation  of  Nav1.6  or  
resurgent  currents  by  Navβ4  proteolytic  fragments  in  DRG  neurons.  Selective  
activators  and  inhibitors  of  different  secretase  enzymes  may  serve  as  tools  to  
address  this  question  (264).    
  
Navβ4  and  nociception  
  
In  the  second  part  of  this  dissertation  we  examined  the  effects  of  Navβ4  
knockdown  in  an  inflammatory  pain  model.  In  the  LID  model,  Nav1.6  has  been  
proposed  to  contribute  to  mechanical  hypersensitivity.  However,  it  is  unknown  if  
fast  resurgent  currents  are  altered  and  if  they  contribute  to  the  hyperexcitability  of  
DRG  neurons  and  mechanical  hypersensitivity.  Our  results  show  that  LID  
increases  fast  resurgent  currents  and  transient  currents  in  DRG  neurons.  
Knockdown  of  Navβ4  prevented  the  increase  in  fast  resurgent  current,  excitability  
and  mechanical  sensitivity.  Navβ4  knockdown  also  reduced  persistent  currents.  
Our  results  suggests  that  in  the  LID  model,  Navβ4’s  modulation  of  resurgent  and  
persistent  currents  contributes  to  hyperexcitability  .  Fast  resurgent  currents  are  
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proposed  to  increase  the  firing  frequency  of  DRG  neurons  (17,  19,  196,  249,  265,  
266).  Persistent  currents  depolarize  the  membrane,  decreasing  the  stimulus  
needed  to  trigger  an  action  potential  (73,  265,  267,  268).  Together  these  
changes,  could  enable  the  spontaneous  burst  firing  similar  to  the  pattern  
observed  in  LID  DRG  neurons  (238,  269).  Future  studies  are  needed  to  confirm  
the  contribution  of  resurgent  currents  and  persistent  currents  with  DRG  neuronal  
simulations  since  selective  inhibition  through  pharmacological  methods  is  not  
currently  feasible.    
  
One  of  the  limitation  of  our  study,  is  that  the  we  performed  patch  clamp  
studies  in  cultured  DRG  neurons  which  lacked  axonal  projections  and  nerve  
endings.  While  we  did  detect  Navβ4  upregulation  in  the  soma  and  the  axonal  
regions  near  the  DRG,  we  did  not  examine  if  resurgent  and  persistent  currents  
are  also  enhanced  at  the  axon  or  nerve  endings.  Furthermore,  we  did  not  
examine  where  spontaneous  activity  is  initiated  (i.e.  at  the  soma  or  in  other  
neuronal  compartments).  If  spontaneous  activity  were  to  be  generated  at  the  
neuronal  soma,  the  action  potentials  generated  may  then  be  relayed  to  the  
periphery,  spinal  cord,  or  both.  Transmission  of  action  potentials  toward  the  
periphery  may  stimulate  release  of  neurotransmitters  and  other  chemical  
substances  that  in  turn  sensitize  the  nociceptive  fibers  to  activation  (270).  On  the  
other  hand,  constant  release  of  neurotransmitters  and  other  chemical  mediators  
at  the  spinal  cord  may  facilitate  the  activation  of  second  order  nociceptive  
neurons  at  the  spinal  cord  (271,  272).  In  this  manner,  maladaptive  changes  at  
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the  periphery  or  at  the  spinal  cord  may  facilitate  a  nociceptive  like-­response  to  a  
normally  innocuous  stimulus.  Future  studies  could  examine  the  potential  changes  
at  the  peripheral  nerve  endings  or  at  the  spinal  cord  in  the  LID  model  employing  
electrophysiological  and  immunohistochemical  methods  to  elucidate  these  
possibilities.    
  
Although  the  location  of  spontaneous  activity  merits  further  examination,  
several  studies  have  shown  that  spontaneous  activity  is  key  for  the  development  
of  persistent  pain  (273-­276).  In  particular,  early  blockade  of  afferent  spontaneous  
activity  (within  10  days  of  injury)  in  some  models  is  sufficient  to  prevent  the  
development  of  chronic  mechanical  and  thermal  hypersensitivity  (119).  Based  on  
our  results,  agents  that  block  both  resurgent  and  persistent  currents  may  be  
effective  in  reducing  spontaneous  activity.  Our  experimental  LID  paradigm  in  
which  β4-­siRNA  was  injected  at  the  time  of  inflammation,  suggest  that  early  
blockade  might  be  sufficient  to  prevent  persistent  mechanical  hypersensitivity  in  
this  model.  Future  studies  are  needed  to  explore  the  therapeutic  potential  of  
agents  that  selectively  target  persistent  and  resurgent  currents  over  the  transient  
current  that  underlies  the  action  potential  upstroke.  For  example,  a  published  
collaboration  study  with  R.  Patel  (277)  suggests  that  cannabidiol,  an  active  agent  
found  in  the  cannabis  plant,  selectively  targets  persistent  and  resurgent  currents.  
It  would  be  important  to  determine  if  cannabidiol  reduces  spontaneous  activity  in  
the  LID  model  and  if  it  has  a  therapeutic  effect.  Alternatively,  future  studies  might  
explore  selective  targeting  of  the  Navβ4  C-­terminal  region.  The  available  Navβ4  
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crystal  structure  might  help  identify  compounds  that  target  the  Nav1.6  and  Navβ4  
interaction  (230).    
  
Aβ  fibers  and  the  LID  model  
  
In  the  LID  pain  model,  hyperexcitability  is  mainly  observed  in  Aβ  fibers.  To  
devise  the  best  therapeutic  strategy,  it  is  important  that  we  understand  how  Aβ  
fibers  contribute  to  the  pathology.  The  role  of  Aβ  fibers  in  nociception  has  been  
controversial  because  these  fibers  were  initially  thought  to  be  mainly  activated  by  
non-­noxious  mechanic  stimulation  (82).  Thus,  Aβ  fibers  have  been  classified  as  
low-­threshold  mechanoreceptors.  However,  there  is  intriguing  evidence  that  
suggests  a  population  of  Aβ  fibers  is  activated  by  noxious  mechanic  or  heat  
stimuli  (82,  278-­285).  Therefore,  a  fraction  of  Aβ  fibers  have  been  identified  as  
putative  nociceptors  or  high-­threshold  fibers.  
  
   There  are  two  main  ascending  pathways  by  which  Aβ  fibers  could  
modulate  nociceptive  impulses  from  reaching  the  CNS  and  alter  pain  perception.  
The  pathways  are  known  as  the  lemniscal  pathway  and  the  spinothalamic  
pathway  (286,  287).  One  way  to  distinguish  between  these  two  pathways  is  by  
identifying  the  second  order  neurons  to  which  the  DRG’s  CNS  branch  mainly  
projects.  The  lemniscal  pathway  second  order  neurons  are  located  in  the  
medulla.  In  contrast,  spinothalamic  second  order  neurons  are  located  in  spinal  
cord.  Second  order  neurons  then  project  to  third  order  neurons  in  the  thalamus.  
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Under  non-­pathological  conditions,  nociceptive  impulses  are  relayed  through  the  
spinothalamic  pathway  (226,  287).  In  contrast,  non-­nociceptive  (low  threshold)  
DRG  neurons  are  proposed  to  mainly  relay  impulses  through  the  lemniscal  
pathway  (286).  Aβ  fibers  form  part  of  the  lemniscal  pathway.  It  is  important  to  
note  that  this  is  a  simplified  scheme  of  the  circuitry.  In  reality  there  are  many  
collateral  projections  at  each  relay  point.  For  example,  Aβ  fibers  that  send  
projections  to  the  medulla  also  send  collateral  projections  to  the  spinal  cord  (226,  
286).  Importantly,  the  collateral  projections  of  low-­threshold  and  high-­threshold  
Aβ  fibers  may  modulate  the  activation  of  the  spinothalamic  pathway  at  the  spinal  
cord.    
  
In  the  spinal  cord  there  is  a  variety  of  neurons  that  can  be  divided  by  the  
lamina  (anatomical  surface  division)  they  occupy  (288).  Classic  DRG  nociceptors  
(i.e.  C-­fibers  and  Aδ-­fibers)  mainly  project  to  lamina  I-­II  nociceptive  specific  
projection  neurons  (289,  290).  Some  DRG  nociceptors  may  also  project  to  wide-­
dynamic  range  (WDR)  neurons,  which  are  predominantly  located  in  lamina  V  
(226,  291,  292).  WDR  neurons  can  respond  to  a  variety  of  stimuli  intensities  (low-­
threshold  and  high-­threshold)  (292).  Nociceptive  impulses  from  DRG  neurons  
can  be  relayed  by  WDR  or  projection  neurons  through  the  spinothalamic  pathway  
(226,  292).  Lemniscal  collaterals  projections  at  the  spinal  cord  can  display  
different  projection  patterns.  Putative  Aβ  nociceptors  collaterals  project  to  lamina  
I  through  V  in  a  “flame-­shaped”  aspect  (279-­281).  Thus,  it  has  been  proposed  
that  these  putative  Aβ  nociceptor  projections  may  directly  activate  second  order  
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nociceptive  neurons  at  the  spinal  cord  in  lamina  I-­II  or  V,  relaying  impulses  
through  the  spinothalamic  tract.  However,  it  is  not  clear  which  neurons  Aβ  
nociceptors  communicate  with  at  the  spinal  cord  and  if  the  net  effect  is  inhibitory  
or  excitatory.  In  contrast,  low  threshold  Aβ  mechanoreceptors  collaterals  mainly  
project  to  lamina  III-­V  (and  lamina  II  to  a  lesser  extent)  stimulating  interneurons  
that  activate  and  inhibit  nociceptive  neurons  (291).  The  net  effect  of  low  threshold  
Aβ  collaterals  reduce  the  probability  of  nociceptive  impulses  from  being  relayed  
to  the  thalamus  by  activating  inhibitory  interneurons  (293).  It  is  proposed  that  
activation  of  low  threshold  mechanoreceptors  reduces  the  perception  of  pain  by  
generating  a  segmental  control  or  gate  at  the  spinal  cord  level.  Melznack  and  
Wall  introduced  this  concept  in  the  gates  control  theory  of  pain  (294,  295).  They  
proposed  that  at  each  relay  point,  “gates”  modulate  the  successful  transmission  
of  the  nociceptive  impulses  to  the  next  relay  point.  For  example,  descending  
pathways  from  the  brain  to  the  spinal  cord  can  activate  inhibitory  interneurons  at  
the  spinal  cord  (293,  296-­298).  
  
Further  studies  are  needed  to  explore  which  population  of  Aβ  fibers  might  
contribute  to  LID  pain.  If  hyperexcitability  of  low  threshold  Aβ  fibers  are  
responsible  for  mechanical  hypersensitivity  then  the  normal  circuitry  may  have  
been  altered.  One  possibility  is  that  inhibition  control  at  the  spinal  cord  is  
somehow  compromised.  Several  studies  have  found  a  reduction  in  inhibitory  
signaling  at  the  spinal  cord  in  some  pain  conditions,  although  the  mechanism  is  
not  clear  (299-­302).  Other  studies  have  suggested  that  a  substantial  portion  of  
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non-­nociceptive  A-­fibers  sprout  connections  to  laminas  associated  with  
nociceptive  signaling,  i.e.  LaminaI/II  (303-­305).  However,  concerns  regarding  the  
selectivity  of  the  neuronal  tracers  have  questioned  the  interpretation  of  the  
results  (306,  307).  A  more  robust  study,  using  neuronal  tracers  and  selective  
markers,  found  a  small  portion  of  A-­fibers  sprout  contacts  into  lamina  II  (308).  It  
is  possible  that  these  abnormal  contacts  activate  nociceptive  specific  neurons  
within  lamina  II  overriding  the  inhibitory  input.  Interestingly,  several  studies  have  
suggested  that  Navβ4  and  Navβ4  proteolytic  fragments  promote  neurite  
outgrowth  (146,  147,  196).  Future  studies  are  needed  to  explore  if  upregulation  
of  Navβ4  promotes  sprouting  of  Aβ  fibers.  On  the  other  hand,  if  hyperexcitability  
of  nociceptive  Aβ  fibers  contributes  to  mechanical  hypersensitivity,  this  
hyperexcitability  may  produce  changes  at  the  peripheral  nerve  endings  or  second  
order  neurons  at  the  spinal  cord  facilitating  activation  of  the  spinothalamic  
pathway  as  previously  discussed.  Further  studies  are  required  to  elucidate  how  
the  Aβ  fiber  circuitry  contributes  to  nociception  under  normal  and  LID  conditions.  
  
FHF2  and  resurgent  currents  
  
Resurgent  currents  are  observed  in  a  subpopulation  of  DRG  neurons  (27),  
raising  the  possibility  of  endogenous  negative  regulators  which  restricts  
resurgent  current  generation  (27).  Our  results  suggest  that  FHF2A  negatively  
regulates  resurgent  currents.  We  identified  the  long-­term  inactivation  sequence  
(or  particle)  in  the  N-­terminus  of  the  FHF2A  protein  as  being  important  for  
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FHF2A’s  negative  regulation.  The  chimeric  construct  that  lacked  the  long-­term  
inactivation  particle  failed  to  negatively  regulate  resurgent  currents.  Furthermore,  
a  peptide  derived  from  FHF2A’s  long-­term  inactivation  particle  recapitulated  
negative  regulation  of  resurgent  currents.  Based  on  our  results  it  is  possible  that  
in  neurons  where  FHF2A  is  abundant,  resurgent  currents  may  be  repressed.  In  
contrast,  FHF2B,  which  lacks  the  long-­term  inactivation  particle,  greatly  
increased  resurgent  currents.  This  effect  is  likely  mediated  by  FHF2B  modulation  
of  fast  inactivation  to  positive  potentials,  which  may  increase  the  probability  of  the  
open  channel  blocker  to  bind  to  the  sodium  channel.  The  core  regions  of  FHF2A  
and  FHF2B  bind  at  the  same  site  in  the  C-­terminus  of  the  alpha  subunit.  
Therefore,  it  is  possible  that  the  ratio  of  FHF2A  and  FHF2B  levels  may  regulate  
the  degree  of  fast  resurgent  current  generation  in  a  given  DRG  neuron.  
  
However,  the  interpretation  of  our  results  is  limited  since  we  mainly  used  
an  overexpression  approach  of  FHF2  isoforms  and  chimeric  constructs.  
Overexpression  of  a  given  subunit  may  induce  an  interaction  that  may  not  
endogenously  occur  otherwise.  Therefore,  different  experimental  approaches  are  
required  to  provide  a  more  complete  picture.  One  potential  approach  would  be  to  
couple  single  cell  analysis  with  electrophysiological  recordings.  Using  this  
approach,  we  could  determine  if  a  given  DRG  neuron  generates  resurgent  
currents  and  what  are  the  corresponding  levels  of  FHF2A,  FHF2B,  Navβ4.  If  our  
model  is  correct,  FHF2A  levels  would  be  negatively  correlated  with  resurgent  
current  amplitude.  In  contrast,  we  predict  that  FHF2B  and  Navβ4  levels  would  be  
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positively  correlated  with  resurgent  current  amplitude.  Alternatively,  in-­vivo  
knockdown  of  FHF2A  or  FHF2B  would  allow  us  to  examine  the  effects  on  
endogenous  fast  resurgent  current.    
  
In  the  LID  pain  model,  we  found  that  FHFA  isoforms  are  upregulated,  
whereas,  FHF2B  is  downregulated.  Based  on  our  overexpression  results  of  the  
individual  proteins,  downregulation  of  FHF2A  and  upregulation  of  FHF2B  may  
contribute  to  the  enhanced  resurgent  currents  we  detected  in  the  LID  model  (see  
part  2  results).  Further  studies  are  needed  to  examine  which  FHFA  isoforms  are  
downregulated.  One  approach  would  be  to  use  Reverse  transcription  polymerase  
chain  reaction  (RT-­PCR)  or  in-­situ  hybridization  with  specific  primer  probes  to  
examine  mRNA  levels.  While  mRNA  levels  do  not  always  correlate  to  protein  
expression,  this  approach  would  allow  us  to  distinguish  between  FHFA  isoforms  
and  overcome  the  limitation  of  lack  of  specificity  of  current  available  antibodies.  
  
Future  studies  might  also  explore  the  individual  contribution  of  FHF2A  and  
FHF2B  subunits  to  nociception.  For  example,  it  will  be  interesting  to  determine  if  
FHF2A  knockdown  or  overexpression  of  FHF2B  is  sufficient  to  induce  pain  
associated  behaviors.  While  we  have  identified  these  two  potential  players,  other  
FHFs  might  also  modulate  Nav1.6  or  other  α  subunits.  In  addition  to  FHF2,  FHF1  
and  FHF4  are  expressed  in  adult  DRGs.  FHF3  mRNA  is  detected  in  embryonic  
DRG  but  expression  has  not  been  studied  in  adult  DRG  neurons  (309).There  is  
always  a  possibility  that  expression  of  these  isoforms  is  modulated  in  specific  
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pathophysiologies.  Additionally,  there  is  some  evidence  that  suggests  FHFs  
interact  with  other  partners  such  as  kinases  (150-­152)  and  calcium  channels  
(310)  in  CNS  and  cardiomyocytes.  Therefore,  it  is  possible  that  FHF  modulation  
in  DRG  neurons  alters  other  targets  and  may  also  contribute  to  pain  pathologies.  
Further  studies  are  necessary  to  determine  such  possibilities  and  provide  more  
insights  into  FHFs  potential  role  in  peripheral  sensory  neurons.    
  
FHF2A  and  FHF2B  as  potential  therapeutic  targets    
  
   Based  on  our  findings  FHF2A  and  FHF2B  may  be  useful  targets  for  
therapeutic  interventions  in  the  LID  model.  One  potential  strategy  for  a  
therapeutic  intervention  would  be  to  disrupt  FHF2B  interaction  with  Nav1.6.  We  
hypothesize  that  FHF2B  disruption  with  Nav1.6  attenuates  the  increase  in  
resurgent  currents  and  might  decrease  hyperexcitability  observed  in  the  LID  
model.  However,  selective  disruption  of  FHF2B  interaction  with  the  C-­terminus  of  
Nav1.6  may  prove  to  be  difficult  since  the  core  binding  region  for  Nav1.6  is  
conserved  between  FHF2A  and  FHF2B.  Inadvertent  disruption  of  the  FHF2A  
interaction  with  Nav1.6  might  end  up  exacerbating  hyperexcitability  by  further  
reducing  long-­term  inactivation.    
  
An  alternative  strategy  for  a  therapeutic  intervention  would  be  to  increase  
FHF2A’s  long-­term  inactivation  activity.  We  hypothesize  that  increasing  long-­term  
inactivation  activity  would  reduce  resurgent  current  generation  and  
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hyperexcitability.  Future  studies  might  explore  in-­vivo  overexpression  of  FHF2A  
in  the  LID  model.  An  alternative  approach  would  be  to  inject  the  long-­term  
inactivation  particle  (175)  in  the  form  of  a  cell-­penetrating  peptide.  Our  
preliminary  in-­vitro  results  with  this  approach  are  promising  (Figure  31).  The  
FHFA  peptide  sequence  corresponding  to  FHF2A’s  long-­term  inactivation  particle  
(175)  was  coupled  with  a  transactivator  of  transcription  (tat)  motif  to  yield  
tatFHFA,  a  predicted  cell  membrane  penetrating  peptide  (311).  The  tatFHFA  
peptide  effectively  reduced  spontaneous  activity  in  DRG  neurons  cultured  from  
LID  animals  at  POD5  (Figure  31A-­B).  In  contrast,  no  spontaneous  activity  was  
observed  in  DRG  neurons  cultured  from  sham  animals.  Interestingly,  the  
tatFHFA  peptide  also  reduced  spontaneous  activity  from  DRG  neurons  
transfected  with  Navβ4  (Figure  31C-­D).  Further  studies  are  needed  to  confirm  
these  results  with  additional  controls  such  as  a  tat  only  peptide.  Additional  
studies  may  also  explore  if  tatFHFA  is  selective  to  Nav1.6.  We  speculate  that  it  
might  not  be.  Therefore,  one  concern  is  that  tatFHFA  might  have  side  effects  that  
limit  its  therapeutic  potential  by  targeting  VGSCs  in  other  parts  of  the  body  such  
as  the  CNS,  heart  or  muscle  tissues.  For  example,  resurgent  currents  play  a  
prominent  role  in  the  activity  of  cerebellar  Purkinje  neurons  (17,  18,  167,  210).  
Reduction  of  cerebellar  resurgent  currents  mediated  by  tatFHFA  might  impact  
motor  coordination.  Thus  preliminary  studies  might  explore  the  best  dose  and  
delivery  method  to  minimize  these  side  effects.  Once  optimized  and  proper  
controls  are  established,  it  will  be  interesting  to  see  if  the  tatFHFA  peptide  can  
reduced  hypersensitivity  in  the  LID  model  or  other  pain  models  (16,  26).  
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Figure  31:  Preliminary  results  of  tatFHFA  peptide.  A,  Representative  trace  of  spontaneous  
activity  recorded  from  cultured  DRG  neurons  from  a  post  operative  day  5  animal  that  underwent  
LID  surgery.  No  spontaneous  activity  was  observed  in  sham  control.  B,  Spontaneous  activity  is  
abolished  after  a  20min  incubation  with  tatFHFA  peptide  at  a  1mM  concentration.  C,  
Representative  trace  of  spontaneous  activity  recorded  from  DRG  neurons  transfected  with  
Navβ4.  D,  After  20  min  incubation  with  tatFHFA  Navβ4  mediated  spontaneous  activity  is  
abolished.  Representative  traces  correspond  to  one  electrode  (n=1)  from  a  multielectrode  array  






Overall,  this  dissertation  addressed  key  questions  regarding  the  
modulation  of  resurgent  currents  in  DRG  neurons.  The  results  of  this  dissertation  
have  provided  key  insights  into  how  resurgent  currents  are  modulated  in  normal  
and  pathophysiological  conditions  such  as  inflammation.  Our  results  can  be  
integrated  into  a  new  working  model  for  resurgent  current  modulation  in  DRG  
neurons  (Figure  32),  in  which  Navβ4  mediates  resurgent  currents,  FHF2B  
enhances  resurgent  currents  and  FHF2A  limits  resurgent  current  generation.  We  
propose  these  auxiliary  subunits  modulate  resurgent  currents  and  the  biophysical  
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properties  of  Nav1.6  resulting  in  changes  in  neuronal  excitability.  In  this  manner,  
we  propose  that  neuronal  excitability  can  be  modulated  by  enhancing  or  reducing  
resurgent  currents.  Regulatory  auxiliary  subunits  may  serve  as  alternative  
therapeutic  targets  to  pore-­forming  Nav1.6.  As  such,  our  findings  may  prove  to  
be  useful  for  other  conditions  in  which  hyperexcitability  contributes  to  the  
disorder.  In,  particularly,  these  results  may  be  relevant  to  pathologies  associated  





Figure  32:  Proposed  working  model  for  Nav1.6  resurgent  current  modulation.  Navβ4  (red  
cylinder)  associates  with  Nav1.6  (grey  tetramer).  Part  of  C-­terminal  region  of  Navβ4,  also  known  
as  the  β4  peptide  (red  sphere),  interacts  with  Nav1.6  to  mediate  resurgent  currents.  FHF2A  (blue  
octagon)  or  FHF2B  (green  octagon)  can  bind  to  the  C-­terminal  region  of  Nav1.6  and  modulate  
biophysical  properties  of  the  channel.  FHF2B  binding  delays  fast  inactivation  (yellow  sphere)  
increasing  the  probability  of  the  β4  peptide  interaction.  FHF2A  binding  to  the  C-­terminus  of  
Nav1.6  also  delays  fast  inactivation  but  introduces  a  new  competitor  which  is  the  long-­term  
inactivation  particle  (blue  sphere)  contained  within  FHF2A’s  N-­terminal  domain.  If  the  long-­term  
inactivation  particle  outcompetes  the  β4-­peptide  interaction  it  results  in  a  decrease  of  resurgent  
current  generation  by  Nav1.6.     
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